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 ABSTRACT 
Pluripotent stem cells (PSCs) are the most favourable sources of cells for tissue 
engineering applications due to their unique potency and self-renewal characteristics 
however they are quite fragile and can be directed to differentiate erroneously by the 
application of external forces.  A novel multi-nozzle valve-based bioprinting platform 
was developed that was able to position droplets of bio-ink – such as cells in suspension 
– with high spatial accuracy and low impact.  Volumes as low as 2 nL were successfully 
dispensed.  Several different versions of the machine were created before the final 
machine was made integrating improvements and solutions to problems encountered 
during development.  A complete evaluation of cell compatibility was carried out in 
order to quantify the response of cells to the bioprinting process.  In the first ever study 
of this kind, the viability and pluripotency of human embryonic and induced pluripotent 
stem cells was investigated post-printing and were found to be almost completely 
unaffected by the bioprinting process.  Many cells require a 3D culture environment in 
order to maintain their in vivo functions.  A hybrid bioprinted-hanging-droplet 
technique was used to create uniform spheroid aggregates of programmable sizes from 
PSCs which could be used to direct PSC differentiation or as building blocks for tissue 
generation.  Hydrogels can also be used to recreate the 3D in vivo cellular environment 
using the bioprinter.  Alginate and hybrid polypeptide-DNA hydrogels were used, the 
latter for the first time with a bioprinting platform.  Complex 3D structures could be 
created in a layer-by-layer approach with programmable heterogeneous properties 
throughout.  Cells were added to the hydrogel precursor solution and used to bioprint 
3D structures.  The cells were found to be functional and highly viable while being 
encapsulated throughout the 3D structure of the bioprinted hydrogel which will allow 
the future creation of more accurate human tissue models.  PSCs were successfully 
directed to differentiate into hepatocyte-like cells.  It was shown that the bioprinting 
process did not interrupt or alter the pre-programmed differentiation of the cells which 
means that these cells can be patterned in 3D using the bioprinter while differentiating, 
greatly speeding up the creation of mini-liver tissue.  Hepatic stellates and HUVECs 
were co-cultured with the hepatocyte-like cells in various ratios in an attempt to 
improve their hepatic function.  However, no clear improvement in cytochrome P450 
activity was observed indicating that further optimisation is required in this area. 
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Chapter 1 – Introduction 
1.1 Background 
“Every contrivance of man, every tool, every instrument, every utensil, every 
article designed for use, of each and every kind, evolved from a very simple 
beginning.” 
Robert Collier  
Biological cell printing is a relatively new technology in the fields of Bioengineering 
and Regenerative Medicine.  It can be defined as the use of computer-aided transfer 
processes for the quick and reliable patterning and assembling living and non-living 
materials with a prescribed two- or three-dimensional organisation in order to produce 
bio-engineered structures for various applications including regenerative medicine, 
pharmacokinetic and cell biology studies [1]. 
1.1.1 Timeline 
Printing technology has come a long way from its origins, when information was 
recorded on clay tablets in Mesopotamia [2].  By the 15
th
 century, printing had become 
prevalent in Europe due to the widespread availability of paper which spurred advances 
from simple woodblock printing to the much quicker and more durable moveable type 
printing press [3].  Up until this point printing technology had been purely mechanical 
in nature, but in the 18
th
 century a new process – lithography – was invented [4].  
Lithography utilises hydrophobic chemicals to repel the ink solution from the negative 
areas of the image, creating the first method for printing with a completely smooth 
surface [5]. 
Developments in the late 20
th
 century in modern, computer-based printing techniques 
developed the photocopier and laser and inkjet printers.  The photocopier was invented 
by an American office worker named Chester Carlson; it operates on the principle of 
static electricity, attracting toner to the drum before transferring it to the paper [6].  
Laser printers were a direct descendent of photocopier Xerography technology, but 
rather than using natural light to determine the patterns of toner on the photosensitive 
drum, a scanning laser beam is used to neutralise the charge on the drum [7].  Inkjet 
printing technology is divided into Continuous Inkjet and Drop-on-Demand, the latter 
being further divided into thermal and piezoelectric types.  The basic premise of the 
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inkjet techniques is to apply an electrical signal to a heating pad or piezoelectric 
material, triggering the production of a single drop of ink (in the case of Drop-on-
Demand) or a stream of droplets (in Continuous Inkjet) [8]. 
Printing technology has advanced; it is no longer limited to the mass production of the 
written word.  Just before the turn of the millennium, a paper was published which laid 
the foundations of a completely new field using the techniques of printing to pattern 
biological materials [9].  The authors of this paper used a modified Optical Tweezers 
technique to gently nudge cells in the required direction, but even at this early point it 
was clear that the authors grasped the power of this novel technology: “the ability to 
organize cells spatially into well-defined 3D arrays that closely mimic the native tissue 
architecture can potentially help in the fabrication of engineered tissue” [9,10]. 
Only a few years later this exciting new field had emerged, now widely referred to as 
Biofabrication, with experiments being conducted worldwide [10–12].  Until very 
recently the majority of the research being undertaken was focused on “proof-of-
principle” of several different printing techniques, including those based on laser pulses, 
inkjets and other, more novel, approaches.  So much has already been achieved, but how 
could this field be developed further? 
1.1.2 Motivation 
Due to the different ways that biological cell printing technology can be set up, it can be 
applied to many diverse applications. 
Prescription drugs are extremely widespread in society today, but the amount of time 
and money that is expended on the development of new drugs is not well known.  New 
drug development can take from 10 to 20 years, with an estimated average of about 9 to 
12 years [13,14].  In addition, only around 16% of the drugs that begin preclinical 
testing are approved for human use [15].  This low success rate can be partly attributed 
to the different responses that animals and humans have to the drugs being tested; some 
drugs may be dropped that would have worked on humans because they didn’t have the 
desired effect on animals.  A possible solution to this might be the creation of micro-
tissue-laden chips called “organ-on-a-chip” [16], which produce the same physiological 
reaction that the entire organ would, but on a much smaller scale.  This would result in a 
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shorter period of clinical testing, more effective drugs and an end to animal testing and 
vivisection. 
The disparity between the number of patients on waiting lists for organ transplants and 
the number of transplants that are performed each year has continued to grow over the 
last decade; in the US in 2009 there were 105,567 waiting list candidates but only 
28,459 transplant procedures took place [17].  A possible solution to this might be the 
creation of whole organs using a biological cell printer.  
However, construction of thick tissues via cell printing such as the heart, kidney, lung 
and liver is not currently possible due to the inability to include the intricate vascular 
system required to ensure that every cell in the tissue are no further than ~1 mm away 
from a source of nutrients and oxygen within the engineered tissue mass [18,19].  
Therefore, tissues created using cell printing have been limited to thin tissues such as 
skin.  For instance, the current research focus of the Wake Forest Institute for 
regenerative medicine is printing skin over open wounds with simple inkjet valves 
attached to an XYZ plotter [20,21].   
1.2 Aims and Objectives 
The overall aim of this thesis is to develop a novel mechanical device that can quickly 
and reliably position viable biological cells and other liquid materials into pre-
determined three-dimensional patterns – a cell printer.  Cells must be viable and 
morphologically identical post-printing.  Manual cell patterning methods are inefficient, 
costly, critically dependent on skilled operators and developed by trial and error with 
little process optimisation.  Cell printing techniques automates this task, greatly 
improving the reliability of the results through increasing the repeatability of 
experiments and greatly sped up experiments.  These techniques also open the door for 
the bottom-up generation of 3D tissues. 
Aside from the development of the cell printer platform, this work has the following 
research objectives: 
 To validate that the printer can dispense repeatable and programmable numbers 
of cells into pre-determined patterns. 
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 To investigate the response of cells, including fragile cells such as stem cells, to 
the printing process, including an analysis of the effect of altering the parameters 
of the printer. 
 To further develop the printing platform to allow portability and for multiple cell 
types and biomaterials to be printed together. 
 To design and carry out experimental work to explore possible applications for 
this technology. 
1.3 Structure of the Thesis 
Each chapter of this thesis will describe a different part of the research: 
 Chapter 1 presents the background of this thesis and details the aims and 
objectives of the research. 
 Chapter 2 summarises the fundamentals of biological cell printing technologies, 
including detailed descriptions of each technique, as well as cellular response, 
comparisons and conclusions.  A background in human stem cell biology is 
provided, in particular the generation of liver cells from human stem cells.  
Three-dimensional culturing techniques are also reviewed, including spheroid 
aggregates and the use of hydrogels. 
 Chapter 3 describes the methodology and experimental details for the projects in 
the following chapters.  This will include aspects of design, calibration, and initial 
testing phases. 
 Chapter 4 presents the experimental work on the creation and development of 
the biological cell printing platform.  This includes aspects of the design, 
construction and software development. 
 Chapter 5 evaluates the response of cells, including fragile human stem cells, to 
the bioprinting process.  The function and viability of human embryonic stem 
cells and human induced pluripotent stem cells were examined to ensure they 
were unaffected by the bioprinting process. 
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 Chapter 6 describes the first example of the generation of spheroid aggregates 
from human embryonic stem cells together with an analysis of the dimensions of 
the aggregates compared to the initial number of seeded cells. 
 Chapter 7 covers the experiments with the aim of creating 3D liver micro-
tissues.  This includes the bioprinting of alginate hydrogels, an analysis of the 
effect of different concentration ratios and the creation of complex 3D 
structures.  Also presented in this chapter are descriptions of the protocol for 
directing the differentiation of human pluripotent stem cells into hepatocytes and 
the analysis of these cells functionality and an investigation into the effect of 
supporting cells on these generated hepatocyte-like cells. 
 Chapter 8 contains the three-dimensional bioprinting of smart DNA related 
hydrogels.  This will include analysis of results after experiments in cell 
viability, hydrogel component biocompatibility and bioprinting and analysis of 
complex 3D structures. 
 Chapter 9 concludes this thesis and provides recommendations for future work 
in this area. 
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Chapter 2 – Literature Review 
2.1 Introduction 
This multi-disciplinary thesis draws from several different topics, and research areas, 
from biological cell printing to biocompatible hydrogels to stem cell biology.  These 
topics are reviewed in this chapter.  Section 2.2 describes a number of different 
approaches for printing viable biological cells into programmed patterns, including 
traditional and modern techniques.  The methods of each technique are described and 
their advantages and limitations listed.  Section 2.3 provides a background to human 
stem cell biology, and in particular the methods used to direct the differentiation of 
human stem cells to specific lineages.  Section 2.4 presents some of the different 
hydrogels used for three-dimensional cell encapsulation.  Finally, Section 2.5 relates 
specific conclusions and insights drawn from the literature review. 
2.2 Biological Cell Printing 
2.2.1 Optical Tweezers 
Optical Tweezers, a well-known technique for the manipulation of nanometre and 
micrometre-sized particles suspended in a solution, was pioneered in 1970 by Arthur 
Ashkin at Bell labs [1].  Optical tweezers are now well-established tools in the physical 
and life sciences. Forces up to 200 pN can be applied to particles with extremely small 
dimensions; even particles as small as 5 nm, such as cells, can be manipulated [2,3].  
Cell throughput rates can be extremely high and have been measured in the region of 
~1106 cells/s [2]. 
A typical optical tweezers setup is shown in Figure 2.1.  A laser beam is tightly focused 
by sending it through a microscope objective; small dielectric spherical particles (such 
as biological cells) can be trapped and manipulated at the narrowest point of the focused 
laser beam, known as the beam waist.  Two forces act on the cell(s) located at or 
sufficiently close to the beam waist; the scattering force produced by the photons 
striking the cell along their propagation direction, and the force produced by a gradient 
of field intensity [3].  The magnitude of these forces exerted on the cell depends on the 
cell size and laser wavelength.  These forces act together to bring cells which are out of 
the trap to the centre of the trap.  Almost all cell types can be harmlessly trapped by 
selecting a wavelength of laser that is not absorbed by the cells [4]. 
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Figure 2.1 – Simplified schematic of an optical tweezers system: a) typical experimental setup; b) 
working principles of optical tweezers 
Optical tweezers has several advantages compared to other techniques. As this 
technique is non-contact, cells can be moved from one reservoir to another in a few 
seconds without any extra-cellular media being dragged along with them.  This means 
that there is no contamination if different types of cells are used and studies can be 
conducted in real-time [4].  
It was originally thought that the optical tweezers technique was purely non-invasive in 
nature; however, studies by Liu et al. showed that cells can be heated sufficiently to 
affect their physiological state [5]. 
Unfortunately this technique is only suitable for transporting cells on a single plane and 
the small size of the volume that can be trapped limits the number of cells that can be 
manipulated at once [6].  Therefore, despite its advantages over other techniques, 
Optical Tweezers do not meet the demands of cell printing. 
2.2.2 Laser-Based Direct-Write Techniques 
Laser-based additive writing was originally used to create mesoscopic electronic 
components such as conductors, capacitors and resistors with a high spatial accuracy of 
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~1-3 µm [7].  Thanks to this high accuracy laser-based direct-write techniques became 
extremely attractive to the fields of biomedicine and bioengineering. 
There are several variations on the standard laser-based direct-write technique; the most 
prolific techniques for cellular applications are matrix-assisted pulsed laser evaporation 
direct writing (MAPLE DW) [8,9], biological laser processing (BioLP) [8,10,11], 
laser-induced forward transfer (LIFT) [8,12–14], absorbing film-assisted laser-induced 
forward transfer (AFA-LIFT) [8,15], and laser-guided direct writing (LG DW) [8].  
With the exception of LG DW, these techniques operate in distinctly similar ways [8] 
(Figure 2.2).  Each of these techniques utilise a laser transparent ribbon, usually glass or 
quartz, the underside of which is coated with cells that are uniformly suspended within a 
thin layer of cell culture medium mixed with glycerol (or similar) to a cell concentration 
of around 1108 cells/mL to a thickness of between approximately 10-100 µm [9,10].  
A receiving substrate is coated with 50-200 µm of cell culture medium to maintain 
cellular viability [10,11], mounted on a computer-controlled motorised stage and 
positioned beneath the ribbon facing the cell-coated side.  In order to transfer the cells 
from the ribbon to the substrate, a pulsed laser beam is fired at the transparent ribbon.  
The energy of the laser passes through the ribbon and causes the rapid volatilization of 
the cellular support layer creating the necessary force to allow the cells to drop the small 
distance (30-1000 µm [13]) between the ribbon and the receiving substrate.  The 
amount of biomaterial that is transferred, including cells and suspension, can be 
expressed as a function of the focused laser spot size, the thickness of the biomaterial 
layer on the target, and the laser fluence [9,13]. 
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Figure 2.2 – Simplified schematic of a LIFT, AFA-LIFT, BioLP or MAPLE DW system used for cell 
printing (adapted from [8]). 
Laser-induced forward transfer (LIFT) [8,12,13,16] utilises a high-powered pulsed 
laser.  Guillotin et al. used a Nd:YAG crystal laser (Navigator 1, Newport Spectra 
Physics) with 1064 nm wavelength, 30 ns pulse duration, 5 kHz repetition rate and 7 W 
mean power [12].  In addition to the higher powered laser, LIFT adds a thin (~50-60 nm 
[12,13]) coating of a laser-absorbing biocompatible material such as titanium, titanium 
oxide, gold or silver [8] to the laser transparent ribbon in order to protect the cells from 
the laser pulses. 
 
Figure 2.3 – Simplified schematic of a LIFT ribbon arrangement (adapted from [8]). 
Absorbing film assisted laser induced forward transfer (AFA-LIFT) [8,15] uses the 
same technique as LIFT, but rather than a thin layer of laser-absorbing material, a 
thicker (~100 nm [8]) sacrificial layer of metal is used to interact with the laser.  Hopp 
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et al. used a KrF Excimer laser with 248 nm wavelength, 30 ns pulse duration, laser 
fluences varied between 35-2600 mJ/cm
2
 and a 50 nm thick layer of silver [15]. 
Matrix assisted pulsed laser evaporation direct write (MAPLE DW) [8,9,11] is a slightly 
different technique compared to the previous two, the major difference being that 
MAPLE DW utilises a low-powered pulsed laser operating in, or near, the UV range of 
the spectrum. Barron et al. used an ArF Excimer laser (Lambda Physik LPX-300i) with 
193 nm wavelength, 20 ns pulse duration, laser energies between 15 and 30 µJ/pulse 
and laser fluences between approximately 157–315 µJ/cm2 [9].  The other difference 
that sets this method apart is that instead of thin laser absorption or sacrificial layers, the 
underside of the laser transparent ribbon is coated in an aqueous based biological 
support layer, typically composed of a laser absorbing biopolymer and cell attachment 
layer.  The UV light from the laser is absorbed by the water, causing vaporisation of 
some of the liquid at the interface in the biological support layer and resulting in the 
ejection of the material below [11].  
Biological laser printing (BioLP) [8,11,14] is the most recent adaptation of the classic 
laser-based techniques.  The technique is similar to LIFT and MAPLE DW, but utilises 
a laser absorbing interlayer rather than the biological matrix support used in MAPLE 
DW [10,11]. This absorption layer is typically composed of titanium or a titanium oxide 
coating approximately 75–85 nm thick [10]; like the layers used in the other techniques, 
it prevents the laser from interacting with the biomaterial but also improves the 
reproducibility of transfer by normalising the laser interaction [11].  An example of a 
laser system used for BioLP would be the one used by Barron in [10,11] which was a 
quadrupled Nd:YAG (Continuum Mini-Lite) with 266 nm wavelength, 5 ns FWHM, 1–
15 Hz repetition rate and laser fluences approximately 191–382 mJ/cm2. 
Table 2.1 – A comparison of the different laser-based techniques in this review. 
 Laser 
Laser 
fluence/ 
energy 
Spot 
size 
(µm) 
Drop 
size 
Cell 
viability 
(%) 
Bio-ink 
viscosity 
range 
(mPas) 
Advantages/ 
limitations 
References 
LIFT 
Nd:YAG 
λ = 1064 nm 
65-260 
nJ 
10 12 fL ~98 >100 
Extremely small 
droplets possible 
[6,12,13,17] 
AFA-
LIFT 
KrF Excimer 
λ = 248 nm 
355 
mJ/cm
2
 
~10 
Not 
reported 
75 
Not 
reported 
 [15] 
MAPLE 
DW 
ArF Excimer 
λ = 193 nm 
157-315 
µJ/cm
2
  
80-100 90 pL 100 >40 
Laser radiation 
transferred to cells 
[8,9,18–20] 
BioLP 
ArF Excimer 
λ = 248 nm 
33 
mJ/cm
2
 
30-120 30 pL >95 2-431 
<1% laser radiation 
transferred to cells 
[10,21,22] 
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Substantial amounts of stress can be applied to cells during the printing process, 
especially at higher velocity transfer speeds possible with laser direct-write techniques.  
The expression of heat shock proteins (HSP) are a good marker of stress endured during 
the printing process as they are known to be expressed by cells undergoing thermal and 
mechanical stresses [23,24].  Barron et al. conducted an experiment to show the amount 
of HSP expressed by BioLP deposited cells with a positive and negative control, the 
results indicated that only minimal amounts of HSP60/70 were expressed [21]. 
Various types of cells have been used to test this technique including human 
osteosarcoma cells (MG-63 ATCC CRL-1427), Chinese hamster ovary (CHO) cells, rat 
cardiac cells (ATCC CRL-1764, Rat-2) cells encapsulated in picolitre droplets at rates 
varying from 1-5,000 droplets per second (higher rates are possible but these are more 
usual).  Cell viabilities were demonstrated to be high. 
Laser-based cell printing techniques have proven their ability to print cells into precise 
pre-programmed patterns.  An example of this control would be Guillotin et al. with 
their Olympics logo printed using the LIFT technique [12] (Figure 2.4). 
 
Figure 2.4 – Cells printed in the form of the Olympics logo (scale bar 500 µm) [12]  
Nahmias et al. created a 3D cellular structure on a collagen-coated surface by depositing 
three alternating layers of hepatocytes and hydrogels on top of each other using laser 
guided 3D cell writing [25].  Cell viability and proliferation was well-maintained post-
deposition [26]. 
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Figure 2.5 - Three cells (indicated by arrows) deposited on top of each other.  Image taken perpendicular 
to the axis of deposition (scale bar 50 µm) [25] 
Laser-based direct-write techniques have several advantages over other techniques.  As 
these techniques use an orifice-free transfer process, it is unaffected by biomaterial 
adhesion and therefore adapts easily to variations in the viscosity of the biological 
material [11].  Other advantages include an extremely fast material transfer (910-8 
mL/s) [9,11,24], and contamination is avoided because there is no direct contact 
between the laser, ribbon and substrate [11]. Spatial accuracy is better than 5 µm [9,11], 
and live/dead assays reveal a near 100% cell viability with this technique [8,9,11]. 
Current techniques can transfer various numbers of cells, either single or multiple; 
between 0 and 8 cells can be dispensed per droplet [9], so laser-based techniques have 
great potential to be used to create micro-cellular features such as micro-vasculature 
networks. 
As laser-based direct-write techniques were not originally developed for biological 
material transfer, there are a number of disadvantages.  These include expensive 
instrumentation, varying transfer rate due to inhomogeneous biological layer [27], 
possible genetic damage due to UV/IR laser energy exposure [5,21], poor 
reproducibility in certain techniques, limited deposition rates depending on the laser 
repetition rate [11] and possible damage to cells due to mechanical shear forces during 
the jet formation and impact on the substrate [22].  An added weakness of the MAPLE 
DW technique is its requirement of laser absorbing matrix materials [15]. 
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2.2.3 Inkjet Printing 
Inkjet printing was, until recently, used almost exclusively to print documents in 2D.  
With a few slight modifications, however, this technology can be used to print bio-ink 
solutions containing live cells.  Inkjet technology was first adapted for use with 
biological materials by Wilson & Boland in 2003 [28]; their printer was converted from 
an off-the-shelf ink-jet printer.  Due to their low cost and high throughput, inkjet 
printing has become an extremely popular cell printing technique [8,28–31].  
Inkjet printing techniques can be differentiated from some similar techniques by their 
use of the surface tension of the bio-ink itself as a valve [32].  There are many different 
types of inkjet printing techniques, but they can generally be sorted into two main 
groups: continuous (CIJ) and drop-on-demand (DOD).  Continuous inkjet technology is 
unsuitable for bioprinting applications due to the lower accuracy and increased sources 
of potential contamination of the bio-ink [33,34]; therefore, only DOD inkjet techniques 
are described here. 
Droplets are ejected from a nozzle by applying a pulse of pressure to the fluid bio-ink 
solutions in the supply tube upstream of the nozzle.  There are several methods of 
creating this pressure pulse: thermal bubble, piezoelectric, and electrostatic.  Both 
thermal and piezoelectric types have been modified for use as cell printers [28,35]. 
 
Figure 2.6 – Simplified schematic of an inkjet system used for cell printing (adapted from [36]) 
Piezoelectric materials are crystalline materials which deform when subjected to an 
electric potential.  There are two common types of piezoelectric material: bimorphs 
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(which bend like a drum head) and rods (which elongate).  A section of this material 
(either in a rod or bimorph configuration) is attached to the outer wall of the bio-ink 
channel upstream of the nozzle and configured to squeeze the channel.  This creates a 
pressure pulse which results in a droplet being ejected from the nozzle.  The electrical 
pulses which energise the piezoelectric materials are typically in the microsecond range 
[37–39]. 
 
Figure 2.7 – The process of droplet ejection in a push pull piezoelectric inkjet system: a) initial state; b) 
DC voltage applied across the piezoelectric material and a droplet is ejected (push); c) DC voltage is 
removed (pull) (adapted from [40]) 
Thermal bubble inkjet operates in much the same way as piezoelectric-based printers 
but, instead of piezoelectric material, the pressure pulse is created by a heater.  The 
heater is composed of a thin film resistive metallic layer, typically less than 1 µm thick 
and around 15 µm across each side, attached to the inner wall of the bio-ink channel just 
upstream of the nozzle.  By passing an electrical pulse of sufficient amplitude through 
the heater the temperature of the heater rises to a point high enough to boil the bio-ink.  
The bio-ink within a fraction of a micrometre of the heater vaporises, forming a bubble 
which expands.  This expansion of the bubble creates a pressure pulse that results in a 
droplet being ejected from the nozzle.  The bubble cools and collapses after a few 
microseconds and the surface tension of the bio-ink meniscus at the nozzle pulls more 
bio-ink down from the reservoir to refill the bio-ink channel.  The electrical pulses 
which energise the resistive materials are typically in the microsecond range [37,38]. 
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Figure 2.8 – The process of droplet ejection in a thermal bubble inkjet system: a) initial state; b) DC 
voltage applied across the piezoelectric material and a droplet is ejected (push); c) DC voltage is 
removed (pull) 
SEA-JET (Static-Electricity Actuated InkJET) printing was developed by the Seiko 
Epson Corporation in 1998 [41].  It was created to address the cavitation problems 
associated with piezo and the large power requirements of thermal inkjet printing.  The 
mechanism of the electrostatic actuator is comprised of a silicon pressure plate and an 
electrode which are positioned in parallel between two glass plates.  The cavity above 
the pressure plate is filled with bio-ink from the reservoir. 
 
Figure 2.9 – The process of ink ejection in an electrostatically actuated inkjet system: a) initial state; b) 
DC voltage applied between the pressure plate and the electrode (pull); c) DC voltage is removed and a 
droplet is ejected (push) (Adapted from [41]). 
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An interesting new technique for inkjet printing called Superfine Inkjet Printing has 
recently been developed by Japan’s National Institute of Advanced Industrial Science 
and Technology (AIST).  Superfine Inkjet (SIJ) Printing dispenses droplets of sub-
femtoliter volume which is 1/1000 of the volume of current inkjet devices on the market 
[42,43] (Figure 2.10).   
 
Figure 2.10 – Comparison of standard and SIJ droplet sizes (Adapted from [43]). 
However, due to the novel nature of this technology, the majority of the technical 
information about the technique is protected, but based on the little information 
available, it is clear that this technique would not be suitable for printing viable cells as 
the size of each droplet is smaller than a single mammalian cell.  It could be possible to 
use SIJ to deposit other biomaterials such as growth factors with extremely high control 
over the volume dispensed at set locations. 
Table 2.2 – A comparison of the different inkjet-based techniques in this review. 
 
Spot size or 
resolution 
(µm) 
Drop size 
Cell 
viability 
(%) 
Bio-ink 
viscosity range 
(mPas) 
Advantages/ 
limitations 
References 
Piezoelectric 10 1-100 pL 75-80 1-20 
Vibrations can 
damage cells 
[34,44,45] 
Thermal 85 130 pL 89 1-5 
Ubiquitous 
Higher power 
[34,45] 
Electrostatic 30 1-100 pL 
Not 
reported 
Not reported Lower power [46,47] 
 
Cells can undergo substantial shear forces during the printing process, especially with 
the narrow nozzle internal diameters used in inkjet techniques.  Thermal inkjet also 
applies thermal energy so is more likely to damage the cells during printing.  Cui et al. 
conducted an in-depth experiment to investigate the viability and apoptosis of printed 
2 pl (ø 16 µm)
Droplets ejected from 
commercial inkjet printers
Droplets ejected from the super-
fine inkjet printer
Volume: At least 1/1000 
times smaller
<1 fl (ø <1 µm)
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cells; they discovered that transient pores were developed in the cell membranes during 
printing which yielded a 30% transfection efficiency with co-printed plasmid-DNA 
[48]. 
Various types of cells have been used to test this technique including Chinese hamster 
ovary (CHO) cells, smooth muscle cells (SMC) encapsulated in picolitre droplets at 
rates varying from 1-10,000 droplets per second.  Cell viabilities were demonstrated to 
be over 80% across various cell types. 
Nakamura et al. (2008) used a custom built electrostatic inkjet 3D bioprinter to 
successfully fabricate a miniaturised tube with an external diameter of 100 µm and an 
inner lumen measuring approximately 25 µm in diameter from alginate hydrogel [46]. 
 
Figure 2.11 – Detail view of the miniaturised tube with 50 µm radius; arrow indicates inner lumen [46] 
Inkjet-based techniques have several advantages over other techniques.  Chief among 
them is the lower cost and simplicity of the technique facilitated by modifying off-the-
shelf inkjet printers.  Other strong points in its favour are the ability to using several 
different types of cells by simply adding more nozzles [35,49], and the high-throughput 
nature of the mechanism [28]. 
Inkjet-based techniques also have a number of disadvantages, the biggest of which is 
due to the technique being driven by the size of the nozzle: droplet diameters are 
approximately double the internal diameter of the nozzle used (which leads to larger 
droplet sizes compared to some of the other techniques).  Nozzle clogging from cell 
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sedimentation and aggregation is also a problem if high cell concentrations (>5 x 10
6
 
cells/mL) are used [31]; however, adding a calcium ion (Ca2+) chelating agent to the 
bio-ink, such as EDTA (ethylenediaminetetraacetic acid), could help prevent nozzle 
failure and increase the bio-ink cell concentration by reducing cell aggregation [27,37]; 
however EDTA may be toxic to cells [50]. Other problems include a spatial accuracy of 
only ~50 µm (which is sufficient for cell printing but a higher spatial accuracy would be 
desirable), shear stress applied to the material being printed, and possible contamination 
[11,35,49,51]. 
Piezoelectric-based printers have increased power requirements (12-100 W) and higher 
vibration frequencies (30 kHz) due to the use of high viscosity bio-ink, which is enough 
to break and damage cell membranes [35]. 
Thermal-based printers suffer from possible heating effects as temperatures can reach 
300°C or higher in some techniques which can cause many cells to die during printing 
[24,35,49]. 
2.2.4 Valve-Based Printing 
Valve-based printing techniques are extremely similar to inkjet techniques.  They 
comprise a static pressure reservoir, a small diameter nozzle, a voltage-controlled valve, 
and a two-dimensional translation mechanism (the print head) to which the other 
components are mounted (Figure 2.12).  The reservoir is loaded with cells that are 
uniformly suspended within cell culture medium.  The cells are delivered to the 
substrate by activating the voltage-controlled valve [52,53]. The amount of biomaterial, 
including cells and suspension, that is transferred can be expressed as a function of the 
nozzle diameter, the size of the cells, the inlet pressure and the amount of time the valve 
is open [54]. 
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Figure 2.12 – Schematic drawing of the valve-based cell dispensing system. 
Various types of cells have been used to test this technique, including NIH-3T3 mouse 
fibroblasts, AML-12 hepatocytes, HL-1 cardiomyocytes, mouse embryonic stem cells, 
fibroblasts and human Raji cells encapsulated in nanolitre droplets at rates varying from 
1 to 20,000 droplets per minute.  Cell viabilities were demonstrated to be over 90% 
across various cell types [53,54]. 
Weiss et al. (2012) developed a multi-head micro-solenoid valve-based bioprinter to 
fabricate heterogeneous structures with a bottom-up concentration gradient.  Multiple 
growth factors were printed with spatial precision in a functionally graded manner into 
rat calvarial defect in-situ [26,55]. 
Valve-based techniques are one of the newest additions to this field and have repeatedly 
demonstrated extremely high final cell viability [56,57]; this can partly be attributed to 
the comparatively low shear stress created in this technique.  Another useful advantage 
is that cell numbers in the dispensed droplets are more uniform than in other techniques 
[56].  Other advantages include the high-throughput nature of the technique (even with a 
single nozzle 1000 droplets could be dispensed in under a second [53]); as with inkjet 
printing it is easily expandable and cheap. 
Just like inkjet techniques, valve-based techniques also have nozzles and therefore 
nozzle-based problems, such as clogging and the link between droplet diameters and 
nozzle diameters.  However, nozzles used in valve-based systems are larger than those 
used in inkjet printers [37], so these problems are encountered far less often. 
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2.2.5 Bio-Extrusion Methods 
Unlike the other techniques reviewed here, which typically deposit discrete droplets of 
low viscosity bio-inks in two-dimensional patterns, bio-extrusion deposits continuous 
streams of medium to high viscosity bio-inks. 
Bio-extrusion (also called bioplotting) is defined as the process of extruding bio-inks of 
medium viscosity through a syringe.  Bio-ink is extruded in continuous streams from a 
nozzle by applying a force to the bio-ink in the syringe, upstream of that nozzle.  By 
drawing the tip of the nozzle along the substrate, 2D shapes can be created [58] and 3D 
structures can be formed by simply adding more layers to the top of the previous layer.  
This technique is usually applied to the creation of 3D scaffolds into which cells are 
seeded before culture, but it is also possible to deposit cells at the same time as the 
matrix material [59].  The basic mechanism of all bio-extrusion techniques is the same, 
but there are some differences introduced by various research groups.  There are two 
main techniques used to apply the force to the bio-ink: motor-driven and pressure-
driven systems.  Some techniques also utilise temperature modifying components to 
increase the “printability” of bio-inks or to improve the properties of the printed 
structures or simply speed-up the curing time of certain gels. 
Cohen et al. have constructed a custom solid freeform fabrication robotic platform that 
uses a motor to drive the deposition system [60].  The deposition system is a linear 
actuator-driven syringe with interchangeable nozzles in the form of syringe tips.  The 
body of a disposable syringe serves as the bio-ink reservoir and as such can be easily 
exchanged to change the bio-ink during experiments.  Bio-ink is dispensed in 
continuous cylindrical filaments by driving the linear actuator; by altering the speed of 
the linear actuator, more or less material is deposited.  Coupled with the travelling speed 
of the deposition system (when driven using an XYZ positioning system such as a CNC 
machine) and the diameter of the nozzle attached to the syringe, the width of the 
extruded filament can be controlled. 
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Figure 2.13 – Simplified schematic of a bio-extrusion system. 
Pressure-driven systems operate in much the same way as motor-driven systems but 
instead of mechanically driving the bio-ink with a linear motor, the driving force is 
provided by positive low and constant pressure [58].  Bio-ink is dispensed in continuous 
cylindrical filaments by applying pressure to the inlet of the syringe.  By precisely 
modulating the inlet pressure, more or less material is deposited.   
Often solutions deposited using this technique requires the bio-ink to be stored and 
extruded at certain temperatures so they include cartridge heaters to keep the bio-ink at 
certain temperatures.  For example, high viscosity materials would usually be 
unprintable, but they can be extruded if they are first heated to a higher temperature.  
Also, gelatin is a solution at physiological temperature (37 °C), but can reversibly form 
a gel when cooled (<29 °C).  This is due to a conformational change from coil to helix 
that leads to chain association and eventually the formation of a three-dimensional 
network [59]. 
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Figure 2.14 – Simplified schematic of a bio-plotting system 
Two commercial machines are available that utilise bio-extrusion techniques for 
bioprinting: the EnvisionTEC 3D-Bioplotter® from Germany [61]; and Organovo's 
NovoGen MMX bioprinter from the USA [62]. 
Yan et al. (2005) used this technique to create a 3D structure composed of hepatocytes 
suspended in a gelatin/alginate hydrogel; cells remained viable and performed 
biological functions for more than 12 days [63].  
Norotte et al. (2009) created small diameter vascular tubes (OD ranging from 0.9 to 2.5 
mm) from cellular aggregate cylinders of human umbilical vein smooth muscle cells 
(HUVSMCs) and human skin fibroblasts (HSFs) to create multicellular constructs [64]. 
 
Figure 2.15 – A double-layered vascular wall constructed from HUVSMC (green) and HSF (red) 
multicellular cylinders were assembled according to a specific pattern shown in a); b) results of 
histological examination of the structure in a) after 3 days of fusion [64] 
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Bio-extrusion techniques have several advantages including the capability to create 
structures with highly accurate and structurally rigid 3D geometries which can be 
fabricated in a controlled manner.  Complex 3D geometries are also possible due to the 
ability to deposit extra materials as a support matrix or scaffold.  Furthermore, the 
ability to deposit cell-laden hydrogels potentially facilitates homogeneous distribution 
or positioning of cells, and therefore the capability to seed cells of specific cell types at 
discrete sections within the 3D structure [59,65]. 
There are also several limitations of the technique due to the use of high-viscosity 
biomaterials and nozzles in the technique; shear stress will be applied to cells as they 
pass through the nozzle and clogging is a potential issue [26].  This can be limited by 
optimising the applied force and nozzle diameter to the biomaterial currently in use 
[66].  Sufficiently high viscosity is essential for the bio-ink to overcome the surface 
tension-driven deposition which imposes a lower limit on bio-ink viscosity, highly fluid 
bio-inks with viscosities less than 100 mPas tend to leak out of the nozzle because the 
flow is controlled by surface tension effects [58,67].   
A disadvantage of using pressure for bio-ink deposition is the extra limit on bio-ink 
viscosity; solutions with a viscosity greater than 700 mPas require much higher 
pressures to deposit, which may damage the tip and be a danger to the user [58,67]. 
2.2.6 Electrohydrodynamic Jet Printing 
Electrohydrodynamic Jet Printing (or EHDJ), otherwise known as Bio-electrospraying 
or e-jet printing, was first demonstrated in the 1980s by John Fenn at Yale University 
[68].  Cell electrospinning (also considered a modified form of EHDJ) and 
electrospraying work on similar principles and are both described in this section.  
Rather than using thermal or laser energy to produce droplets, Electrohydrodynamic jet 
printing operates by applying an electric field between two charged electrodes which 
draws a jet of bio-ink which can form either discrete droplets or continuous fibres. [69]. 
A typical Electrohydrodynamic Jet Printing setup is composed of a syringe pump 
attached to a ~500 μm nozzle which is kept at a positive potential (0.5-0.9 KV/mm) 
with respect to the ground electrode above the receiving substrate positioned 
approximately 15 mm below the nozzle orifice [70,71].  The reservoir of the syringe is 
loaded with cells that are uniformly suspended to a concentration of between 1106-
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2106 cells/mL [71].  In order to transfer the bio-ink between the nozzle and the 
substrate, a potential difference is applied between the nozzle and the ground electrode 
placed centrally below it; this external electric field accelerates the charged bio-ink 
exiting the nozzle towards the ground electrode.  A cone of bio-ink forms at the nozzle 
orifice and a jet forms at the apex; either continuous fibres or discrete droplets are 
formed depending on the properties of the bio-ink.  Flow rate, applied voltage and 
instrument setup determine the diameter and geometry of the generated fibres [72]. 
 
Figure 2.16 – Simplified schematic of an Electrohydrodynamic Jet system used for cell printing (adapted 
from [71]) 
Several cell types have been used, including Jurkat cells and mouse neuronal cells 
[70,71].  Each investigation showed that the process of Electrohydrodynamic Jet 
Printing does not in any way damage the cells.  Cells that were examined post printing 
exhibited growth comparable to that of the control cells. 
In this form, this technique has no control over the direction of bio-ink fibre generation 
during jetting, but has the ability to handle standard materials in large quantities for 
forming scaffolds in short periods of time.  A modified version of the technique has 
been developed which increases the stability of the jet while retaining the high speeds of 
deposition by incorporating a co-axial nozzle [73,74].   
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Figure 2.17 – Schematic of a modified Electrohydrodynamic Jet system used for cell printing 
Bartolovic et al performed a study to determine if the cell electrospinning process 
affected the differentiation potential of mouse hematopoietic stem cells using a 
functional in vitro assay and an in vivo mouse model to investigate possible side effects.  
No negative effects were discovered [75].  
 
Figure 2.18 – A representative micrograph of the heterogeneous cell population derived from 
hematopoietic progenitor cells of CD-1 mouse BM [75] 
 
Target 
substrate
Ground electrode
Nozzle
Hydrogel
To reservoir of 
bio-ink
Chapter 2 – Literature Review 
 
28 
A slightly different technique is Pyroelectric Jet printing, also known as pyro-
Electrohydrodynamic Jet printing, instead of electrodes, liquid is dispensed by 
temperature varying the temperature of polar dielectric crystals [76].  A typical 
pyroelectric jet setup is shown in Figure 2.19.  A heat source (usually a laser or a hot 
soldering iron tip) is applied to a sheet of pyroelectric material (such as lithium niobate).  
As the pyroelectric material heats up, local electric potentials are created that initiate the 
electrohydrodynamic effect in the fluid on the surface of the glass.  This leads to the 
ejection of small droplets of fluid that are printed onto an intervening substrate with 
nanoscale resolution [77]. 
 
Figure 2.19 – Simplified schematic of a pyroelectric jet system 
Problems may arise with this technique due to the effect of heating on the printed 
droplets: the evaporation rate of the fluid could be increased, and if cells are suspended 
within the fluid, they could be affected as well. 
Electrohydrodynamic Jet Printing presents a new advantage that none of the other 
techniques have yet to achieve: both a continuous stream and discrete droplets of cell 
solution is possible which may be used to form cells into polymer threads that can be 
used as scaffolds [78].  Other strong points in its favour are: the 100% cell viability, the 
size of the droplets is independent of the nozzle size; extremely high concentrations of 
cells (>10
7
 cells/mL) are possible; and the ability to use bio-inks with high viscosities 
(>10,000 mPa·s) [68–72,79].  Pyroelectric jet printing has the advantage of not having 
nozzles, thus avoiding the problems that so many of the other techniques can suffer 
from such as clogging.  Since the pyro-electrohydrodynamic effect is triggered by a heat 
source, electrodes need not be used, making the system more flexible and easier to set 
up than EHDJ.  Furthermore, attolitre droplets have been demonstrated with this 
technique [76,77,80]. 
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However the use of heat and the small volume of the droplets in pyroelectric jet printing 
make it unsuitable for cell patterning. 
Unfortunately to date there has been no papers published demonstrating that 
Electrohydrodynamic Jet Printing can be used to pattern cells in a controlled and 
reproducible manner.  Another disadvantage is that the wide range of droplet sizes – 
between tens of microns and millimetres in diameter – during the same experiment 
[70,71].  Regrettably this means that this approach, in its current form, is unsuitable for 
high-resolution cell printing, as position and droplet size reproducibility are an absolute 
requirement for the majority of cell printing applications. 
2.2.7 Acoustics 
The first experiments using acoustic energy to transfer liquids was carried out by Alfred 
Lee Loomis in 1927; he observed that by immersing a high-power acoustic generator in 
an oil bath, a mound would appear on the surface that would “[erupt] oil droplets like a 
miniature volcano” [81,82].   
Although there are variations in the techniques, they generally operate on the same 
principle: an acoustic generator is placed below (or above, depending on the desired 
direction for dispensation) the fluid to be dispensed and sends acoustic waves 
propagating through the fluid which focus at the interface between the fluid and the air 
creating a swell at the focal point which grow until they are large enough to pinch off 
and become droplets [82,83]. 
The first version of this technique utilised a single focused transducer located below a 
micro plate with multiple fluid-filled wells.  The transducer moves from well to well 
and can trigger the ejection of droplets by sending acoustic waves that travel through the 
fluid to form a focal point, set using an acoustic lens, located just below the surface of 
the fluid [82,84,85].  This technique lacks the ability to simultaneously dispense 
multiple droplets unless multiple transducers are used which would increase the already 
relatively high power requirements [85]. 
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Figure 2.20 – Simplified schematic of a classic transducer-based acoustic system (adapted from [82]). 
A newer version created by Utkan Demirci at Harvard-MIT Health Sciences and 
Technology and Harvard Medical School employs acoustically focused 2D micro-
machined micro-droplet ejector arrays.  Instead of using an acoustic lens to create the 
focal point, the focal point in this technique is formed by the constructive interference 
of surface acoustic waves which leak into the fluid medium.  The substrate uniformity 
and fabrication ease ensures repeatability and the stable operation of the ejector array.  
The addition of microfluidic channels constantly refill the fluid, keeping the level 
constant and allowing the array to be orientated in any direction without affecting the 
printing process [85,86]. 
 
Figure 2.21 – Simplified schematic of an interdigitated transducer-based Acoustic system (adapted from 
[85,86]). 
Various types of cells have been used to test this technique including AML-12 
hepatocytes, HL-1 cardiomyocytes, mouse embryonic stem cells, fibroblasts and human 
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Raji cells encapsulated in acoustic picolitre droplets at rates varying from 1-100,000 
droplets per second [87].  Cell viabilities were demonstrated to be over 89.8% across 
various cell types, even at high-throughput rates [85]. 
Acoustic techniques boast many advantages over other techniques: the droplets are 
ejected from an open pool without requiring a nozzle, thus avoiding the problems 
associated with them (such as clogging, heating and high pressures), and enabling the 
encapsulation and ejection single cells (or a few cells e.g. 1-3 cells per droplet was 
demonstrated by Demirci & Montesano [85]) with uniform ejection directionality, high 
consistency, and post-ejection viability (>89.8%).  Small volume transfers in the 
picolitre and nanolitre range at low ejection velocities have been demonstrated which 
reduces the chance of cross-contamination due to splashing [82–86]. 
A slight problem with this technique is that heat is generated by the interdigitated 
transducers when they trigger a droplet dispense which raises the temperature in the 
fluid reservoir and could increase the evaporation rate, affecting the properties of the 
fluid, and droplet sizes.  Fortunately the amount of heat generated is extremely small 
(<510-5 °C) and has plenty of time to dissipate before the next dispense is triggered 
even at 10 kHz it only takes ~90 µs to dissipate.  This temperature rise could become an 
issue if the ejector array was much larger, or if it were operated at a continuous mode of 
ejection at higher frequencies for a long time [86]. 
2.2.8 Other Techniques 
Apart from the techniques covered in the previous sections, a number of more 
traditional, but still widely used, cell printing techniques exist.  A selection of these 
techniques are summarised in this section, including Micro-contact printing, Microarray 
spotting, and Photolithography. 
Micro-contact printing (or μCP) uses a stamp created by photolithography to pattern 
cells onto the substrate – just like potato prints.  First, a layer of photoresist is applied to 
a layer of silicon which is patterned by a photo-mask and UV light.  Then a stamp is 
created by pouring PDMS over the patterned surface and curing it at high temperatures.  
Finally, the stamp is coated with cells in solution and brought into contact with the 
substrate, transferring the cells to the substrate in the pre-set pattern [8,88,89].  
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Figure 2.22 – Schematic of the Micro-contact printing procedure (adapted from [90]). 
Micro-contact printing is a simple technique that can quickly pattern cells with a single 
stamp that can be reused to create the same pattern several times.  However, a new 
stamp would be required for each new pattern and stamps can suffer from deformation 
and swelling/shrinking [8,88–90].  
A possible addition to the more modern printing techniques would be to print cell 
adhesion molecules using micro-contact printing before delivering the cells, effectively 
organising the growth of the cells into the desired shape [35]. 
Microarray spotting is similar to some of the more modern techniques, in that it 
employs a computer controlled xyz motion stage to move the biological material.  The 
pen itself operates in the same way as a quill-type ink pen and is used to pick up small 
volumes of biological material from multi-well plates and depositing (or spotting) them 
in the desired location on the substrate [91]. 
Cells to be printed
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Figure 2.23 – Schematic of the Microarray spotting technique (adapted from [92]). 
Providing that the substrate is a flat, solid surface, printing is reliable and repeatable.  
However, if the substrate is a membrane or uneven, then problems can arise such as 
missed spots or surface indentations [91].  Microarray spotting techniques have several 
inherent limitations, including heating and viscosity effects, variable volume transfer, 
clogging, and contamination (if multiple biological materials are used) [11,91]. 
Photolithography, also known as optical or UV lithography, is a microfabrication 
technique that uses light to remove parts of a thin film or substrate.  The desired pattern 
is transferred using light from a photo mask to a light-sensitive chemical photoresist on 
the substrate [93,94].  A series of chemicals are applied which etch the exposure pattern 
onto the substrate.  Photolithography is used in the semiconductor industry to create 
complex integrated circuits. 
With slight modification, the photolithographic process can be used to pattern cells.  By 
depositing cell attachment factors onto a substrate previously coated with agar (which 
retards cell adhesion) and applying a pattern using photolithography, the resulting 
surface will only permit cells to grow in the desired pattern.  This method has been 
successfully used to pattern fibroblasts, cardiomyocytes and HeLa cells with a spatial 
resolution of ±3 µm [90,93]. 
Receiving substrate
Microarrayer tip
Droplet with cell(s)
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Figure 2.24 – Schematic of Photolithographic cell patterning technique 
Photolithography is an extremely useful micro-fabrication technique: so much so that it 
is often used to supplement some of the other techniques described here – for example, 
making patterned substrates to print cells onto [95] or stamps to print cells with [90].  
Unfortunately it is also an extremely expensive process, and is unable to pattern non-
planar surfaces [90]. 
2.2.9 Applications of Biological Cell Printing 
During my investigation into the techniques used in biological cell printing, it became 
apparent that there are a wide range of useful applications.  These applications range 
from in vitro drug screening to organ printing, including tissue engineering and stem 
cell and cancer research. 
2.2.9.1 Tissue engineering 
From the very first paper that was published investigating cell printing, tissue 
engineering was identified as a major application for this new technology [96].  Cell 
printers that are only able to create two-dimensional cellular constructs are useful for 
some applications such as printing skin [97], but a number of studies have shown that 
certain cells require a three-dimensional structure in order to function properly.  Dunn et 
al. showed that hepatocytes cultured as a monolayer lost many of their liver-specific 
functions after a few days, but those cultured with a layer collagen gel in a “sandwich 
configuration” were able to retain their liver-specific functions for several weeks [98].  
Therefore, if more complex structures such as organs and organelles were to be printed 
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the cell printer would need the ability to transfer mesoscopic patterns of viable cells of 
multiple cell lines into well-defined three-dimensional arrays that closely mimic the 
tissue structure.   
Three-dimensional multicellular culture would enable more in-depth investigations into 
the mechanisms and chemical signalling that occurs within in vivo systems and allow 
for the creation of predesigned synthetic tissue for repair, replacement and rejuvenation.  
As many cell printing techniques have proven to be compatible with stem cell transfer, 
this will open the door for the creation of autologous three-dimensional tissues 
generated from patient specific cells directed to differentiate into both organ specific 
and non-organ specific cells [72]. 
2.2.9.2 In vitro drug screening 
Those same three-dimensional multicellular arrays could also be adapted and further 
developed for use in high throughput in vitro drug screening studies of a wide range of 
drugs.  By incorporating microfluidics techniques, micro-tissue-laden chips called 
“organ-on-a-chip” devices [99] could be created, which produce the same physiological 
reaction that the entire organ would but on a much smaller scale.  This development 
would result in faster and more reliable results (due to a much larger testing population 
and less inter-sample variability), better drugs, and an end to animal model-based 
studies, ultimately resulting in a more humane research paradigm [100]. 
2.2.9.3 Cell-sorting and research 
One of the most important requirements for studying components of any biological 
system, either molecules in a cell or cells in an organ, is having pure populations of 
different types of living cells from the biological system being studied [101].  These 
isolated components can them be characterised before being recombined under 
controlled conditions. 
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The ability to create precise in vitro cultures of cells is essential for replicating the in 
vivo microenvironment.  For example, a culture of cancer cells can help us to gain 
further understanding of the influence of spatial and geometric locations on cancer 
induction, proliferation, and metastasis [8].  Cell-to-cell communication between 
healthy normal cells and carcinomas could also be studied in cultures.  A cell-based 
model that emulates the in vitro behaviour offers obvious advantages over traditional 
drug testing techniques saving time, money and increasing predictability [103].   
2.3 Human Stem Cell Biology 
Pluripotent stem cells, which can be divided into embryonic stem cells (ESCs) and 
induced pluripotent stem cells (iPSCs), have the ability to self-renew indefinitely and 
the potential to differentiate into cells constituting all three somatic germ layers (or all 
cells found in an adult) [104–108].  Mouse ESCs were first isolated from early mouse 
blastocysts in 1981 [109,110], followed soon after by human ESCs (hESCs) in 1998 
[111].  In 2006 Takahashi et al. discovered that iPSCs can be derived from somatic cells 
by retrovirally transducing them with four transcription factors – Oct3/4, Sox2, Klf4 
and C-myc [112,113].  These cells have the same self-renewal and differentiation 
capabilities as ESCs but with the added advantage that iPSCs can be used for autogenic 
therapies. 
These unique potency characteristics make hESCs and iPSCs ideal for use in a number 
of applications, such as modelling early embryonic development.  The potentially 
limitless numbers of differentiated hESC progeny can also be used for clinical tissue 
engineering/replacement applications such as novel drug discovery and testing for the 
pharmaceutical industry [104,105,114,115].  Controlled and reproducible methods for 
the directed differentiation of hESCs or iPSCs are essential if these cells are to be used 
for tissue engineering or regenerative medicine applications.  Differentiation of 
pluripotent stem cells is performed in two main ways: monolayer culture or through a 
cell aggregate intermediate step [104,116]. 
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Figure 2.25 – Schematic illustration of the differentiation potential of hPSCs. This cell type has the 
potential to differentiate to all three germ layers, endoderm, mesoderm, and ectoderm, or to the germ line 
cells. Some of the different cell types are exemplified by simple illustrations [117].  
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The use of stem cells rather than adult cells is important as harvested adult cells rapidly 
lose important function and can fail to create new tissues with the other cells, whereas 
stem cells which have been directed to differentiate into the same tissue-specific cells 
result in foetal-like populations, which are more likely to create new tissues [118,119]. 
2.3.1 Cell Aggregates 
In vitro, hESCs typically cluster together to form 3-dimensional spheroid aggregates 
when cultured in medium that had the growth factors removed, which maintains them in 
a non-adherent and undifferentiated state [120].  After the spheroids have formed, the 
medium can be replaced by one which allows the hESCs to differentiate, and the 
spheroids are now commonly known as embryoid bodies (EBs).  Descendants of all 
three germ layers can be generated from hESCs following EB formation including 
hepatic, hemopoietic, pancreatic, cardiac, neural, and even germ cells.  The efficiency 
with which specific cell types are generated within the EB is partly determined by the 
size of the spheroid used to create the EB. A lack of uniformity in EB size can lead to 
asynchronous and heterogeneous differentiation [121,122].  Consequently, the ability to 
reliably create uniform EBs of specific sizes is required to generate the correct cell-cell 
signals needed to produce particular cell types such as cardiomyocytes [123]. 
2.3.1.1 Static suspension 
Static suspension culture is the most basic method used to create cellular aggregates and 
EBs.  A suspension of ESCs are placed in an ultra-low adherence Petri-dish and simply 
allowed to spontaneously form aggregates as shown in Figure 2.26 [106,124].  
Itskovitz-Eldor et al. demonstrated that human EBs created in suspension culture 
acquire molecular markers specific to the three embryonic germ layers [106], therefore 
various lineages can be created in this manner. 
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Figure 2.26 – Schematic of the static suspension aggregation technique 
This is an extremely simple method which is popular for neuronal cells [125], however 
there is little to no control over the size and shape of the aggregates [124].  Since the 
suspended cells are not compartmentalised, aggregates frequently agglomerate into 
irregular large aggregates, thus the subsequent differentiation results in heterogeneous 
populations [106,120,124,126]. 
2.3.1.2 Rotary mass suspension 
There are several different techniques that fall into this category, including spinner 
flasks, rotary orbital culture and combinations and modifications of these techniques.  
The main difference between these techniques and the others described here is that the 
large scale production of EBs with homogeneous size, which is only possible with 
bioreactor techniques [126].  
Spinner flasks are simple systems that utilise paddle-impellers to drive the suspended 
cells to clump together and aggregate into EBs.  The in vitro environment can be 
continuously monitored and regulated (pH, shear forces, medium exchange rate etc.) 
[124]. 
Orbital shakers are a similar technique to spinner flasks, but the rotary movement is 
supplied by moving the entire container which serves to reduce the maximum shear 
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force that is applied to the cells.  EBs created using this technique were reported to 
differentiate more easily than those created using static suspension culture [126]. 
 
Figure 2.27 – Schematic of the rotary mass suspension aggregation technique 
Rotary mass suspension culture is a very simple and scalable technique that allows for 
continuous monitoring and control of the physical and chemical environment, which is 
difficult to achieve by traditional methods [124].  Spheroids with homogeneous size 
distribution can be created with this technique, but the flow environment created by the 
process may damage the hESCs and disrupt cell signalling which could affect 
subsequent cell differentiation [120,123,127]. 
2.3.1.3 Gel encapsulation 
Gel encapsulation is a technique which bridges the gap between hanging drop and static 
suspension culture; it encapsulates the suspended cells into small pockets of suspended 
cells in an effort to improve the homogeneity of aggregate sizes.  A Petri dish is pre-
loaded with hydrogels (such as alginate or methylcellulose) and droplets of suspended 
ESCs are jetted into the hydrogel to form isolated colonies which are physically 
separated but share a common nutrient supply via the hydrogel [124].   
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Figure 2.28 – Schematic of the gel encapsulation aggregation technique 
EBs created in this way have improved synchrony and size reproducibility (and 
therefore differentiation reproducibility) [124].  Different hydrogels can be used to 
create different microenvironments for the ESCs and therefore elicit different responses 
from the ESCs, including inducing or preventing differentiation [128].  However, media 
changes and the retrieval of generated EBs are difficult due to the presence of the 
hydrogel material [120] 
2.3.1.4 Non-adhesive micro-well arrays 
Non-adhesive microwell plates have been developed in various dimensions and shapes 
(i.e. U and V shaped wells) in order to control the size and shape of the resulting 
spheroids.  The surface of the wells is modified using a variety of techniques, such as 
plasma treatment, chemicals etc. to make them hydrophobic.  Defined numbers of cells 
are deposited into the wells and, since they cannot attach to the surface of the well, they 
attach to each other and form an aggregate [124]. 
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Figure 2.29 – Schematic of the non-adhesive micro-well array aggregation technique 
The process is much faster than the other techniques and results in uniform size 
aggregates; however, the resulting aggregates are mechanically forced into a disk shape 
which is unstable, and the cells in the resulting EB form different cell lineages when re-
suspended [121,123,124]. 
2.3.1.5 Adhesive stencils 
In the adhesive stencils method, PDMS stamps are made using soft lithography with 
specified pattern geometries.  The stamps are sterilised, inked with an aqueous solution 
of pH 5 1:30 growth factor-reduced Matrigel (GFR-MG), and then rinsed with sterile 
ddH2O, and finally dried with sterile N2, leaving a monolayer of protein on the surface 
[129].   This layer is transferred to the substrate using the stamp, the surface of which 
has been pre-treated to prevent protein adsorption and cell attachment to unpatterned 
regions of the substrate [130].  Cells are then seeded onto the substrate and are cultured 
in medium to allow them to attach to the patterned regions; unattached cells are 
subsequently removed by washing.  Cells grow to confluence in the patterned regions 
and form flat aggregates. 
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Figure 2.30 – Schematic of the adhesive stencil aggregation technique 
This is an extremely simple and well established technique which can be scaled up very 
easily to be high throughput.  However, adhesive stencils and other surface modification 
techniques are only able to control the initial size of EBs and the aggregates are only 
two-dimensional disks – not the 3D spheroids that are usually required [129].   
2.3.1.6 Hanging-drop 
In hanging-drop culture, cells in suspension are dispensed onto the underside of the lid 
of a Petri dish.  The lid is inverted, creating a micro-environment without a surface for 
the cells to attach to which causes them to attach to each other forming a spheroid 
aggregate at the free liquid-air interface.  The droplets are held in place by surface 
tension.   
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Figure 2.31 – Schematic of the hanging-drop aggregation technique 
The hanging drop technique is a common method that is able to create uniform spheroid 
aggregates of specific sizes and cell numbers [131,132].  Another advantage is that it 
does not require any modification of the substrate surface, as the aggregates are gravity-
induced and the substrate is inverted so there are no surfaces for the cells to adhere to.  
However, the resulting EBs can vary in size, mostly due to variations in droplet volume 
and cell concentrations in each droplet during pipetting, and due to the manual nature of 
this method is can be very time consuming and liable to human error [107,133]. 
Long-term culture is a challenge with this technique as fresh culture media will need to 
be added in order to keep the cells supplied with medium.  Using a cell printer to 
deposit the droplets overcomes this issue since each droplet is in a known location, so it 
would be a very simple matter to flip the plate and overprint with fresh medium.  An 
innovative new solution to this problem has been devised by a company called 3D 
Biomatrix which specialises in 3D cell culture products: Perfecta3D® Hanging Drop 
Plates [134].  These plates have standard well plate format but with the addition of an 
access hole at the bottom of the well (as shown in Figure 2.32) which eliminates the 
need to flip the plate to deposit the cells or add fresh media. 
hESCs in printed 
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Figure 2.32 – Cross section detail of the Perfecta3D® well geometry and the modified hanging droplet 
spheroid creation scheme [134]  
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2.3.2 Bioengineering Livers 
The pharmaceutical industry faces many challenges in the development of new 
medicines.  It can take decades to successfully develop new drugs and only a very small 
number of candidate drugs are approved for human use [135–137].  There are several 
possible causes for this low success rate including externally applied restrictions and the 
increasing complexity of diseases.  The majority of pre-clinical testing models currently 
in use are of non-human origin, leading to different responses when tested on humans 
late in the clinical phase of the trial or at market which, in the case of thalidomide for 
example, can have disastrous results [138].  Cell-based in vitro assays with high human 
relevance would serve to increase the efficiency of drug development but as primary 
cells rapidly lose their function in isolation, other possibilities must be considered 
[118,119]. 
A possible solution to this is the directed differentiation of human pluripotent stem cells 
and the creation of micro-tissues from these cells which would mimic the physiological 
reaction of an entire organ but at a much smaller scale.  Cells from a single source or 
multiple hPSC lines can be used to test individual or population responses to novel 
drugs in high-throughput tests [118].  However, if these cells are to be used for these 
kind of applications, their differentiation must be reproducibly directed to the required 
lineages for each tissue.  Unfortunately, homogeneous cellular differentiation of hPSCs 
into specific germ layers has proven to be hard to accomplish [139,140]. 
The most important cell types for drug discovery are considered to be hepatocytes, 
cardiomyocytes, and neuronal cells [118].  While cardiotoxicity is a common adverse 
effect of some drugs and neurons can be used to develop screening assays and 
establishing drug-target interactions [141], the liver is the most important organ for 
testing drug candidates.  Unexpected drug metabolism, drug-induced injury of the liver 
and alteration of liver function are some of the major causes of drug candidate exclusion 
[142,143]. 
2.3.2.1 Differentiation of hPSCs into hepatocytes 
The first article describing the generation of hepatocyte-like cells from hESCs was 
published in 2003 [144].  The core protocol, guiding cells to differentiate through 
definitive endoderm and early hepatic development by attempting to mimic the 
embryonic development of the liver, was used by several groups with slight 
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modifications.  The resulting cells morphologically closely resemble hepatocytes and 
exhibit other hepatic functions such as albumin production, glycogen storage, ICG 
uptake and release and urea synthesis [145–147]. 
 
Figure 2.33 – Schematic illustration of the differentiation pathway from hPSC to hepatocytes.  Key 
growth and differentiation factors for each pathway are highlighted in blue and small molecules in red 
However, the generated cells in many studies are not truly functional, only a few studies 
demonstrate significant levels of enzymatic activity and so far no study has shown 
activity levels of multiple Cytochrome P450 (CYP) enzymes close to that of in vivo (or 
freshly isolated) human primary hepatocytes [139,140,148].  Obtaining fully functional 
cells from hESCs is a major challenge, one which has only just begun to be addressed.  
2.3.2.2 Creation of liver micro-tissues 
In vitro studies by Dunn et al. and Mauriel have shown that hepatocytes cultured as a 
monolayer lost many of their liver-specific functions after a few days [98,149].  
Therefore harvested primary hepatocytes or hPSC-derived hepatocytes would need to be 
organised and cultured in three-dimensions, using a 3D matrix such as a hydrogel, to 
maintain their function over a longer timeframe [63].  The addition of supporting cells 
which are present in the adult liver could also serve to reproduce more of the functions 
of an adult liver in an in vitro construct. 
The construction of an entire adult liver in vitro would constitute an almost 
insurmountable task with the technology of the day due to the numbers of cells that 
would be required and the highly vascular nature of the liver [63].  Therefore a smaller 
tissue construct such as a micro-tissue or organ bud would be a more reasonable aim. 
Ramaiahgari et al. (2014) created spheroid aggregates from human hepatoma (HepG2) 
cells using hydrogel and allowing the cells to self-organise [143].  They observed that 
the HepG2 cells in the spheroids re-acquired lost hepatocyte functions such as the 
formation of structures resembling bile canaliculi, storage of glycogen and transport of 
bile salts, in addition to this the spheroids also exhibited an increase in the expression of 
Pluripotent 
stem cells
Definitive 
endoderm
Hepatic 
progenitors Hepatocytes
Activin A
HGF
FGF4
EGF
FGF10
RA
Activin/Nodal
SB431542
Chapter 2 – Literature Review 
 
50 
albumin, urea, xenobiotic transcription factors, phase I and II drug metabolism enzymes 
and transporters during long-term (28 days) culture [143].  These spheroids could easily 
be used for high-throughput long-term toxicity screening assays, but HepG2 cells and 
hepatocytes are different – which could result in differences in their responses.  
For many years, it was believed that liver organogenesis was not possible to reproduce 
in vitro, but recently all that changed.  Takebe et al. (2013) were able to construct a liver 
bud in a Petri dish from two-dimensionally cultured hiPSC-derived hepatic endoderm 
cells (iPSC-HEs) with human umbilical vein endothelial cells (HUVECs) and human 
mesenchymal stem cells (hMSCs) [150].  Although the cells were initially cultured in 
2D, after around six days they were able to self-assemble into manipulatable, 
macroscopically visible, mechanically stable, three-dimensional cell clusters – hiPSC-
derived liver buds [150].  It should be noted that there was no development of an 
external bile network, which means these liver buds do not perform all the functions of 
an adult liver [151]. 
 
Figure 2.34 – Generation of liver buds from hiPSCs: a) Schematic representation of the process; b) Self-
organisation of liver buds from co-culture of hiPSC-HLCs with HUVECs and hMSCs (adapted from 
[150]) 
2.4 Hydrogels for 3D Cell Patterning 
The use of biodegradable scaffolds for tissue engineering started in the late 1980s as a 
method to increase the efficiency of transplanted cells using porous scaffolds made from 
biodegradable polymers, which they termed “chimeric neomorphogenesis” [152].  Cells 
(sometimes along with proteins and genes) are cultured within porous biodegradable 3D 
scaffolds which act as the extracellular matrix (ECM) to which cells attach, grow, and 
form new tissues [153].  As the cells start to create their own ECM, the biopolymer 
which the scaffold is made from should start to degrade, allowing the new tissue to 
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support itself [154].  In scaffold design one must consider mass-transport requirements 
for cell nutrition, migration and waste removal, as well as surface features to facilitate 
cell attachment, all of which necessitate a porous scaffold structure [27,153,155].   
Traditionally, cells and other biomaterials are seeded onto the pre-prepared scaffolds 
and cultured in a bioreactor [36,156], however this approach has various limitations and 
challenges including inflammatory responses to the polymer materials [153,154], non-
uniform cell density [36,157–159], undesired triggering of stem cell differentiation 
[160] and the creation of a vascular network is as yet unsolved [36,157,158].  Therefore 
an alternative technique was developed to address these issues which create the 3D 
porous structure from cell-laden hydrogels in a layer-by-layer approach. 
Hydrogels are three-dimensional cross-linked networks of hydrophilic polymer chains, 
which can be either natural or synthetic in origin, that can absorb substantial amounts of 
water, up to 20 times its molecular weight [161–164].  The mechanical and structural 
properties of hydrogels, which are dependent on the crosslink junctions between the 
polymer chains, are comparable to the extracellular matrix (ECM) of many tissues 
[163–168].  The polymer networks contain pores between the polymer chains which 
enhance the supply of nutrients and oxygen throughout the structure in addition to 
providing room for cells and newly forming tissue [169,170].   
The formation of the polymer chain networks, commonly referred to as crosslinking or 
gelation, can be triggered or modified by the addition of light, chemicals or thermal 
transitions (depending on the hydrogel).  Hydrogels used as biomaterials are typically 
biodegradable [163]; they are also extremely customizable, with a very large selection 
of available synthetic and natural components, fabrication techniques, and synthesis 
methodologies which result in tuneable properties such as pore size and mechanical 
strength [163,166].  Encapsulating cells in hydrogels enables three-dimensional cell 
patterning and direct organ (or organoid) printing [169].  Other benefits of using 
hydrogels for 3D cell culture include: biocompatibility, injectability, ease of 
modification, and growth factors which can be released at programmed intervals to 
assist tissue formation or growth [161].  However, degradation and digestion of the 
hydrogel at a complimentary rate to that of ECM formation is not trivial to program 
[169]. 
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When human ES cells (hESCs) are encapsulated within a 3D hyaluronic acid hydrogel, 
the hESCs maintained their undifferentiated state while remaining pluripotent [171].  In 
contrast, hESCs encapsulated in 3D dextran hydrogel are induced to differentiate 
demonstrating that different hydrogels act as microenvironments which can maintain or 
trigger differentiation of stem cells [124,128]. 
2.4.1 Natural Hydrogels 
There are several natural derived hydrogel forming polymers including hyaluronic acid, 
alginate, chitosan, fibrin, collagen and gelatin.  Each natural polymer has specific 
properties depending on their origin and composition which make them more suited to 
certain applications.  A number of polymers are derived from components of the ECM 
such as collagen and fibrin.  Collagen gels are the main component of mammalian tissue 
ECM and make up 25% of the total protein mass of most mammals [163,164].  
Hyaluronic acid is a polysaccharide that can be found in most mammalian tissues.  
Alginate and agarose are also polysaccharides, but they are derived from marine algae. 
Hyaluronan, also known as hyaluronic acid (HA) or hyaluronate, is an anionic, non-
sulfated, long unbranched polysaccharide which is a major constituent of ECM where it 
regulates cell motility and adhesion, as well as mediating cell proliferation and 
differentiation [163,172,173].  Hyaluronate consists of repeating disaccharide blocks of 
(1,4)-linked β-D-guluronic acid and N-acetyl-β-D-glucosamine units [163,172].  Gelation 
of hyaluronate can be achieved by attaching thiols, methacrylates or tyramines [171].  
However, hyalurnate hydrogels can suffer from poor cell attachment due to its 
hydrophilic and polyanionic properties.  This can be remedied by modifying the 
hydrogel, as Shu et al. (2003) did, by adding peptides to enhance cell proliferation 
within the hydrogel [172]. 
Alginic acid, commonly known as alginate, is a naturally occurring anionic 
polysaccharide isolated from the cell walls of brown algae.  Alginate is a copolymer 
with linear blocks of (1,4)-linked β-D-mannuronate (M) acid and α-L-guluronic acid (G) 
residues covalently linked in different combinations of consecutive M-blocks, 
consecutive G-blocks or alternating MG-blocks [59,174].  Gelation of sodium alginate 
is easily achieved through selective binding of carboxylic groups on G-blocks with 
divalent cations such as calcium or barium, subsequently forming bonds with adjacent 
chains, creating an egg-box structure [175,176].  The viscosity of the prepared alginate 
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solution is dependent on the concentration of the polymer, molecular weight (MW), 
average chain segment ratio (G to M ratio), temperature and the pH of the solution 
[59,163,165,166,175,177]. 
Chitosan (Ct) is a linear polysaccharide which can be extracted from arthropod 
exoskeletons by deacetylation of chitin [163,178].  Chitosan consists of β-(1,4)-linked 
D-glucosamine with randomly located N-acetyl-D-glucosamine units [163,173].  Due to 
the structural similarity with mammalian ECM components, chitosan is degradable by 
human enzymes [163].  The crystallinity is determined by the degree of deacetylation 
with maximum crystallinity at 0% and 100% [163,173].  The amount of deacetylation 
also controls the degradation rates with higher deacetylation resulting in lower 
degradation rates [173].  The stable crystal structure of chitosan makes it insoluble in 
solutions above pH 7 but soluble in solutions below pH 5 [173].  Chitosan gelation is 
achieved through hydrogen bonding triggered by exposure to high pH solutions [173].  
Collagen comes in many different types, but the basic structure is composed of three 
polypeptide chains (called alpha peptides) in a triple helix with hydrogen and covalent 
bonds [163].  Collagen I is an α1(I)2α2(I) heterotrimer (two of the chains are identical 
while the third differs slightly in chemical composition), unlike collagen II and collagen 
III, which are α1 homotrimers (all three chains are identical) [179].  The mechanical 
properties of collagen fibres can be modified in several ways including: physical cross-
linking (i.e. with UV irradiation, thermal changes) [180,181]; chemical cross-linking 
(i.e. with formaldehyde, glutaraldehyde, carbodiimide) [180,182]; combination with 
other polymers (i.e. HA, fibrin, PVA) [183,184]. 
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Figure 2.35 – Chemical structure of naturally derived hydrogel polymers: a) HA; b) alginate; c) 
chitosan; d) human type II collagen fibrils described in [185] 
Natural polymers possess an inherent biocompatibility and have often exhibited positive 
cell interaction, but can suffer from large variations batch-to-batch and a lack of 
adaptability [170]. 
2.4.2 Synthetic Hydrogels 
Despite the large numbers of available natural hydrogel forming polymers sometimes 
none of them quite meet all the requirements for a particular application.  Synthetic 
hydrogels can be designed with controllable and reproducible chemical structure, 
molecular weight, degradable linkages, crosslinking modes and mechanical properties 
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[163].  In order to modify the properties of the gel, synthetic polymers can also be 
combined with natural hydrogels including: degradability, porosity, stiffness and 
hydrophilicity [164].  Novel hydrogel materials should possess the ability to survive 
sterilisation procedures and it would be advantageous if they were tailored to be 
compatible with specific bioprinting techniques to enable use in advanced tissue and 
organ fabrication [169].  Examples of synthetic hydrogel materials include PEG and 
PVA. 
Poly(ethylene glycol) (PEG), also known as polyethylene oxide (PEO) or 
polyoxyethylene (POE) depending on its molecular weight, is a polyether compound 
with a wide variety of applications in industry and medicine.  The term PEG is used for 
polymers with a molecular mass below 20,000 g/mol, while PEO refers to polymers 
with a higher molecular mass [186].  PEG/PEO is a hydrophilic polymer that can be 
modified to crosslink in a variety of ways, including photo-crosslinking by adding 
acrylates to the ends of the fibres and mixing with an appropriate photoinitiator 
[163,187].  Thermally reversible hydrogels have also been created synthesising block 
copolymers of PEG/PEO and poly(L-lactic acid) (PLLA) [163].  PEG-based hydrogels 
are extremely popular due to their biocompatibility and the versatility of the material 
[169].  The structural properties, and hence the subsequent transport characteristics, of 
the hydrogel structure can be controlled by changing the molecular weight or the 
concentration of the polymer [187].  Kraehenbuel et al. (2008) showed that PEG-based 
hydrogels can direct the differentiation of pluripotent P19 embryonal carcinoma cells 
along a cardiac lineage in vitro [188]. 
Poly(vinyl alcohol) (PVA, PVOH, or PVA1) (not to be confused with polyvinyl acetate) 
is a hydrophilic polymer that is widely used in biomedical applications including drug 
delivery and tendon repair [163,189].  PVA tends to spontaneously form weak 
physically cross-linked hydrogels which are unsuitable for most applications, therefore 
additional chemical crosslinks are used for longer term applications [169].  This 
additional cross-linking can be achieved through freeze-thaw processes, chemical cross-
linking or radiation [163,189].  Unfortunately, these processes result in harsh 
environments within the forming hydrogel that are not compatible with cells [189].  
PVA can be modified to be photo-crosslinkable by grafting crosslinkable groups onto 
the fibres, hydrogels can then be formed in minutes at physiological conditions which 
allows cells to be present during formation and in situ formation, resulting in 
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homogeneous seeding throughout the structure [189].  While PVA hydrogels possess 
similar water content to articular cartilage, the mechanical properties are not sufficient 
to withstand the typical loading conditions [190]. 
 
Figure 2.36 – Chemical structure of synthetically derived hydrogel polymers: a) PEG; b) PEO; c) PVA; 
and d) a diblock co-polypeptide hydrogel described in [191] 
Censi et al. (2011) used a photopolymerisable, thermosensitive and biodegradable 
synthetic hydrogel based on PEG and HPMAm-lactate to engineer cartilage, the 
polymer exhibited similar characteristics to collagen and encapsulated chondrocytes 
were highly viable [170]. 
Synthetic polymers have well-defined, tuneable structures, are less-prone to issues with 
remaining by-products and batch-to-batch variations which can be an issue with some 
natural hydrogel materials [169,170].  However, biocompatibility and biodegradability 
often present a challenge [170,189].  
2.4.2.1 Synthetic Peptide Hydrogels 
Polymeric hydrogels, both natural and synthetic, can suffer from a number of 
limitations including poorly defined structure and irreversible bonds [192–194].  In 
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recent years synthetic self-assembling peptide-based hydrogels have been developed 
which are composed of short oligomers that tend to aggregate in aqueous solution and 
form distinct sheet structures with charged amino acids on the outside, which enable 
further interactions with ions contained in physiological fluids [169,195].  Peptide-
based hydrogels show much promise due to their biocompatibility, biodegradability, 
easy incorporation of functional groups and well-defined sub-structures [191,196–199].  
2.4.3 Printing with Hydrogels 
By utilising a bioprinting technique to pattern hydrogels, highly porous cell-laden 3D 
constructs with complex tissue-mimicking geometries and reproducible control over cell 
placement can be constructed in a high throughput layer-by-layer approach 
[159,164,170,184].  Several different cell types could be incorporated and the structure 
could be designed to precisely fit into an existing defect to facilitate regeneration.  
Bioprinted hydrogel structures can be used to assist the regeneration of a number of 
different tissues including liver [200], cartilage [170,184], bone [201] and skin [202].  
Hydrogel structures created with a bioprinter have several advantages over those created 
using other techniques: there will be much increased repeatability between structures as 
compared to those created using other techniques such as particulate leaching, gas 
foaming or solvent casting; also, complex internal architectures can be designed in 
computer aided design software using data from medical scans as a template [63,155]. 
Typically, hydrogels are formed from long chains, which result in high viscosity gels 
with non-Newtonian characteristics [203].  However this is usually higher than the 
viscosity range of most bioprinting techniques [34,45,58,67], therefore non-cross-linked 
precursor solutions are usually dispensed separately to be cross-linked post-printing in a 
layer-by-layer self-assembly process to build up a 3D structure from 2D slices [203].  It 
is important to note that in order to create structures with geometric fidelity using a 
bioprinter, the viscosity and gelling speed have to meet very specific requirements that 
depend on the application [159].  In certain situations this is not possible as the hydrogel 
is a single component such as collagen which is a gel at room temperature; in this case it 
is possible to cool the gel to lower the viscosity to a printable range [57].  This has its 
drawbacks as the temperature would need to be raised after each layer to allow it to gel 
sufficiently to support the next layer which drastically increases the time required to 
print a 3D structure. 
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Figure 2.37 – Schematic of the layer-by-layer hydrogel-assisted bioprinting technique (adapted from 
[158]) 
Schuurman et al. (2011) used a bioprinter to create a 3D hybrid hydrogel and 
thermoplastic structure with encapsulated human immortalized chondrocytes.  
Polycaprolactone (PCL) and C20A4-laden alginate was printed in a layer by layer 
fashion with the PCL supporting the alginate which would be challenging to print alone 
at low viscosities.  The post-printing viability of the cells was significantly lower than 
the control which is possibly due to residual heat from the PCL [159]. 
Boland et al. (2003) introduced a new scheme for organ and tissue printing using 
hydrogels.  They proposed using preformed cellular aggregates as building blocks with 
hydrogels added to support and direct their self-assembly [36].  Aggregates are placed 
on the surface of the hydrogel so that they are in contact with their neighbours and 
allowed to fuse into contiguous structures; extra hydrogel can be added to facilitate the 
creation of 3D structures.  This new scheme has several advantages, including lower 
stress experienced by cells during dispensing, minimisation of required hydrogel 
material, large scale tissues that can be created quickly through the process of aggregate 
fusion, a cellular environment which is closer to the in vivo environment so cells will 
work better, and sensitive stem cells are less likely to re-differentiate and lose their 
function [158,204]. 
2.5 Summary and Conclusion 
In this review, several different topics were covered: techniques for printing viable 
biological cells were reviewed and summarised; a background in human stem cell 
biology was provided with descriptions of differentiation, aggregate creation and the 
creation of liver tissue; and hydrogels including their use in 3D cell patterning was 
presented.  Table 2.3 compares the capabilities of the different biological cell printing 
techniques described in this review. 
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There are many different approaches to cell printing, but simply described, it is a rapid 
transfer technique that is easily customised in terms of cell types, printed patterns and 
application.  Many of the techniques utilise CAD/CAM technology (be it software or 
machinery) and have achieved, or are very close to, single cell resolution.  Cells, and 
other biomaterials, can be deposited onto a homogeneous growth surface to ensure 
cellular proliferation is controlled by normal cell-cell interactions.  Precise patterns of 
cells can be deposited to form co-cultures and multi-cultures.  Three dimensional 
printing is possible by depositing cells layer-by-layer, either by repeated deposition of 
cells onto a single point or by the addition of matrix layers.  The majority of cell 
printing techniques are capable of printing high percentages of viable cells quickly and 
reliably.  However, the viability and function of printed cells are affected by different 
factors in each technique, such as shear forces in the nozzle, heat applied during 
dispensing and impact on the substrate surface, each of which need to be optimised 
separately to minimise cell damage. 
Human stem cell biology is far too large a subject to be described in full in this thesis, 
but the relevant topics of this field were described here.  Pluripotent stem cells (PSCs) 
have the capability to differentiate into any of the cells found in the adult body and have 
the ability to self-renew indefinitely but differentiation in vitro can be hard to control.  
There are two types of PSC: embryonic stem cells and induced pluripotent stem cells.  
A number of differentiation protocols have been developed that give specific 
instructions to PSCs and direct them to differentiate down a specific lineage pathway to 
the desired cell type.  Cell-based in vitro assays with human liver cells could be used to 
increase the efficiency of drug development.  PSCs can be directed to differentiate into 
hepatocytes which demonstrate many of the functions of in vivo cells; these cells could 
be bioprinted with hydrogels to create 3D liver micro-tissues that replicate the response 
and functions of a human liver but on a much smaller scale.  If multiple different hPSC 
lines are used then high-throughput population testing of novel drugs would be possible. 
Hydrogels are three-dimensional cross linked networks of hydrophilic polymer chains 
that can absorb substantial amounts of water; the mechanical and structural properties of 
hydrogels are comparable to extracellular matrix (ECM).  Cells can be cultured in 3D 
hydrogel structures and since the networks are porous the cells can grow and get access 
to nutrients.  The hydrogel acts like a scaffold for the cells while they grow and should 
degrade when the cells start to create their own ECM.  An advantage of using hydrogels 
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instead of traditional scaffolds is that they can be created in a layer-by-layer approach 
and do not suffer from the biocompatibility and mechanical incongruity with tissue.  
There are several types of hydrogel, both natural and synthetic, which cross-link in a 
variety of different ways and are extremely customizable.  Hydrogel precursor solutions 
are typically aqueous and can therefore be deposited with a bioprinter in a layer-by-
layer approach to create porous cell-laden 3D constructs with tissue-mimicking 
geometries and high spatial control over cell placement. 
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Chapter 3 – Experimental Methods 
3.1 Introduction 
Myriad experiments were performed in the course of this research in subjects ranging 
from initial testing and characterisation to stem cell culture and micro-tissue 
engineering.  The experimental methods for all of these experiments are described in 
this chapter.  Section 3.2 presents the valve-based deposition system that is at the centre 
of bioprinting platform.  Section 3.3 describes the procedures used to test the 
bioprinting platforms’ compatibility with biological cells including human embryonic 
stem cells.  Section 3.4 presents the techniques used to fabricate the novel components 
for the bioprinters.  Finally, Section 3.5 covers the technique used to create the two 
component solutions used to print hydrogels. 
3.2 Valve-based Deposition System 
Regardless of changes in the surrounding systems – the mechanical motion mechanism, 
control electronics, firmware and software – one system remains largely unchanged 
throughout all the experiments in this thesis: the valve-based deposition system.   
As shown in Figure 3.1, each nanolitre dispensing system is comprised of a solenoid 
valve (VHS 25+ Nanolitre Dispense Valve, Lee Products Ltd) with a Teflon coated 
nozzle (Minstac Nozzle, Lee Products Ltd) controlled by a digital spike signal.  Flexible 
tubing connects the solenoid valve to a static pressure reservoir (like an ink cartridge in 
a standard printer) for the bio-ink solution (i.e. cells in suspension, staining solution or 
just ordinary water for testing purposes) via a custom designed pressure manifold block. 
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Figure 3.1– a) Detailed schematic of the solenoid valve mechanism; b) Schematic of the valve-based 
nanolitre dispensing system. 
Bio-ink is dispensed by opening and closing the valve.  The volume of dispensed fluid 
is affected by several factors: the properties of the fluid (i.e. viscosity, surface tension, 
concentration of suspended particles such as cells.); the internal diameter of the nozzle 
orifice; the valve on-time; and the static pressure applied to the bio-ink reservoir.   
 
Figure 3.2 – Valve operating signals: a) control signal input to the valve driver, b) the output signal to 
the valve.  When the voltage across the valve is 24V (V1) the valve is open. 
a) b)
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3.3 Biological Techniques 
The experiments were performed in collaboration with Jason King, John Gardner, 
Sebastian Greenhough, Catherine Fyfe and Helen Bradburn from Roslin Cellab.  All 
cell culturing was provided by them, in addition to the various different cell media types 
used in the following experiments. 
3.3.1 Cell Culture 
A frozen sample of cells was taken from the freezer, thawed out, suspended in medium 
and centrifuged for a few minutes to separate any large aggregates of cells.  The 
medium was removed and the cells were re-suspended in fresh medium.  By pipetting 
the solution up and down multiple times the cells were separated into single cells.  The 
suspended cells were then transferred to a T25 flask.  When observed under a 
microscope the cells were observed to be circular with “hands” and therefore healthy.  
The flask was then placed inside an incubator at 36.0-37.5°C, 5.0±0.5% CO2. 
To prevent the cells from becoming over confluent they need to be split every few days.  
When subjected to typsin/EDTA, the cells lose contact with the T25 flask but remain in 
contact with each other.  By pipetting the dislodged cells up and down a few times the 
cells can be returned to a single cell suspension and can be split into the required 
amounts. 
3.3.2 Optical Cell Viability 
It is very important to determine if the cells suffered any damage as a result of the 
printing process and, if so, how much.  A solution containing suspended cells was 
loaded into the reservoir of one of the cell deposition systems.  The printing process was 
then performed into the wells of a multi-well plate and a small amount of solution that 
was kept separate and manually pipetted onto the plate provided a non-printed control. 
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Figure 3.3 – Printing scheme for the optical cell viability test with printed wells shown in blue and 
control shown in green 
The viability of the printed and non-printed cells was assessed via trypan blue 
exclusion.  A 0.4% solution of trypan blue (T8154, Sigma-Aldrich) in phosphate-
buffered saline (PBS, pH 7.2, Life Technologies) was prepared.  0.1 mL per 1 mL of 
trypan blue solution was added to each printed and non-printed sample.  Cell viability 
was measured by viewing bright-field images under the microscope (fl0015000m 
Trinocular Fluorescence Microscopes) both immediately and at 24 hours after printing.  
The numbers of live and dead cells were counted using ImageJ.  Between these times 
the control and printed cells were kept in a CO2 incubator (Galaxy S+, RS Biotech) at 
36.0-37.5°C, 5.0±0.5% CO2. 
3.3.3 Fluorescence-Activated Cell Sorting 
Fluorescence-activated cell sorting (FACS) is the most popular type of flow cytometry. 
It is a process for sorting heterogeneous suspensions of biological cells into separate 
containers, based upon the specific light scattering and fluorescent characteristics of 
each cell [1].   
Specific cells within a mixture are labelled using fluorescently tagged antibodies that 
bind selected cell-surface molecules (Figure 3.4a).  The cell suspension is delivered in a 
rapid, thin stream into the centre of a second moving steam of fluid called the sheath 
flow [2].  The two fluids do not mix due to differences in viscosity and density resulting 
in a stable bi-layer stream.  The tube through which the stream flows narrows into a 
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funnel, constricting the flow and resulting in a narrower stream with the cells spaced out 
individually.   
The stream is actuated with a vibrating mechanism which causes it to break up into 
individual droplets each containing one cell.  Each cell passes through a laser beam, 
where its fluorescent properties are measured using two detectors.  The forward scatter 
channel provides information on the cells’ size and viability, while the side scatter 
channel provides information on the fluorescence and granularity of the cell, which can 
be used to identify the cell type.  Depending upon which antibody it carries, the droplet 
is given a certain electrical charge.  The charged droplet then passes between a pair of 
charged metal plates, which diverts droplets into different containers based upon their 
charge (Figure 3.4b). 
 
Figure 3.4 – Schematic of fluorescence-activated cell sorting a) detail view of the fluorescent tag on the 
cell surface, b) diagram of the FACS technique (adapted from  [1,2]) 
BD’s FACSCalibur flow cytometer was used to perform cell analysis for this research.  
Advantages of this system include its high speed and the depth of the data it outputs. 
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Figure 3.5 – BD FACSCalibur 
3.3.4 Multi-marker Pluripotency Validation 
Viability alone is insufficient when printing pluripotent stem cells; printed cells must 
not only be viable but also morphologically unchanged by the printing process.  In other 
words, they need to still be pluripotent stem cells post-printing; the bioprinting process 
must not trigger the cells to differentiate.  Pluripotency can be validated by testing cells 
for the presence of certain biomarkers including SSEA-3, SSEA-4, OCT3/4, SOX2, 
NANOG and many others [3,4]. 
3.3.4.1 OCT3/4 Optical Validation 
Human ES cells were printed out and kept in a CO2 incubator (Galaxy S+, RS Biotech) 
at 36.0-37.5°C, 5.0±0.5% CO2 for 48 hours.  The now adherent hESCs were washed 
once with PBS and fixed using a 4% solution of paraformaldehyde for 20 minutes at 
room temperature (RT).  Cells were permeabilised by washing once with PBS and then 
incubating with 100% ethanol for 5 minutes at RT.  Cells were then washed three times 
with PBS and blocked using 1% normal goat serum (Sigma G9023) in PBST (PBS plus 
0.1% Tween 20) for 1 hour at RT.  Blocking buffer was then replaced with fresh 
blocking buffer containing the primary antibody (goat anti-OCT-4, Santa Cruz SC-
5279) at a dilution of 1:200.  This was incubated on a rocker table at RT for 2 hours or 
overnight at +4 °C.  The primary antibody was removed by washing three times with 
PBST for 5 minutes each at RT.  An Alexa-fluor conjugated secondary antibody (rabbit 
anti-goat, Life Technologies, A-11078) was diluted 1:200 in 1% normal rat serum 
(Sigma R9133)/PBST and used for 30 minutes at RT in the dark on a rocker table.  
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Unbound antibody was removed during three 5 minute PBST washes on a rocker table 
at RT in the dark.  Salt was removed by washing twice with double distilled water.  
Excess water was removed and the sample embedded with Vectashield containing 
DAPI according to manufacturer’s instructions.  Samples were allowed to set at RT in 
the dark overnight before being analysed on a fluorescence microscope. 
3.3.4.2 Multi-marker FACS Validation 
Human ES cells were printed out and kept in a CO2 incubator (Galaxy S+, RS Biotech) 
at 36.0-37.5°C, 5.0±0.5% CO2 for one week.  The now adherent hESCs were washed 
once with PBS and trypsin/EDTA was added to detach the cells from T25 flask.  By 
pipetting the dislodged cells up and down a few times the cells were returned to a single 
cell suspension.  A sample was viewed under the microscope to confirm the presence of 
single cells.  Cells were then washed three times with PBS and centrifuged at 300g for 5 
minutes before being re-suspended in an appropriate volume of PBS for the required 
cell concentration. 
Cells were fixed using a 4% solution of paraformaldehyde for 20 minutes at room 
temperature (RT).  Cells were permeabilised by washing twice with 1X BD Perm/Wash 
buffer (centrifuging at 500g for 5 minutes), re-suspended in 1X BD Perm/Wash buffer 
at 1107 cells/mL and then incubated for 10 minutes at RT.   
Two polystyrene tubes were prepared, each containing 100 µL of permeabilised cells at 
1107 cells/mL, one labelled “specific stain” and one “isotype control”.  20µL each of 
PerCP-Cy5.5 Oct3/4, PE SSEA-1 and Alexa Fluor® 647 SSEA-4 components were 
added to the specific stain tube, while 20µL each of PerCP-Cy5.5 isotype control, PE 
isotype control and Alexa Fluor® 647 isotype control components were added to the 
isotype control tube.  The tubes were mixed gently and incubated for 30 minutes at RT 
in the dark.  Four new tubes were labelled “Negative”, “PerCP”, “PE” and “Alexa 647”.  
To each of these tubes were added 100 µL of Perm/Wash buffer, negative beads and 
anti-mouse beads (except for the negative tube which only had buffer and negative 
beads).  20µL of the relevant stain were added to the tubes (one for each except the 
negative tube).  The four tubes were vortexed and incubated for 30 minutes at RT in the 
dark.  All six tubes were washed twice with 1X BD Perm/Wash buffer (centrifuging at 
500g for 5 minutes), cells and beads were re-suspended in 300 µL of Foetal Bovine 
Serum. 
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The beads were run through the FACS machine to confirm the application settings 
according to manufacturer’s instructions.  Finally the cells were run through the FACS 
machine and the data was recorded. 
3.4 Bioprinter Parts Fabrication 
3.4.1 CO2 Laser Machining 
The carbon dioxide (CO2) laser was invented in 1964 by Kumar Patel [5].  They are the 
highest power continuous wave lasers that exist and they have a reasonably high 
efficiency.   
The active laser medium is composed of carbon dioxide (CO2), nitrogen (N2), hydrogen 
(H2), helium (He) and (sometimes) xenon (Xe).  These gases are mixed and fill the 
discharge tube and energy is pumped through the gas in the form of an electrical 
discharge.  Electron impacts excite the nitrogen molecules into a metastable vibrational 
state.  This excitation energy is transferred to the carbon dioxide molecules during 
collisions.  Helium molecules serve to control the temperature and the other components 
help to reoxidise the carbon monoxide molecules – which were formed in the discharge 
– back to carbon dioxide.  The discharge tube is located between two mirrors, creating a 
laser resonator that continuously amplifies the generated laser light. One of the mirrors 
is partially permeable to the specific desired output wavelength and allows some of the 
laser light of this wavelength to escape. Laser light can then be passed through a lens to 
focus it into a laser beam with an extremely high energy density. 
 
Figure 3.6 – Schematic of a basic laser system 
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Trotec’s Speedy 300 was used to laser cut the acrylic panels which formed part of the 
bioprinters developed during this research.  The advantages of this system are its high 
speed, excellent beam quality, large work area and superior linear motion systems.  The 
system was also very easy to use and accepted designs easily in standard DXF format. 
 
Figure 3.7 – Trotec Speedy 300 CO2 Laser engraving machine 
3.4.2 Additive Manufacturing (3D Printing) 
Fused filament fabrication (FFF), otherwise known as fused deposition modelling 
(FDM) was invented by S. Crump in 1989 [6].  It is one of the most popular additive 
manufacturing techniques due to the simplicity of the mechanism. 
As with all additive manufacturing techniques, a 3D model file (usually in STL format) 
is orientated and scaled.  The file is separated into thin (usually 100 µm) slices in the Z-
direction and tool paths for each slice are calculated for the model (and support 
structures if required).   
A coil of thermoplastic is unwound and fed into the extruder mechanism, which uses a 
driven toothed drive gear and a roller to feed and retract the filament at a controlled rate 
into and out of the heater block.  The heater block heats the filament beyond its glass 
transition temperature and small beads of thermoplastic material are extruded from the 
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nozzle to form layers as the material hardens.  The nozzle traces out the calculated tool-
paths, and the model is built up from the bottom up, layer by layer. 
Several materials can be used with this technology.  The most popular are Acrylonitrile 
Butadiene Styrene (ABS) and Polylactic acid (PLA), and others include: 
 Nylon 
 High Density Polyethylene (HDPE) 
 Polycaprolactone (PCL) 
 Polycarbonate 
 
Figure 3.8 – Schematic of the fused filament fabrication method of additive manufacturing 
Makerbot’s Replicator/Replicator 2X were used to 3D print the extra components used 
to create the bioprinters for this research.  The advantages of these systems are their 
relatively low cost, reasonable part resolution, large work area and simple mechanisms 
which enable easy repair and servicing.  The system was also very easy to use and 
accepted designs easily in standard STL format. 
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Figure 3.9 – Makerbot Replicator 2X 3D printer 
3.5 Hydrogel Material Preparation 
Alginic acid, commonly known as alginate, is a naturally occurring anionic 
polysaccharide derived from the cell walls of brown algae.  Alginate is a copolymer 
with linear blocks of (1,4)-linked β-D-mannuronate (M) acid and α-L-guluronic acid (G) 
residues covalently linked in different combinations of consecutive M-blocks, 
consecutive G-blocks or alternating MG-blocks [7,8].  Gelation of sodium alginate is 
easily achieved through selective binding of carboxylic groups on G-blocks with 
divalent calcium cations, subsequently forming bonds with adjacent chains creating an 
egg-box structure [9,10].  The viscosity of the prepared alginate solution is dependent 
on the concentration of the polymer, molecular weight (MW), average chain segment 
ratio (G to M ratio), and the pH of the solution [7,11]. 
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Figure 3.10 – Alginate hydrogel structure: a) alginate monomers; b-c) representation of “egg-box” 
model binding of monomer blocks to calcium ions (adapted from [10])  
The alginate hydrogel used for this research was formed by mixing two solutions: 
sodium alginate and calcium chloride, varying the volume and concentration ratios of 
these two solutions yielded hydrogels with different mechanical properties.  The 
procedures for creating 2% sodium alginate and 5% calcium chloride solutions are 
provided as an example of the process. 
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1.0 g of Sodium alginate (W201502, Sigma-Aldrich) was measured and added to a 50 
mL centrifuge tube to which was added 50 mL of deionized water.  The centrifuge tube 
was submerged in an ultrasonic bath at approximately 60 °C for approximately one hour 
(or until the solid had dissolved) before further agitation on a vortex spinner to provide 
a more uniform solution. 
2.5 g of calcium chloride dehydrate (223506, Sigma-Aldrich) was added to 50 mL of 
deionized water in a 50 mL centrifuge tube and allowed to dissolve. 
3.6 Plasma Surface Treatment 
Plasma treatment was used to modify the surface wettability of materials used as 
bioprinting substrates.  Oxygen plasma removes organic contaminants by chemical 
reaction with highly reactive oxygen radicals and through ablation by energetic oxygen 
ions; it also promotes surface oxidation and hydroxylation which serves to increase 
surface wettability [12]. 
Samples (glass microscope slides) were placed inside the chamber of the plasma 
treatment machine and the vacuum pump evacuates the chamber creating a low pressure 
environment.  At a pressure of approximately 0.1 mbar the process gas (i.e. oxygen) is 
fed into the chamber.  When the working pressure is reached, the process gas is ignited 
creating the plasma which treats the exposed surfaces of the workpiece.  Gas is 
continuously refreshed and contaminated gas is removed.  When the treatment is 
complete the chamber is vented and the treated workpiece can be removed. 
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Figure 3.11 – Schematic of the plasma system (adapted from [13]) 
Diener Electronic’s Zepto plasma system was used to treat the glass microscope slides 
used as bioprinting substrates for this research.  The advantages of this system are its 
low cost, suitable chamber volume and ease of use.  
 
Figure 3.12 – Diener electronic Zepto plasma system 
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Chapter 4 – Development of Novel Valve-based 3D Cell Printing 
Platforms  
4.1 Introduction 
Based on the findings of the literature review, the valve-based technique was chosen 
over the other printing techniques described in Chapter 2 because it is cheaper and more 
expandable than laser printing, gentler for cells, and able to use materials with a wider 
range of viscosities than inkjet, has greater control over droplet size and location than 
electrohydrodynamic jetting; and is less prone to heating than acoustics. 
The development of a valve-based bioprinter, including improvements and challenges 
encountered, are described in this chapter.  Section 4.2 presents the first generation 
bioprinter.  Section 4.3 details the creation of a portable valve-based deposition system.  
Section 4.4 describes an improved bioprinter that corrects some of the issues 
encountered in the first generation model.  Finally, Section 4.5 presents the final version 
of the bioprinter developed in the course of this research. 
4.2 Mark I 
4.2.1 A Single Nozzle System 
There have been several different generations of the cell printer setup from the very first 
to the current setup.  The first version was a very crude proof-of-concept system.  A 
single valve-based deposition system was mounted to a 3-axis CNC machine (High-Z 
S-400 CNC Machine, Heiz CNC-Step) with the valve assembly and some control 
electronics mounted to the tool head, while the bio-ink reservoir – which at this point 
was a small reagent bottle with tubing passing through holes drilled into the lid and 
sealed with glue – was located on the worktop next to the CNC machine (Figure 4.1). 
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Figure 4.1 – Single nozzle system setup 
The CNC machine uses G-code to define its movements, so an algorithm was developed 
in MATLAB which takes the coordinates of the target points as an input and outputs a 
G-code file that can be read by the CNC machine.  First, the algorithm takes in the 
target point coordinates in the form of a binary image with 1 representing a target point 
and 0 a non-target point (as shown in Figure 4.2 below).  The coordinates of all the 
target points are then stored in a 2 column array.  The array of target points is analysed 
and an optimal order is calculated using a Travelling Salesman algorithm, which passes 
through each point only once in the shortest path.  The MATLAB algorithm stores the 
G-code commands in a text file for each target point in the calculated order, which can 
be used to instruct the cell printer to follow the calculated path, pausing at every target 
point to allow for printing by manually triggering the deposition system. 
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Figure 4.2 – Target point coordinates to G-code 
This initial version performed reasonably well but suffered from a number of usability 
issues.  Firstly, the system ran on two completely separate control systems (Figure 4.3) 
– the CNC machine controller did not communicate with the deposition system in any 
way.  The only way to print an array of droplets was therefore to either manually 
program each movement of the CNC machine before manually triggering the deposition 
system or to program the entire array pattern – including pauses at each dispense 
position – and manually trigger the deposition system when the CNC machine paused.  
This meant that even simple patterns were extremely time consuming to set up and to 
run.  Secondly, the deposition control system was a LabVIEW program which ran on 
the lab computer and was quite slow to respond, so was not capable of outputting 
signals with small enough pulse widths and high standard of accuracy and repeatability 
to dispense the small volumes which would be required for bioprinting. 
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Figure 4.3 – Pictographic Diagram of experimental setup for the Mark Ia bioprinter 
4.2.2 Switching from LabVIEW to Arduino and MATLAB 
In order to address some of the issues encountered with the first version, a number of 
refinements were added to the bioprinter.   The main alteration was the replacement of 
the LabVIEW control system with a new control program running on a microcontroller 
(Arduino UNO, Arduino) to generate the control signals for the deposition system.  A 
series of new MATLAB and Arduino programs were created to control the cell printer 
using this new hardware setup.   
The first program developed was an algorithm written in C code for the Arduino which 
triggers the dispense cycle by sending a short impulse signal to the valve driver, 
opening and closing the valve and allowing the bio-ink to be dispensed at the cell 
printers current location.  This program allowed for various volumes to be dispensed 
either by varying the width of the generated signal or specifying a number of droplets to 
dispense in quick succession. 
The signal to trigger the dispensing of a droplet was initially sent by pressing a button 
attached to the Arduino for testing purposes.  As the aim was to create a single control 
system for the cell printer, the dispense trigger signal needed to be sent from the 
computer over the serial line.  The algorithm therefore required the ability to handshake 
with the computer to agree on a communications protocol.  The dispensing program was 
modified accordingly to enable serial communication with a new MATLAB program 
which ran on the lab PC and could trigger the deposition system through the Arduino. 
 
LabVIEW 
CNC Software 
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4.2.3 An Optical Vision System 
The next upgrade was the addition of a USB microscope for visual inspection of the 
target substrate during the printing process.  Due to the type of deposition system used, 
a direct line-of-sight view through the nozzle was not possible, so the USB microscope 
had to be mounted at an offset angle from the valve assembly.  A support frame was 
constructed from perforated zinc sheeting and jubilee clips and mounted to the tool head 
of the CNC, as shown in Figure 4.4. 
 
Figure 4.4 – Single nozzle system with USB microscope 
While also useful for simply observing the printing process during experiments, the 
main purpose of the USB microscope was an attempt to tie together the two separate 
control systems.  The first idea was to have single closed-loop control system with the 
USB microscope supplying the feedback as shown in Figure 4.5.  By scanning over the 
area to be printed and capturing several images sufficient to describe the entire area, it is 
possible to join the images together like a mosaic and create an image of the entire 
target region.  Features, such as the wells on a microfluidic device, can be extracted 
from this image and their coordinates saved in array.  This control system would send 
the movement commands to the CNC machine over the parallel line from the computer 
and the dispense signals over the serial line to the Arduino. 
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Figure 4.5 – Flow diagram of the proposed MATLAB vision based control system for the Mark I 
bioprinter 
Unfortunately, the communications protocol used by the CNC machine proved difficult 
to mimic, so a different program had to be devised.  The final algorithm was developed 
in MATLAB, using the USB microscope to identify the pauses of the CNC machine as 
the points to dispense bio-ink.  The program captures real-time images from the USB 
microscope and compares them to previous frames to determine whether or not the 
CNC machine tool head is in motion.  If the absolute difference between the two frames 
is below a pre-set threshold (determined experimentally), then the algorithm designates 
the current position as a target point and sends a signal to the Arduino to trigger the 
dispensing of a droplet of bio-ink.  Some timers were added to the algorithm to ensure 
that target points weren’t accidentally assigned in incorrect locations: for example, if the 
tool head was moving too slowly it could be possible for two frames to be similar 
enough to trigger an erroneous dispense.  The timers also ensure that the cell printer 
dispenses only one droplet at each target point, regardless of how long the CNC 
machine dwells at a single location.  In order to simplify the printing process, this 
algorithm runs continuously until the CNC machine stops moving (the dwell timer 
measures an extremely long pause).  Furthermore, to prevent the algorithm triggering 
the dispense of a droplet before the CNC machine has moved to the first target point, an 
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enable signal was added which activates after the first movement is detected.  A 
flowchart for this control system is shown in Figure 4.6. 
 
Figure 4.6 – Flow diagram of the implemented MATLAB vision based control system for the Mark I 
bioprinter 
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Figure 4.7 – Pictographic Diagram of experimental setup for the Mark Ib bioprinter 
While these upgrades greatly improved the printing resolution and speed of the system, 
there were still a few issues upon which to improve.  The mount for the USB 
microscope was too unstable and wobbled violently whenever the CNC machine was in 
motion; this, coupled with the defocusing of the USB microscope due to the vibration, 
meant that the USB microscope could not be used to reliably monitor or control the 
printer.  Another issue was that the length of the tubing between the valve and the bio-
ink reservoir was far too large.  This meant that the system took a long time to sterilise 
and load new bio-inks and this large dead volume created a lot of wasted biomaterials.  
Finally, the vision based control system was too Heath Robinson; it worked inefficiently 
and the system was slower than it could be.  Improvements could be made; for instance 
a direct communication between the CNC machine controller and the deposition 
system. 
4.2.4 Arduino – CNC Machine Communication 
Happily, an error in development led to an alteration that greatly improved the system.  
While attempting to rationalise the wiring of the system, one of the stepper motors was 
inadvertently disconnected from the CNC machine controller while the system was 
powered-on which unfortunately damaged the CNC machine controller beyond repair. 
 
MATLAB 
CNC Software 
Arduino program 
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Building a new CNC machine controller allowed for much greater control over the 
system and tied the separate control systems together more effectively.  A 4-axis stepper 
motor driver (G540, Geckodrive Motor Controls) and a suitable 36V 20A power supply 
(S-360-36, MeanWell) were mounted in an enclosure (LC540-4A, Camtronics Inc.).  
This new controller had a few outputs that could be triggered by G-code which meant 
that the CNC controller could finally connect directly to the deposition system 
controller and the entire system could therefore be run using a single G-code file. 
 
Figure 4.8 – Replacement CNC machine controller 
There were a few issues to overcome: the triggerable outputs operated at 36V but the 
Arduino operated at 5V, so some electrical relays were added to the outputs and 
connected to a 5V power supply in such a way that when the outputs went high a 5V 
signal also went high.  The deposition system could then be triggered by the CNC 
machine controller with the appropriate G-code. 
Initially the trigger system operated simply by triggering the dispense cycle on the 
rising edge of the control signal.  However, the relay is a rather slow component and 
took time to physically switch between states.  In order to speed up the system, the 
deposition system controller was programmed to trigger the dispense cycle on both the 
rising and the falling edge of the control signal as shown in Figure 4.9, cutting the wait 
time in half. 
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Figure 4.9 – CNC deposition trigger signals illustrating the halving of the dispensing wait time: a) CNC 
machine controller output, b) the control signal output to the valve. 
4.2.5 Dual Nozzle System with On-board Bio-Ink Reservoirs 
More complex experiments that were being planned required more than one bio-ink to 
be printed in a single experiment, so a second cell deposition system was added to the 
CNC machine tool head.    
The reagent bottle that was being used as a bio-ink reservoir was replaced by two 50 mL 
centrifuge tubes which were repositioned onto the CNC machine tool head to shorten 
the length of tubing between the solenoid valve and the reservoir.  This served to 
decrease the amount of time required to purge the system of a bio-ink after it has been 
used and to prime the system with the next bio-ink to be used.  The tubes were passed 
through holes drilled into the lids of the tubes and sealed with epoxy resin. 
The USB microscope mount was augmented with the addition of an extra supporting 
beam to reduce the vibration caused during movement. 
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Figure 4.10 – Dual nozzle system with USB microscope and integrated bio-ink reservoirs 
This version has the capability to print two different biological materials independently 
of each other in the same pre-programmed pattern. 
Unfortunately, the seal on the centrifuge tubes was insufficient and there were periodic 
leaks when higher pressures were used.  These leaks were not always immediately 
obvious, which meant that if went undetected it could waste a lot of time and bio-ink 
during an experiment. 
4.2.6 A Laser-cut Tool Head Mount 
The existing tool head mount performed reasonably well but a more robust tool head 
mount was needed for the dual deposition systems to improve the reliability of the 
system and reduce the unwanted vibrations of the USB microscope.  A new, sleeker 
mount was designed in CorelDRAW and fabricated from 4 mm thick clear Acrylic sheet 
on a laser cutter (Trotec Speedy 300 CO2 Laser Engraver, Trotec). 
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Figure 4.11 – A laser-cut tool head mount 
After the new tool head was finished, a number of other refinements were made, which 
included new valve mounting clips which ensured that the valves remained vertical and 
at a fixed relative distance apart.  A more important change was the addition of new 
pressure manifolds (Fluiwell-1C-15 mL, Fluigent S.A.) that provided a pressure seal 
between the bio-ink reservoirs and the tubing that goes to the valves and the pressure 
regulators.  The bio-ink reservoir centrifuge tubes were replaced with 15 mL versions as 
Fluiwell does not manufacture manifolds to fit the 50 mL tubes and such large volumes 
are not normally required for the experiments conducted in this course of research. 
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Figure 4.12 – Final hardware upgrades to the Mark I bioprinter 
4.2.7 Graphical User Interface 
The bioprinter uses G-codes to define the movement and droplet patterns to dispense.  
These files were manually written in Notepad, meaning that new patterns would take a 
long time to create.  For that reason a new program was created to automatically 
generate the G-code files. 
The Graphical User Interface (GUI) program had an axis where dispense points could 
be plotted by clicking with the mouse.  In addition to their location, plotted points stored 
a variable to control the droplet volume at that point; this variable could be altered by 
selecting the point, and points could be deleted.  Since the points were likely to be 
added in a non-optimal order, two path planning routines were available: shortest path 
and raster scan path.  The shortest path used a genetic algorithm implementation of the 
Travelling Salesman Problem to find the shortest path between every point while 
stopping at each point only once; this path is useful when sparse patterns were created.  
The raster scan path sweeps vertically bottom-to-top, then moves to the left, where it 
turns and sweeps out the next path top-to-bottom (the paths have been optimised 
slightly to speed up the system); this path is useful for more densely populated patterns 
are created. 
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Figure 4.13 – Graphical User Interface (GUI) program for the Mark I bioprinter in free plot mode. 
Points entered into the program (top), generated shortest path through these points (left) and optimised 
raster scan path through the points (right) 
Since several planned experiments required the use of multi-well plates, the GUI 
included multi-well plate options.  The properties of the well plate, including the 
number of wells and columns as well as the well spacing, could be entered into the GUI 
and displayed on the plot axis.  Dispense points could be added in the same manner as 
before, but points outside the wells would snap to the nearest well, or the wells could be 
automatically be populated with the current size setting. 
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Figure 4.14 – Graphical User Interface (GUI) program for the Mark I bioprinter in multi-well plate 
mode. Well coordinates generated from Well Setup (top left), points auto-populated to every well (top 
right), generated shortest path through these points (bottom left) and optimised raster scan path through 
the points (bottom right) 
4.2.8 Additional Software Development 
A number of other algorithms were developed during the development of the control 
software.  Although they were not directly used in the control software for this version 
of the bioprinter, they contributed to the development of the current version of the 
control software. 
The first of these algorithms was written in C code for the Arduino and it performs a 
dynamic purge of the cell deposition system to remove any air bubbles that are present.  
Different size bubbles “break off” at different frequencies; therefore the algorithm is 
required to cycle through the dynamic response range of the value.  This is done by 
rapidly opening and closing the valve at 100 Hz, 150 Hz, 200 Hz and so on up to 500 
Hz for 1 second at each frequency.  Depending on the system pressure and 
configuration, the purge cycle may need to be repeated.  If the system has been unused 
for an extended period of time or a new bio-ink is to be used the purge cycle should be 
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run repeatedly with water until all the remnants of the previous bio-ink have been 
flushed from the system.  This new purge program also allowed for the system to be 
cleaned and sterilised more easily than before and a sterilisation protocol was 
established by flowing solutions through the deposition system using the purge 
program: 
 2% bleach solution; 
 70% ethanol alcohol solution; 
 Millipore filtered water/Sterile culture media. 
This is similar to the cleaning techniques used by a number of different groups: Pardo et 
al. [1] and Roth et al. [2] rinse the bio-ink cartridges with ethanol and deionised water; 
and Boland et al. have a similar rinse procedure but the entire bioprinter assembly is 
placed beneath a UV lamp in a laminar flow hood and irradiated overnight.  The 
addition of the bleach solution and the use of sterile culture media before printing serves 
to speed-up the procedure and ensure that there are no left-over salts in the deposition 
system. 
4.2.8.1 Optical Control Software Development 
Due to the offset positioning of the USB microscope, the view the control system 
receives of the substrate is oblique, so a vision algorithm was written in MATLAB that 
corrected the perspective view.  The algorithm corrects the view by identifying the side 
of the image that is furthest from the USB microscope and stretching it so that it 
matches up with the side that is closest to the USB microscope.  An exemplar input and 
output is shown in Figure 4.15 using an ideal input image.  Unfortunately, this 
algorithm takes too long to execute (an average time of ~1.2 seconds per frame) and as 
it would ideally be used on every frame it would severely limit the ability of the control 
program to run in real time.  Therefore it was ultimately removed from the main control 
system algorithm. 
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Figure 4.15 – Exemplar input and output from the perspective correction algorithm 
Another algorithm was developed to allow the control program to check the coordinates 
of a target point before dispensing bio-ink to ensure it was not erroneous.  The 
algorithm determines the location of the nozzle by comparing the current camera view 
to a generated target area map (which is a composite image made up of different views 
of the target area).  This algorithm was abandoned with the perspective correction 
algorithm due to their time requirements.  An exemplar input and output is shown in 
Figure 4.16 using test images. 
↑ Input 
Resultant Image → 
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Figure 4.16 – Nozzle coordinate calculation using exemplar data, Top left: target area map; Top right: 
current view; Bottom: calculated location within target area 
4.3 A Portable Deposition System 
Not all experiments required the use of the entire printer; occasionally, only the 
deposition systems were required, so a portable deposition system was created that 
could be handheld for ease of transportation. 
A single valve, bio-ink reservoir and microregulator were mounted on a small boss-
clamp stand and connected together with tubing; this would be the basis of the system.  
Up until this point the bioprinting systems had always been connected to the lab 
compressed air supply; however, a portable system requires a portable air supply.  This 
would necessitate either a small air compressor or an air cylinder; a small medical air 
cylinder was acquired (298123-AZ, BOC Ltd.) to ensure that the biomaterials would 
remain in a sterile environment without the need to filter the air coming from a 
compressor, and to limit the number of mains connections required by the system. 
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There were a number of challenges encountered while creating the portable pneumatics 
system.  The most critical of these was a very serious error when BOC supplied an 
oxygen cylinder in place of the ordered medical air cylinder which could have resulted 
in serious and explosive consequences should it have come into contact with the 
lubricants and oils used in the system.  Extra safety checks were implemented after this 
near-incident. 
A new control system was created from a microcontroller (Arduino UNO, Arduino) and 
a valve driver with two buttons providing the interface: one button triggered a dispense 
cycle and the other a purge cycle.  The parameters of the dispense and purge cycles can 
be altered via USB from a PC if required. 
 
Figure 4.17 – Schematic of the portable deposition system 
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Figure 4.18 – Portable deposition system: detailed views of the mounting system and the electronics 
control box 
The control system requires two different voltage inputs: 24V for the valve and 6-12V 
for the microcontroller.  In the first version of the portable system the 24V supply was 
provided by a 24V 2.5A switch mode power supply unit (Model 9177, Mascot) and the 
microcontroller was powered by a 9V battery.  However, the batteries did not seem to 
last very long in the system, so a DC-DC converter (SDS-030B24, Sunpower) was 
added to power the microcontroller from the existing 24V mains PSU. 
This portable system was transferred to Roslin Cellab and has been used for a variety of 
cell-based experiments described in this thesis.  It proved to be so useful that a second 
system was created as an additional testing platform. 
4.4 Mark II 
The Mark I bioprinter was only intended to be a proof of concept, and as such it 
performed excellently within its research parameters while highlighting areas requiring 
improvement.  The most obvious of these was the size and weight of the machine, 
which prevented it from being moved from the lab.  Since a lot of the experiments 
performed during the course of this research require cells from Roslin Cellab it would 
be useful to be able to install the bioprinter there to perform some experiments, 
especially those that use fragile or expensive-to-produce cells that suffer on the journey 
between labs.  Another issue was the slow speed of the machine; if small volumes were 
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dispensed in a large pattern, the first droplets had quite often evaporated before the 
pattern was completed.  With these points in mind, the second version of the bioprinter, 
the Mark II, was designed. 
4.4.1 An Open Source Foundation 
Since my background in engineering did not cover the design and construction of high 
resolution XYZ translation stages, it was decided that an existing off-the-shelf system 
should be selected as a base to build the new bioprinter.  The requirements for the donor 
system were that it be relatively inexpensive, portable (meaning that it should be as 
small and light as is feasible) and that it be fully documented, or “hackable”, so that the 
deposition electronics could be integrated into the system without too much work. 
Several manufacturers produce small translation stages with high resolution, but these 
systems either have travel ranges which are too short for the project’s requirements, or 
are too heavy or expensive.   
Attention was then turned to the systems which already include XYZ translation stages, 
such as the CNC machine on which the Mark I was based.  CNC machines themselves 
are almost always too large, heavy, or difficult to interface; with but there are other 
machines that include XYZ translation stages: 3D printers.  Most 3D printers made by 
large companies such as Stratasys are just as unsuitable as CNC machines due to their 
large size, weight and complexity but thanks to the expiration of a key additive 
manufacturing patent [3] in 2009 there was an explosion of open-source 3D printers that 
were relatively cheap, small, lightweight and fully documented.  It was therefore a 
simple matter to modify the hardware and software of one of these 3D printers to 
support bioprinting. 
A Makerbot Replicator (Single) was chosen to be the base of the Mark II bioprinter over 
other possible machines due to its sturdy frame construction, high movement resolution 
and its ability to run stand-alone without being connected to a PC. 
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Figure 4.19 – The Makerbot Replicator 
4.4.2 Making New Components 
A number of parts on the Replicator were not required for bioprinting, so the plastic 
extruders, heated build plate and plastic filament management systems were 
immediately removed. 
The Fluiwell pressure manifolds worked well on the Mark I system, so were retained for 
the Mark II, though with some modifications: the volumes that were used for the 
majority of the experiments rarely required the use of even half the capacity of the 15 
mL centrifuge tubes so it was decided to switch to 2 mL micro centrifuge tubes.  Rather 
than buy new pressure manifolds from Fluiwell to fit these new smaller tubes 
(Fluiwell’s products were rather expensive), new pressure manifolds were designed in 
SolidWorks and manufactured from Delrin by the Mechanical Engineering 
Department’s workshop technicians. 
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Figure 4.20 – Original drawings for the custom designed pressure manifolds 
The three holes were tapped with the required threads for each of the connecting 
components to seal correctly: a finger tight ferrule is screwed into the top to seal the 
tubing that connects to the valve; a 2 mL micro centrifuge tube screws into the bottom 
to hold the bio-ink; and a 4 mm push in adapter screws into the side to connect to the 
pressurised air supply. 
Because this version of the bioprinter was intended to be mounted into a laminar flow 
hood for some experiments, it needed to have the ability to be wiped down and cleaned 
with ethanol, meaning that the existing wooden panels were unsuitable for the 
bioprinter.  As the Replicator is open source, the designs of the body panels are freely 
available.  New panels were laser cut from 5 mm thick acrylic sheets, the donor 3D 
printer was completely dismantled and the bioprinter was assembled using the new 
acrylic body panels and the mechanical and electronic components from the donor 
machine. 
The tool carriage had two mounting holes and recessed pads where the plastic extruder 
used to be attached.  A new tool mount was designed in SolidWorks with mounting 
points for four valves and four bio-ink cartridges.  The valves were set at exactly 10 mm 
apart in a square configuration to make offset calculations easier in the software later 
on.  The tool mount was printed out on another 3D printer (Makerbot Replicator, 
Makerbot), assembled, and mounted to the tool carriage. 
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Figure 4.21 – Quad-valve tool mount on the Mark II bioprinter 
Unfortunately the location of the X-axis endstop switch was higher up than the designed 
tool mount.  Therefore, an extra “shoe” component that correctly triggered the endstop 
was designed, printed and mounted to the machine. 
 
Figure 4.22 – Endstop shoe on the Mark II bioprinter 
The microregulator that regulated the pressure of the bio-ink reservoirs on the Mark I 
bioprinter was never securely mounted.  This was rectified on the Mark II by mounting 
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the microregulator to the machine with a new mounting bracket which was designed to 
fit into the mounting holes that used to hold the filament guides on the donor system at 
the top of the rear panel granting easy access to adjust the inlet pressure for the bio-ink 
reservoirs. 
 
Figure 4.23 – The completed mechanical system of the Mark II bioprinter 
A number of substrate trays were laser cut for holding a variety of different substrates 
including 60-well plates, 72-well plates and 90 mm petri dishes.  These trays could be 
located on the Z-axis translational stage with four locating bolts to fix their position.  
The coordinates of salient reference positions were recorded for use when creating G-
code programs to run on the bioprinter.  Additional panels were laser cut from 
transparent acrylic to fully enclose the bioprinter and keep the inside free from dust and 
other airborne contaminants. 
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Figure 4.24 – The Mark II bioprinter with enclosing panels 
Some of the valve control electronics were mounted on the tool head on the Mark I, 
which meant that there were a large number of cables trailing on the machine.  On the 
Mark II the wiring was rationalised to streamline the machine as far as possible; 
therefore, all of the electronics were mounted on the underside of the machine leaving 
far fewer wires connecting to the tool head.  It also served to reduce the travelling mass 
of the tool head, which should improve the positional repeatability of the system. 
4.4.3 Control System Augmentations 
The donor system was controlled by a single mainboard (Mightyboard Rev E, 
Makerbot) with open-source firmware.  The original plan was to modify this firmware 
to incorporate new subroutines to control the deposition systems but although the 
firmware was open-source, it was largely undocumented, extremely convoluted, badly 
commented and spanned several programming languages, making it prohibitively 
difficult to adapt. 
Since it was not possible to alter the firmware, further research into the mainboard was 
conducted with the aim of finding another way to augment the system.  There is an 
output on the mainboard labelled ‘Extra FET’ which, when the correct G-codes are 
entered into the program, enabled or disabled a 24V supply – M126 enabled the output 
and M127 disabled it.  This would provide the spike voltage required by the valves.  
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Now all that was required was four 5V control signal lines, one for each valve, but 
finding them proved to be very difficult indeed. 
While investigating output pins on the mainboard with a multi-meter one of the probes 
shorted out the 5V power rail and the 5V regulator went up in smoke.  A replacement 
was ordered and the mainboard was sent to the Electronics workshop for repairs.  
Unfortunately the damage was too severe for the technicians to repair so a replacement 
was needed.  Regrettably, Makerbot do not sell Mightyboards separately but luckily the 
Makerbot support team was kind enough to provide a replacement since the damage 
was incurred accidentally.   
Unlike other stepper motor drivers used on other 3D printer controllers, the ones used 
on the mainboard do not have a potentiometer to alter the current sent to the stepper 
motors; rather, they have a voltage reference pin to set the current.  Since the plastic 
extruder mechanism control circuits were not required for the Mark II system, there 
were two empty stepper driver slots on the mainboard, each with a Vref pin.  These Vref 
pins can be set by a G130 G-code command to any value between 0 and 255, 
representing a range of analogue voltages between 0 and 5V.  An Arduino UNO 
microcontroller was wired up to these output pins and measured the voltages generated 
and it worked (with a small margin of error).  Three voltage ranges were defined for 
each output pin to enable control of 4 deposition systems as shown in Table 4.1.  A 
program was written for the Arduino that checked the voltages fell into one of three 
voltage ranges and triggered the corresponding deposition system as appropriate. 
Table 4.1 – Variables for triggering four deposition systems using G130 G-code command 
 Off On1 On2 
Vref A ≤63 64-126 127≥ 
Vref B ≤63 64-126 127≥ 
 
During the hydrogel printing experiments it was discovered that the two hydrogel 
components required different pressures to dispense comparable volumes; for example, 
the calcium solution requires much less pressure than the sodium alginate solution due 
to the different viscosities of the two solutions.  Therefore, a second microregulator was 
added to the system between the existing microregulator and one of the bio-ink 
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reservoirs so that one bio-ink can be dispensed using reduced pressure relative to the 
other bio-ink reservoir. 
The final addition to the Mark II system was a DC-DC converter; this was required to 
power the Arduino microcontroller from the mainboard 24V supply as the Arduino 
requires 6-12V input.  Up until this point the printer had been constantly connected to 
the lab PC to power the Arduino, which was certainly not ideal if it was to be a portable 
system. 
4.4.4 Second Generation Graphical User Interface 
The Mark II bioprinter uses different G-code commands from the Mark I so some 
modifications would be required to the Mark I GUI for it to work with the Mark II.  
This opportunity was used to rewrite the interface program to reflect the development of 
my programming knowledge. 
Several improvements were added, the first of which being the droplet property controls 
which allow the operator to specify not only the volume of each droplet but the 
percentage of up to four bio-inks that constitute it.  The droplet volume and specified 
inlet pressure were used to calculate the needed valve on-time using an equation derived 
experimentally (Equation 5.2).  The proportion of each bio-ink is displayed using a 
labelled pie chart. 
A number of tabs were added to the program for the different substrates that the Mark II 
bioprinter could use: the multi-well plate system was adapted from the original GUI; a 
new free plot mode was created for printing onto 90 mm Petri dishes; and a new small 
plate mode was written for printing onto the 60/72 well Terasaki plates. 
The free plot mode is similar to the one in the original GUI but it includes a circle in the 
plot axis defining the limits of the Petri dish.  It also contains a “snap-to” setting to align 
user-entered points to a grid with a specified spacing. 
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Figure 4.25 – Graphical User Interface (GUI) program for the Mark II bioprinter in free plot mode 
showing the new droplet properties controls 
The small plate mode has buttons that represent each well on a plate and by selecting 
the buttons, the current droplet properties are applied to that well as shown in Figure 
4.26.  The small plate substrate tray can hold 4 Terasaki plates which can have 60 or 72 
wells; the setup can be specified using the controls at the bottom of the window. 
 
Figure 4.26 – Graphical User Interface (GUI) program for the Mark II bioprinter in the new small plate 
mode. Selected target points shown highlighted in green displaying the applied droplet properties in the 
tooltip 
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Paths can be created using a raster or shortest path in the same manner as in the original 
GUI; indeed, the same functions are used, though slightly modified.  The G-code file 
with the correct commands and syntax is generated and displayed in the interface for 
easy error checking. 
 
Figure 4.27 – Graphical User Interface (GUI) program for the Mark II bioprinter showing the generated 
G-code for the pattern entered in the previous figure 
Before the generated G-code file could be run on the Mark II bioprinter it had to be 
translated into an s3g or x3g file that the firmware could understand.  This was not ideal 
as the translation required running the G-code file through another piece of software, 
but it worked. 
Another issue was the large plate mode; as it was copied across from the old program it 
had a number of issues including incorrect coordinates and the interface wasn’t as clean 
and polished as the rest of the program.  There were plenty of programming issues that 
were encountered during the creation of this new user interface, mostly caused by 
dealing with empty of zero valued variables or percentages greater than 100, but they 
were all located and resolved. 
4.5 Mark III 
The Mark II bioprinter was a generally successful machine.  It managed to significantly 
improve and correct a large number of the shortcomings of the Mark I bioprinter, but 
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there still remained a number of improvements which could be made and some new 
problems arose.  The most important new issue was the slight loss of printing resolution 
introduced by the new mainboard. 
4.5.1 RAMPS Electronics 
Since the Makerbot Mightyboard mainboard was the cause of the new issues it was 
replaced by a new, more open source electronics solution: the RepRap Arduino Mega 
Pololu Shield, or RAMPS for short.  The RAMPS board sits on an Arduino Mega 2560 
which uses an ATmega2560 microcontroller which has twice as much flash memory as 
the Mightyboard (which uses an ATmega1280); this means that there is much more 
space for firmware alterations. 
The Mark II used the same power supply as the Makerbot Replicator, which was a 
cable-and-box setup.  While this was perfectly adequate, it sometimes got in the way or 
was difficult to position without putting strain on the cables.  Therefore, the Mark III 
has an on-board power supply unit.  The valves require 24V to operate while the 
RAMPS electronics including the stepper motors run on 12V.  Initially, two separate 
PSUs were used, a 12V 20A embedded switch mode power supply unit (S-240W-12, 
YXDY) and a 24V 2.5A switch mode power supply unit (Model 9177, Mascot) 
mounted to the underside of the bioprinter and connected to an IEC power connector 
with an integrated fuse.  In order to simplify the system, the two units were replaced 
with a single embedded switch mode power supply (QP-320D, MeanWell) that outputs 
both 12V and 24V. 
The same high quality NEMA 17 hybrid stepper motors from the Mark II were used for 
the Mark III, but interestingly the RAMPS board stepper motor connections used a 
different pin order than the Mightyboard, which was unexpected and took some time to 
correct.  Instead of each wire connecting in order, the last two were reversed. 
The RAMPS electronics has a number of different options for LCD interfaces.  The 
Smart 2004 LCD controller was selected due to its popularity and screen size.  It uses a 
combined potentiometer and momentary switch to navigate the on-board menu system 
in contrast to the five push buttons (4 directions and enter) which made navigation quite 
slow on the Mark II. 
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Another advantage of the RAMPS electronics over the Mightyboard is that it can read 
G-code files from an SD card rather than s3g or x3g files which the Mightyboard 
requires.  The Mark II programs had to be translated from G-code before loading them 
onto the bioprinter but the Mark III is able to take the G-code programs directly.  This 
makes program creation much simpler for the user. 
 
Figure 4.28 – Schematic of the Mark III electronics system with two deposition systems 
4.5.2 Firmware 
There are several available firmwares for RAMPS; the most common option is Marlin 
which is written entirely in C++ and is well documented.  This means that alterations 
are easy to implement. 
Two new G-code commands were added to the firmware to enable the system to control 
the deposition systems.  The first was the variable dispense command:  
M45 V# S# 
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This allows the user to specify the valve to use (1-4) and the duration of the dispense 
cycle in microseconds (≥150).  The Mark III bioprinter uses a slightly modified version 
of the Mark II’s GUI and the dispense cycle duration can be calculated from the desired 
volume in the same manner. 
The second new G-code command triggers the dynamic purge routine: 
M46 V# 
This finally integrates the dynamic purge algorithm into the bioprinter control system 
and allows the user to purge a specified valve (1-4) without uploading the separate 
purge algorithm to the control system or using the portable deposition system controller 
(as was the case with the Mark II system). 
The dynamic purge trigger command was also integrated into the LCD interface menu 
system to allow users to easily trigger the purge routine at the push of a few buttons. 
 
Figure 4.29 – The purge routines integrated into the interface menu system 
The configuration settings for the X, Y and Z translation stages were calculated by 
measuring the mechanical characteristics of the translation stages, including belt and 
acme rod pitches, the number of teeth on the pulleys and the maximum translation 
distances. 
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Initially there was some difficulty with the system refusing to store new configuration 
variables in the EEPROM (electrically erasable program memory), but eventually the 
correct variables were stored and the system operated correctly. 
4.5.3 Body Redesign and Improvements 
The basic mechanical layout of the X, Y and Z axes were maintained so the design of 
the Mark II body panels was used as the basis of the new design.  A number of 
alterations were made to the body panels to suit the new components: the mounting 
holes were altered to suit the new electronics and the LCD interface board was a 
completely different design to the one used in the original design. 
 
Figure 4.30 – The redesigned Mark III bioprinter 
There was an issue with the laser-cut holes for the Arduino/RAMPS mounting not 
lining up exactly; this was due to contradictory information about the position of the 
mounting holes on the internet.  This was solved by simply drilling new holes in the 
panel. 
While printing with hydrogels using the Mark II bioprinter it was discovered that the 
different components had different viscosities and required different inlet pressures to 
allow for minimum volumes to be dispensed.  The Mark III bioprinter was therefore 
designed with two micro-regulators to allow different pressures to be applied to 
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different bio-inks.  The standard pneumatic tubing used on the Mark II was replaced 
with coiled tubing to reduce the strain on the tool carriage at the extreme edges of the 
movement range. 
 
Figure 4.31 – Two micro-regulators mounted to the Mark III bioprinter and the new coiled pneumatic 
tubing 
The tool mount on the Mark II worked perfectly well but was slightly restricted and 
changing the valves and bio-inks was difficult due to the lack of space.  Therefore, a 
new tool mount was designed in SolidWorks for the Mark III which was much wider.  
The valves were set at exactly 10 mm apart in a linear configuration to make alterations 
and maintenance easier.  The tool mount was printed out on a 3D printer, assembled and 
mounted to the tool carriage. 
Chapter 4 – Development of Novel Valve-based 3D Cell Printing Platforms 
 
129 
 
Figure 4.32 – New quad-valve tool mount on the Mark III bioprinter 
Taking advantage of the new coiled pneumatic tubing, the hood for the Mark III 
bioprinter was designed to be much lower than the Mark II hood.  This reduced the 
amount of acrylic required and made the Mark III bioprinter easier to transport, as it was 
slightly smaller. 
 
Figure 4.33 – The Mark III bioprinter with side panels and lower profile hood 
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New substrate trays were laser cut to suit the experiments carried out on the Mark III 
bioprinter – namely, 96-well plates and microscope slides.  These substrate trays are 
interchangeable with the Mark II substrate trays as they use the same mounting holes.  
Again, the coordinates of salient reference positions were recorded for use when 
creating G-code programs to run on the bioprinter. 
 
Figure 4.34 – Interchangeable substrate trays 
4.5.4 Graphical User Interface Upgrades 
With a few small modifications, the GUI for the Mark II could be used to create 
programs to run on the Mark III as well.  An extra menu was added which allows the 
user to specify for which machine they are creating G-code programs.  The GUI uses 
this to determine which style of G-code commands and which header and footer (in 
separate text files) to apply to the G-code program. 
The multi-well plate tab that was adapted from the original GUI was replaced with a 
large plate mode that was similar to the small plate mode with buttons that represent 
each well on a plate.  The large plate substrate tray can hold 1 large plate which can 
have a number of different well arrangements; a selection of popular options (1, 6, 96 & 
384) are included allowing the user to specify which plate they are using. 
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In the small plate mode in the second generation GUI, when the user applied a set of 
droplet properties to a well, the button representing that well took the colour of the bio-
ink component with the highest volume percentage of that well – green for valve 1, red 
for valve 2, blue for valve 3 and purple for valve 4.  In this version of the GUI the 
colour applied to the buttons is defined by the ratio of the volumes of each bio-ink, with 
the valve 4 colour being replaced by white.  Any colour can therefore be created using 
the red, green and blue percentages, and can be made lighter or darker given the 
percentage of white in that well.  This is shown in Figure 4.35. 
 
Figure 4.35 – Graphical User Interface (GUI) program for the Mark III bioprinter in large plate mode 
showing the new average colour system to show droplet components 
4.5.5 Basic Interface Program 
The Mark I bioprinter used a MATLAB algorithm to create G-code files from binary 
(black and white) images created in MS Paint.  This was a very useful program for 
creating shapes from arrays of droplets printed onto Petri dishes and microscope slides.  
A refined version was created with added features which allowed users to specify the 
number of layers to dispense, which components to dispense, and the spacing between 
each pixel (to define a scale for the pattern).  This new program was used for hydrogel 
printing and many of the simple geometric patterns were programmed using this 
algorithm. 
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Chapter 5 – Response of Pluripotent Stem Cells to the Valve-based 
Bioprinting Process 
5.1 Introduction 
In the field of biofabrication, great advances are being made towards fabricating 3D 
tissue and whole organs with techniques utilising very fine spatial control of cell 
deposition.  Rapid progress has been made in recent years in developing and testing 
printing techniques, including those based on laser pulses, inkjets and other – more 
novel – approaches.  Laser based printing techniques are accurate and reliable but they 
are more suited to single cell deposition and could be prone to heating problems that can 
cause cell damage [1–8].  Inkjet printing techniques are inexpensive, easy to set up and 
potentially expandable but can suffer from clogging, shear forces leading to cell 
damage, and the bio-inks must be within a specific range of viscosity and surface 
tension [9–20].  Bio-extrusion techniques are able to create cell-laden 3D structures, but 
issues include nozzle-based disadvantages, the impossibility of printing discrete 
droplets within a reasonable range of volumes, and the bio-inks must be within a 
specific range of viscosity and surface tension [21–28].  Electrohydrodynamic Jet 
printing has the unique ability to create continuous streams as well as discrete droplets, 
but the droplet sizes and dispense location are not currently controllable [29–32].  
Acoustic based printing techniques do not rely on nozzles to deliver the biological 
materials, preventing any clogging problems, but may have issues with overheating over 
longer printing sessions [33–36].  Valve-based printing techniques are one of the newest 
additions to this list and have the advantage of being one of the gentlest techniques for 
printing any number of cells, but – as with all other nozzle-based techniques – clogging 
is potentially an issue [37–40]. 
Although human mesenchymal stem cells (hMSCs) [41] and mouse embryonic stem 
cells (mESCs) [42] have been printed in the past, until now there have been no reports 
of attempts to print human embryonic stem cells (hESCs) or induced pluripotent stem 
cells (iPSCs).  hESCs are known to be more sensitive to physical manipulation, more 
demanding in terms of their requirement for extracellular matrix coatings for routine 
cell culture, and are more difficult to transfect with plasmid DNA.  However, they do 
have a greater potential to generate a wider variety of differentiated cell types than 
hMSCs, and tissues generated using iPSCs would be expected to yield better models of 
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human biology than those using mESCs as precursors.  Here is the report of the first 
investigation into the response of hESCs and iPSCs to the bioprinting process. 
5.2 Project Acknowledgements 
The project was performed in collaboration with Jason King, John Gardner, Catherine 
Fyfe and Helen Bradburn from Roslin Cellab.  Human Embryonic Kidney cells (line 
293), Human Embryonic Stem cells (lines RC-6 and RC-10) and Human Induced 
Pluripotent Stem cells (line RCi-22) were provided at various concentrations.  All cell 
culturing was provided by them, in addition to the various different cell media types 
used in the following experiments. 
5.3 Preliminary Testing Results 
In order to test the basic functionality of the system, a series of tests were performed 
using water.  Water was used instead of cells in solution because it acts in much the 
same way and is much easier to work with.  A number of experiments were devised and 
conducted to test the functionality of the cell printer in different ways, including spatial 
and droplet size repeatability, scope of possible droplet sizes and speed of printing.  
Each experiment is described in detail; the results are here presented and discussed. 
5.3.1 Characterisation of Droplet Size 
The first study was an investigation into the possible range of droplet sizes that could be 
dispensed by the cell printer, with a particular emphasis on determining the size of the 
smallest possible droplet.  The volume of dispensed fluid is affected by several factors: 
the properties of the fluid (i.e. viscosity, surface tension, etc.); the diameter of the 
nozzle orifice; the valve on-time; and the inlet pressure.  As water is being used as a 
substitute for cells in suspension for this preliminary study, the fluid properties are 
constant.  The orifice of the nozzle was chosen to be the smallest available (0.0508 
mm).  The valve on-time was set at the smallest period of time that the hardware was 
rated to handle (0.3 ms); in this setup, the valve controller is the slowest component.  
This leaves the inlet pressure as the only remaining variable that can affect the volume 
of dispensed fluid.  An experiment was therefore devised where the inlet pressure 
applied to the static pressure reservoir was set at a high value and slowly decreased, 
with several droplets deposited at each pressure. 
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Altering the inlet pressure applied to the static pressure reservoir is one method for 
varying the droplet sizes.  However, if several different sized droplets were required in 
the same experiment, there would be insufficient time to alter the inlet pressure for each 
droplet.  Therefore, another means of quickly altering the droplet sizes was required.  
One approach would be simplicity itself: overprinting existing droplets until they were 
of sufficient size, but what if there was another way?  As stated at the beginning of this 
section, the valve on-time also affected the volume of dispensed fluid and, apart from 
the inlet pressure, it is the only variable remaining that is not fixed by the properties of 
the bio-ink or the dimensions of the nozzle.  A second experiment was devised where 
the valve on-time was set at a small value and gradually increased, with a single droplet 
deposited at each separate on-time. 
Measuring the volume of a single droplet directly would be quite challenging and would 
require recording images of the droplet from multiple angles and estimating the 
diameter, height and contact angle of the printed droplet, or alternatively using a high-
speed camera to capture an image of the droplet before it impacted the substrate and 
measuring the volume from the mean diameter.  A far simpler approach was adopted; 
the volume of the droplets was calculated from their weight and the density of the water.  
10,000 droplets were deposited onto a precision micro scale (Adventurer Pro AV812, 
Ohaus Co) at each pressure/pulse duration combination and the weights were recorded.  
The volumes were calculated using the following formula: 
𝑉𝑜𝑙𝑢𝑚𝑒 𝑜𝑓 1 𝑑𝑟𝑜𝑝𝑙𝑒𝑡 (𝑛𝐿) =
𝑤𝑒𝑖𝑔ℎ𝑡 𝑜𝑓 𝑁 𝑑𝑟𝑜𝑝𝑙𝑒𝑡𝑠 (𝑔) × 1.09 × 106
𝑁
   (5.1) 
 
The results are shown in Figure 5.1 and Figure 5.2. 
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Figure 5.1 – The results from the investigation into the relationship between inlet pressure and droplet 
volume 
The smallest possible droplet produced during this investigation was 2.094 nL.  Due to 
the relationship between the inlet pressure and droplet volume, setting the inlet pressure 
at a particular value would be a quick way of fixing the minimum or modal droplet size 
for a particular application.  This means that when the water is exchanged for cells in 
suspension the maximum number of cells that are deposited in a single droplet will be 
controllable.
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Figure 5.2 – The results from the investigation into the relationship between inlet pressure, applied voltage pulse duration and droplet volume
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The relationship between the applied voltage pulse duration and the dispensed volume 
for each pressure is clearly linear but the relationship between each line is slightly more 
complex.  The bioprinter is controlled via a graphical user interface which allows users 
to specify the position and properties of droplets in an array.  This program calculates 
the required settings for each droplet using the following equation which was derived 
from the experimental data and describes the relationship between the inlet pressure, 
valve time and droplet volume: 
𝑡𝑣𝑎𝑙𝑣𝑒 =
𝑉𝑑𝑟𝑜𝑝𝑙𝑒𝑡 + 1.202
35.507 × (ln(𝑃) − 0.240)
                                      (5.2) 
 
 
Figure 5.3 – Dispensed droplets of varying sizes (scale bar 5 mm) 
5.3.2 Positional Repeatability 
The next study was an investigation into the positional repeatability of the cell printer – 
in other words, was the cell printer accurate enough to allow us to return to a previous 
location specified by the same coordinates without drifting either in the x-direction, y-
direction, or both?  The CNC machine is largely responsible for the positional 
repeatability, but it could be affected by the lower spatial accuracy of the inkjet-based 
droplet deposition system.  It is extremely important that the cell printer be capable of 
positional repeatability in order to allow printing of precise patterns and the 
overprinting of droplets.  Overprinting droplets would be an extremely useful feature of 
the cell printer as it would allow other biological materials to be transfected into 
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dispensed cells or materials, such as oil to cover the droplets to prevent evaporation of 
the medium.  Therefore, an experiment was devised where the cell printer was 
instructed to print at four locations in a repeating square grid pattern as shown at the top 
of Figure 5.4. 
 
Figure 5.4 – The results from the investigation into spatial repeatability. Top: grid pattern. Bottom: 
snapshots from the printing process, one taken after every pass through the grid 
This demonstrates that the cell printer has high spatial accuracy and is capable of 
returning to previous locations using the same coordinates.  By factoring in the linear 
offset between the two nozzles, droplets can be overprinted, using either different 
materials (as mentioned above) or the same material to increase the concentration. 
5.3.3 Complex Grid Printing 
The next logical step would be to increase the complexity of the grid pattern to be 
printed.  A low resolution image of the Heriot-Watt University logo was created in MS 
Paint with black pixels representing the dispense points.  Blue food colouring was 
added to the water in the bio-ink reservoir to improve the visibility of the printed 
1  2  3  
4  5  6  
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droplets.  A G-code file was created from the image using the dedicated MATLAB 
algorithm and fed into the bioprinter; the results are shown in Figure 5.5. 
 
Figure 5.5 – An array of droplets printed in the form of the Heriot-Watt University Logo 
This proves that not only can the cell printer print a small repeating pattern, but it can 
also print a large and complex pattern without drifting in either direction.  An added 
advantage of this particular experiment was that due to its large size, there was time to 
measure the response time of the control software and decrease the built-in pauses for 
dispensing, thus speeding up the system.  Unfortunately, printing such large arrays takes 
a relatively long time (tens of minutes) so by the time the last droplet has been printed, 
the first few had evaporated.  This would easily be solved by printing onto a wet 
substrate coated with a cell culture medium such as fibrin, soy agar gel or collagen. 
5.3.4 Sterility Testing 
Some of the experiments conducted using the Mark II bioprinter used cells that were 
very expensive to produce, so it was important to ensure that not only would these cells 
be unaffected by the printing process, but also that no contamination entered the system 
which could affect the results.  The Mark II system was therefore transferred to Roslin 
Cellab and tested for sterility.  The deposition system was cleaned out with a 2% 
solution of Presept (Johnson and Johnson Medical) and left to stand for 30 minutes, then 
cleaned with a 70% solution of Ethanol and water (all micro-filtered), before bacteria-
feeding broth was finally printed into the wells of a 96-well plate for testing.   
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The plate was examined 21 days post-printing and there was no evidence of microbial 
contamination present; the system was therefore deemed sterile.  As the Mark II and 
Mark III bioprinters both share the same deposition system setup they are both 
sterilisable. 
5.4 HEK293 Viability 
The HEK293 cell line was named for Frank Graham, a scientist at a lab at the 
University of Leiden, who invented the calcium phosphate method for transfecting cells 
in 1977; it was named as such because it was Graham’s 293rd experiment.  The 
popularity of this particular cell line is due to its extreme transfectability by various 
techniques, including the calcium phosphate method [43].  
A frozen sample of HEK293 cells (293FT, Life Technologies) was thawed out, 
suspended in high glucose Dulbecco's Modified Eagle Medium: Nutrient Mixture F-12 
(DMEM ⁄ F-12) (Life Technologies) and centrifuged at 300 rpm for 2 minutes to 
separate the large clumps of cells.  The medium was removed and the cells were re-
suspended in fresh medium; by pipetting the solution up and down multiple times, the 
cells were separated into single cells.  The suspended cells were then transferred to a 
T25 flask.  When observed under a microscope the cells were observed to be circular 
with “hands” and therefore healthy.  The flask was then placed inside an incubator at 
36.0-37.5°C, 5.0±0.5% CO2. 
A single cell suspension of HEK293 cells at a concentration of approximately 1×10
5
 
cells/mL in DMEM was loaded into the cell printer and primed.  Droplets were 
dispensed into a Petri dish and a control was created in a second Petri dish; Trypan Blue 
was applied to both dishes before being examined under the microscope.  10 random 
sample images were taken for both the printed and control groups and the number of 
live cells and dead cells were counted in each image.  The results of this study are 
shown in Figure 5.6. 
 
Chapter 5 – Response of Cells to the Bioprinting Process 
 
142 
 
Figure 5.6 – A graph to show the percentages of live cells per sample. 
The normalised cell viability was calculated to be >99% for the Mark I valve-based cell 
printer.  This confirms that this printing process did not appear to damage the cells or 
affect the viability of the vast majority of dispensed cells. 
5.5 hESCs and hiPSCs 
5.5.1 Cell Culture 
Human embryonic stem cell lines RC-6 and RC-10 were cultured in complete 
StemPro® hESC SFM (supplement, DMEM/F-12, BSA, FGF basic, and 2-
mercaptoethanol) (Life Technologies) supplemented with 8 ng/mL of human basic 
fibroblast growth factor (hbFGF).  Human induced pluripotent stem cells line RCi-22 
were cultured on Geltrex matrix with Essential 8 medium (Life Technologies).  Cells 
were stored in an incubator at 36.0-37.5°C, 5.0±0.5% CO2.  Under these conditions, the 
cells are maintained in an undifferentiated state. 
5.5.2 hESC Viability 
Human ES cells (line RC-10) were suspended in StemPro® hESC SFM to a 
concentration of approximately 1×10
6
 cells/mL and loaded into the reservoir of one of 
the cell deposition systems.  A program was written that dispensed approximately 1 mL 
of bio-ink (the volume varied with pressure); this large volume was required to allow 
for analysis to be carried out on a FACS machine.  Different experiments sometimes 
require different experimental variables such as applied pressure and nozzle geometry.  
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Two main types of nozzle have been used for the experiments in this thesis: a shorter, 
thick-walled nozzle; and a longer, thin-walled nozzle.  Since such a large volume was 
required for each pressure/nozzle combination, only 6 different pressures were used to 
limit the number of cells required for this experiment.  Cells were printed into micro-
centrifuge tubes and the unprinted cells were used as a viability control. 
The printed samples were examined using a BD FACSCalibur flow cytometer at 
approximately 30 minutes post printing.  The control sample was split in two; half were 
stained and used to calibrate the data thresholds.  The raw data plots and a graph of the 
results are shown in Figure 5.7 and Figure 5.8 respectively. 
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Figure 5.7 – Raw FACS data plots showing the numbers of live hESCs per sample: a-b) controls: a) 
unstained control; b) stained control; c-h) short nozzle: c) 2PSI; d) 4 PSI; e) 7 PSI; f) 10 PSI; g) 15 PSI; 
h) 20 PSI; i-l) long nozzle: i) 7 PSI; j) 10 PSI; k) 15 PSI; l) 20 PSI 
a) b) c) 
d) e) f) 
g) h) i) 
j) k) l) 
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Figure 5.8 – A graph of the FACS data to show the percentages of live hESCs per sample as a function of 
pressure and nozzle length 
Cell viability was calculated to be >84% for the short nozzle and >68% for the long 
nozzle over all pressures.  This clearly shows that the viability of the cells is affected by 
the length of the nozzle used; this is most likely due to the increased time the cells are 
subject to shear forces experienced by the cells on their transit through the nozzle.  
However, cell viability remains high with the shorter nozzle at pressures below 15 PSI 
even for sensitive cells such as hESCs, which is consistent with the observations of 
other groups with stem cells [42,44] and other cell types using similar bioprinting 
approaches [37–40]. 
It should be noted that the viability immediately post printing is believed to be higher 
than the results presented here; the lower results can be attributed to the time delay 
between the printing and analysis of the cells and the fact that the FACS machine was 
not in the same location as the printing took place (it was some 15 minutes away by 
car).  Initially, the plan was to use the FACS machine on site but it was found to be out 
of order so an alternative had to be used. 
5.5.3 hiPSC and hESC Viability 
Human iPS cells (line RCi-22) viability was measured in much the same way as the 
hESC viability, but without a variation in nozzle geometry or pressures.  The printed 
samples were examined using the FACS machine. 
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The raw data plots and a graph of the results are shown in Figure 5.9 and Figure 5.10 
respectively.   
 
Figure 5.9 – FACS data plots showing the numbers of live hiPSCs per sample with numbers of hESCs per 
sample for comparison: (a-b) hiPSC: a) control; b) printed cells; (c-d) hESC: c) control; d) printed cells 
 
Figure 5.10 – A graph to show the percentages of live hiPSCs per sample with hESC data for comparison 
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There is negligible difference in terms of viability between the printed and non-printed 
hiPSCs, proving that our valve-based printing technology is compatible with hiPSC 
transfer without negatively affecting the viability of these fragile cells. 
5.5.4 Multi-marker Pluripotency Validation 
It is not sufficient to confirm only the post-printing viability of pluripotent stem cells; 
the printed cells should remain pluripotent in order to confirm that they are completely 
unaffected by the printing process.  The printed cells were examined to check that they 
still possessed two of the most common pluripotency markers: Oct3/4 and SSEA-4.  
SSEA-1 (stage-specific embryonic antigen 1) was used as a negative test as it should 
only be expressed in differentiated cells. 
Two lines of hESCs and one line of hiPSCs were tested for these markers – lines RC-6, 
RC-10 and RCi-22 – and cells were examined one week after printing using flow 
cytometry. 
 
Figure 5.11 – FACS results of multi-marker pluripotency validation: a) hESC line RC-6 non-printed 
control; b) hESC line RC-6 printed results 
SSEA-4SSEA-1 Oct3/4
a)
b)
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Figure 5.12 – FACS results of multi-marker pluripotency validation: a) hESC line RC-10 non-printed 
control; b) hESC line RC-10 printed results 
 
Figure 5.13 – FACS results of multi-marker pluripotency validation: a) hiPSC line RCi-22 non-printed 
control; b) hiPSC line RCi-22 printed results 
At one week post-printing there is very little observable difference between the printed 
cells and the non-printed control, confirming that all the tested human pluripotent stem 
cells remain pluripotent.  The Oct3/4 marker levels are lower than the normal range for 
pluripotency in the printed RC-10 and RCi-22, though still acceptable; in the case of the 
RC-10 sample, the gating may not be tight enough.  In the RCi-22 sample the control 
exhibits a similar marker level.  Also, the RC-6 SSEA-4 printed result is lower than the 
control, but the results are still positive as they are within an acceptable range. 
5.6 Characterisation of Droplet Cell Concentration 
The number of cells encapsulated within a single droplet can be controlled by changing 
the droplet size (by altering the parameters as previously discussed) or the initial 
concentration of cells in the bio-ink.  The cell size also plays a part in determining cell 
SSEA-4SSEA-1 Oct3/4
a)
b)
SSEA-4SSEA-1 Oct3/4
a)
b)
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concentrations; the larger the cell, the smaller the number of cells that can be 
encapsulated within a droplet of a fixed size. 
An array of the Heriot-Watt University logo was designed and 10 mL of StemPro® 
hESC SFM with RC-10 hESCs, suspended at a concentration of 5×10
6
 cells/mL, was 
loaded into the reservoir of one of the cell deposition systems.  2 µL of DAPI (4′, 6-
Diamidino-2-Phenylindole, Dihydrochloride) (Life Technologies) was added in order to 
fluorescently label the cell nuclei.  The printing process was then performed and cell 
numbers were obtained by viewing the droplets under the microscope (fl0015000m 
Trinocular Fluorescence Microscopes) immediately after printing.  Fluorescence images 
of the whole array were recorded using a 2D gel imager (ChemiDoc™, Bio-Rad 
Laboratories, Inc.). 
 
Figure 5.14 – a) Fluorescence image of an array of Human Embryonic Stem cell droplets printed in the 
form of the Heriot-Watt University Logo; b) optical image of a single droplet showing the RC-10 cells. 
Each droplet was ~60 nL and it appears that around 28 RC-10 cells were transferred per 
printed droplet of solution.  However, as the number of cells transferred per droplet is 
mainly determined by the concentration of cells in the bio-ink and the ratio of droplet 
size to cell size, these results can be altered by adjusting the droplet sizes or cell 
concentration. 
5.7 Conclusions  
Using the valve-based bioprinter the first investigation into the response of iPSCs to the 
printing process was undertaken and a deeper analysis of the response of hESCs 
including viability and pluripotency validation was made.  This work demonstrates that 
10 mm 250 µm 
b) a) 
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the valve-based printing process is gentle enough to maintain hESC and hiPSC viability 
and that printed cells maintain their pluripotency.  The effect of nozzle geometry was 
investigated and the effects of nozzle length on the post-printing viability of cells were 
recorded; longer nozzles lower the post-printing viability of the cells.  The ability to 
print human pluripotent stem cells (both hESCs and hiPSCs) while maintaining their 
pluripotency will allow us to create more accurate human tissue models, which is 
essential to the in vitro drug development and toxicity testing. Additionally, this may 
also lay the foundations for human stem cells to be incorporated into clinical protocols, 
either for patient implantation of in vitro regenerated organs or direct in vivo cell 
printing for tissue regeneration.  
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Chapter 6 – Generation of Human Embryonic Stem Cell Spheroids 
6.1 Introduction 
The rapidly developing field of regenerative medicine aims to repair, replace, and 
regenerate damaged cells, tissues or organs through stem cell therapy.  Human 
embryonic stem cells (hESCs) and induced pluripotent stem cells (iPSCs) have the 
ability to self-renew indefinitely and the potential to differentiate into any cell type [1–
5].  Totipotent stem cells can differentiate into all cell types found in an organism, 
whereas pluripotent stem cells can only differentiate into those cells which are found in 
an adult [5].  These unique potency characteristics make hESCs ideal for use in a 
number of applications, such as modelling early embryonic development.  The 
potentially limitless numbers of differentiated hESC progeny can also be used for 
clinical tissue engineering and replacement applications, such as novel drug discovery 
and testing for the pharmaceutical industry [1,2,6,7].  In vitro, hESCs typically cluster 
together to form 3-dimensional spheroid aggregates when cultured in medium that has 
the growth factors removed, which maintains them in a non-adherent and 
undifferentiated state.  After the spheroids have formed, the medium is replaced by one 
which allows the hESCs to differentiate, and the spheroids are now commonly known 
as embryoid bodies (EBs).  The efficiency with which specific cell types are generated 
within the EB is partly determined by the size of the spheroid used to create the EB. A 
lack of uniformity in EB size can lead to asynchronous and heterogeneous 
differentiation [8].  Consequently, the ability to reliably create uniform EBs of specific 
sizes is required to generate the correct cell-cell signals needed to produce particular 
cell types such as cardiomyocytes [9]. 
Various techniques can be used to create spheroid aggregates, including static 
suspension, rotary mass suspension, non-adhesive microwell arrays, adhesive stencils, 
and the hanging-drop method; however, it is still difficult to obtain uniform specific 
sized spheroids in a controllable manner.  Static suspension has limited control over the 
size of cell aggregates that are formed, and the subsequent differentiation results in 
heterogeneous populations [3,10].  Rotary mass suspension successfully creates 
homogeneous size distribution of spheroids, but the process may damage the hESCs and 
disrupt cell signalling which could affect subsequent cell differentiation [9,11,12].  
Non-adhesive microwell plates have been developed in various dimensions and shapes 
(i.e. U and V shaped wells) in order to control the size and shape of the resulting 
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spheroids; however, the resulting EBs were mechanically forced into a disk shape and 
were found to be unstable, forming different cell lineages when re-suspended [8,9].  
Adhesive stencils and other surface modification techniques are only able to control the 
initial size of EBs [13].  The hanging-drop method is a common method to form EBs 
using hESCs, despite the fact that the resulting EBs can vary in size, mostly due to 
variations in droplet volume and cell concentrations in each droplet during pipetting.  
Further issues include the time consuming manual method, which is also liable to 
human error [4,14]. 
A new cell printing platform has been developed which is capable of depositing hESCs 
with precise quantity and high cellular viability, whilst maintaining their pluripotency.  
The combined methods of hanging-drop spheroid formation with valve-based cell 
deposition systems were used for the controllable and repeatable creation of uniform 
human embryonic stem cell spheroids of specific sizes.  The combination of a single 
valve-based deposition system and the hanging-drop technique has recently been shown 
to be effective in producing spheroids from mESCs using a single nozzle system [4].  
This chapter presents the development of a dual nozzle system which enables 
combinatorial printing of hESCs and results in a system with increased throughput, as 
multiple bio-inks can be printed simultaneously.  In addition, the combined technique 
was further improved by printing cells directly into the wells of micro-well plates.  This 
allowed the spheroids to form in situ without the need to transfer them to a well plate 
after they have formed, lowering the amount of stress applied to the cells during the 
aggregation procedure.  The response of hESCs to the aggregation procedure was 
investigated to determine whether it differed in any way to that of other stem cells. 
6.2 Project Acknowledgements 
The project was performed in collaboration with Jason King, John Gardner, Catherine 
Fyfe and Helen Bradburn from Roslin Cellab.  Human Embryonic Stem cells (line RC-
10) were provided at a concentration of 3×10
6
 cells/mL.  All cell culturing was provided 
by them, in addition to the various different cell media types used in the following 
experiments.  The School of Life Sciences at Heriot-Watt University provided access to 
and use of an incubator and optical microscope for the later experiments. 
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6.3 Pluripotent Stem Cell Testing 
6.3.1 hESC Viability 
The hESCs were cultured in complete StemPro® hESC SFM (supplement, DMEM/F-
12, BSA, FGF basic, and 2-mercaptoethanol) (Life Technologies) supplemented with 8 
ng/mL of human basic fibroblast growth factor (hbFGF).  Cells were stored in an 
incubator at 36.0-37.5°C, 5.0±0.5% CO2.  Under these conditions the cells are kept in 
an undifferentiated state. 
hES cells were suspended in StemPro® hESC SFM to a concentration of approximately 
2×10
6
 cells/mL and loaded into the reservoir of one of the cell deposition systems.  The 
valve-on time was set at 8000 ms to allow for a significant volume to be dispensed, 
improving the reliability of the results.  Due to the fact that different pressures are often 
used in different experiments, cellular viability was investigated at a number of 
pressures to give a more accurate indication of viability for various circumstances.  
Several droplets were dispensed at each pressure onto microscope slides; the unprinted 
cells were used as a control. 
The slides were examined under the microscope at 24 and 72 hours post printing and 
sample images were recorded.  The number of live and dead cells was counted using the 
ImageJ image processing program and the results are shown in Figure 5.8. 
 
Figure 6.1 – A graph to show the percentages of live cells per sample as a function of pressure. 
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The normalised cell viability was calculated to be >95% after 24 hours and >89% after 
72 hours for all pressures.  This confirms that this technique does not affect the short 
and longer term viability of cells even those as sensitive as hESCs.  This is consistent 
with the observations of other groups [4,15–18]. 
6.3.2 Oct-4 Immunofluorescence 
In order to confirm that the hESCs were still pluripotent post-printing, they were 
examined to check that they still possessed one of the pluripotency markers: octamer-
binding transcription factor 4 (Oct4).  After performing the procedure detailed in section 
3.3.4, the cells were examined under the microscope 72 hours after printing.  The results 
are shown in Figure 6.2. 
 
Figure 6.2 – Detailed views of hES cells 72 hours after printing: a) optical image; b) fluorescence image 
(scale bar 10 µm) 
Three days after printing, hESCs remained positive for the Oct-4 pluripotency marker, 
which confirms that the printing process does not affect the pluripotency of hES cells. 
The results presented here clearly show that even fragile cells like hESCs are unaffected 
by the printing process.  Another advantage of the cell printing approach is the 
increased speed of the technique: the cell printer can deposit ~50 distinct droplets per 
minute and could therefore populate an entire 96-well plate in less than 2 minutes, 
whereas a manual approach would take significantly longer.  As a consequence of this 
decreased time and the graphical user interface, the cell printer is a high throughput and 
user-friendly operation. 
a) b) 
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6.4 Combinatorial Printing Scheme for Spheroidal Aggregate Creation 
Due to the fact that the size of an EB will influence the differentiation path of the hESC 
within it, by altering one or more of these characteristics it may be possible to discover 
how much influence they have over hESC differentiation and perhaps discover the 
perfect conditions required to produce different lineages.  The size of an EB is 
determined by the number of cells from which it was formed and the time the cells were 
cultured for.   
The droplet volume is easily controllable by the bioprinter and the number of cells 
present in each dispensed droplet can be set by the concentration of cells in the bio-ink 
and the volume of the dispensed droplet as discussed in section 5.3.1.  Therefore, it is 
possible to create a gradient of cell numbers by depositing a gradient of droplet 
volumes.  By overprinting a similar gradient of medium in the opposite direction, the 
resulting array will have a constant volume but a gradient of cell concentrations.  Such 
an array could be used to create EBs with controllable sizes and show the minimum cell 
concentration required to create a stable aggregate. 
Prior to using cells to create aggregates, DMEM (medium) was used to check that the 
cell printer could print a gradient of droplet volumes.  Programs were written for the cell 
printer that would create an 1111 array of droplets with gradients of droplet volumes.  
The droplet spacing was set at 1 mm, taking into account surface properties (such as 
hydrophobicity) and maximum droplet volume to ensure that they remained isolated and 
did not merge with neighbouring droplets.  The first program created a decreasing 
gradient of droplet volumes in each row from 1.5-0 µL (no bio-ink was dispensed on the 
11
th
 row); the resulting array is shown in Figure 6.3a.  The second program created the 
reverse (increasing) gradient in each row from 0-1.5 µL (no bio-ink was dispensed on 
the 1
st
 row).  When the two programs were run consecutively, the resulting array of 
droplets had a constant volume of 1.5 µL but a gradient ratio between the two different 
bio-inks.  Since the two programs omit one row each, a pure row of each bio-ink is 
present in the final array.  The results are shown in Figure 6.3. 
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Figure 6.3 – a) An array of DMEM (with red dye for clarity) with a gradient of droplet sizes (1.5 – 0 μL); 
b) the same array with an opposing gradient of water overprinted to create uniform volume droplets with 
a gradient of DMEM (scale bar 10 mm) 
These results show that the printer is able to create an array with a volume gradient and 
overprint an opposing volume gradient on top to create a constant volume array with 
two opposing gradients.  The last row of the array in Figure 6.3b contains only water 
which is why they are a different shape. 
6.4.1 Printing Hanging Droplets 
The hanging drop method of culturing embryoid bodies customarily suspends the 
physically separated droplets of cells suspended in medium from the lid of a Petri dish, 
which can lead to problems when the dish is inverted.  There are also issues with 
production scale and the amount of labour required to manually create the array [10,19].  
Other disadvantages include the limitation on droplet volume (<50 µL) due to 
maintaining the droplets on the substrate surface by surface tension and the practical 
impossibility of medium exchange [20]. 
To overcome these drawbacks, the bioprinter was used to print the droplets, improving 
the homogeneity and repeatability of the created EBs.  The Petri dish lid was replaced 
with 60-well Terasaki plates (653102, Greiner bio-one).  These particular plates were 
chosen due to their flat bottomed conical well profile, angled at 56°, which both lowers 
the surface area of the hanging droplet and removes the unwanted corners at the bottom 
of most standard well plates.  This increases the droplets resistance to drying and 
potentially induces the cells to aggregate quicker, lowering the likelihood of multiple 
aggregates.  In order to further reduce the amount of media evaporation of the small 
b) a) 
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(tens of µL or fewer) volume deposited in each well, the lid of the multi-well plate is 
filled with water to act as a reservoir. 
An additional benefit of printing into the wells of a multi-well plate is that the droplet 
locations, and hence the EB locations, are indexed.  Therefore if long-term culture is 
required, fresh media can be added to each well very quickly and accurately to keep the 
EBs supplied with nutrients.  
 
Figure 6.4 – Schematic of the printing process for aggregate creation and culture 
In the research performed by Xu et al. [4] aggregates were formed in hanging droplets 
on the lid of a Petri dish and then transferred to a microwell plate for further culture.  
The process described here improves on existing techniques as it eliminates the need for 
moving the aggregates after they have formed, enabling the investigation into the effects 
of external agents (i.e. nanoparticles or chemicals) on different sized aggregates in the 
same array.  Keeping the aggregates in the microwells where they formed eliminates a 
source of possible contamination and reduced the stress encountered by the cells and the 
spheroid, decreasing the chances of the spheroids fragmenting. 
6.4.2 Gradient of Cell Concentration 
In order to confirm the repeatability of the creation of a cell gradient array, an 
experiment was devised using the printed hanging-drop method and the combinatorial 
printing process for creating arrays with concentration gradients.   
Cells in medium printed 
into well
Plate is flipped - droplet 
hangs 
Cells attach to each other 
and form an aggregate
Aggregate grows and 
medium is used up
Plate is flipped and fresh 
medium is printed into 
wells
Plate is re-flipped and 
aggregate is cultured 
further
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60-well Terasaki plates were used as the substrate for this experiment.  The wells were 
coated in a thin layer of CELLStart™ to assist in maintaining the pluripotency of the 
hESCs.  The multi-well plates were transferred to an incubator and allowed to incubate 
for 1 hour before the extra CELLStart™ was removed. 
One of the bio-ink reservoirs was loaded with cells suspended in medium, while the 
other was loaded with medium alone.  An array of droplets containing cells was printed 
onto the wells of the multi-well plate with the size of the droplets decreasing by a set 
amount for each column, thus creating a gradient of droplet sizes and hence a gradient 
of cell concentration.  An opposing gradient of droplets which contained only medium 
was dispensed over the existing array, resulting in an array of droplets with uniform size 
but a cell concentration gradient.  The completed array was then inverted, making the 
droplets hang down from the surface and forcing the cells to aggregate.   
 
Figure 6.5 – Schematic of the combinatorial printing process for aggregate creation  
Based on the results in Figure 5.8, the inlet pressure was set at 8 PSI as it resulted in a 
higher viability than the other pressures during that experiment.  Using the existing 
valve time settings, 8 PSI also resulted in the desired volume of ~4 µL. 
Gradient of cells with an opposing gradient of medium
Left nozzle: Cells in medium Right nozzle: Medium
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Firstly, the program was run to check that cell concentration gradients were being 
created correctly.  Human ESCs were suspended in complete StemPro® hESC SFM to a 
concentration of approximately 1×10
6
 cells/mL and loaded into the left reservoir.  The 
other reservoir was loaded with complete StemPro® hESC SFM.  The gradient of 
medium was printed into the wells of a 60-well plate first in order to reduce potential 
impact on the cells.  Next, the opposing gradient of cells in medium was printed over 
the medium droplets, resulting in droplets of uniform size in every well (~4 µL).  The 
cells were monitored under the microscope (fl0015000m Trinocular Fluorescence 
Microscopes) immediately and at 24 hours after printing.  Between these times the cells 
were kept in a CO2 incubator (Galaxy S+, RS Biotech) at 36.0-37.5°C, 5.0±0.5% CO2. 
Two plates were populated and examined under the microscope before being placed into 
an incubator. The results are shown in Figure 6.6 and Figure 6.7. 
 
Figure 6.6 – Detailed views of selected wells of the printed array immediately after printing: a) 1st 
column; b) 2
nd
 column; c) 3
rd
 column; d) 4
th
 column; e) 5
th
 column; f) 6
th
 column; g) 7
th
 column; h) 8
th
 
column; i) 9
th
 column (scale bars 250 μm) 
a)  b)   c) 
d)  e)   f) 
 g)  h)  i) 
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Figure 6.7 – A graph to show the average cell numbers in each column after printing. 
These results show that a gradient of cell concentration can be created using this 
approach.  The error bars are very small, indicating that the data is highly reliable and 
correct; furthermore, the relationship is linear, which means that specific cell 
concentrations could easily be specified for future experiments. 
The original plan was to perform one long experiment in one day, wherein cells were 
printed and analysed immediately post printing, then measure the resulting aggregate 
sizes at 24 and 48 hours post printing.  Unfortunately, upon examination of the cells 
after 24 hours post printing, it became apparent that the incubator had failed, and a large 
number of the cells had consequently died due to the evaporation of the medium.  The 
experiment was not a complete loss, however as we had confirmed that it was possible 
to print a gradient of cell concentrations. 
The error bars in Figure 6.7 for the cell numbers in the first and second columns are 
larger since there was insufficient volume of suspended cells to fully populate two 
multi-well plates.  The cell counts for these two columns are taken mostly from the first 
multi-well plate and a small number of wells from the second plate and the larger error 
bars reflect the increased uncertainty. 
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A further issue arose when initially analysing the plates, as it transpired that the 
microscopes had insufficient optical magnification to view all the cells in the wells 
clearly.  Multiple images were therefore taken and stitched together.   
6.4.3 Gradient of Spheroid Aggregate Sizes 
In order to combat some of the problems encountered in the previous attempt, the 
experiment was repeated with several modifications.  Complete StemPro® hESC SFM 
with hES cells suspended at a concentration of 3×10
6
 cells/mL were loaded into the left 
reservoir.  The other reservoir was loaded with complete StemPro® hESC SFM.  As 
before, the two opposing gradients of medium and cells in medium were printed onto a 
60-well plate, resulting in droplets of uniform size in every well.  The volume printed in 
each was increased to ~10 µL instead of 4 µL in order to combat the quick evaporation 
encountered previously.  This plate was then placed into an incubator and the procedure 
was repeated on a second plate which was also placed into the same incubator.  As the 
immediate cell concentration results had been verified previously, the plates were 
examined under the microscope 24 and 48 hours after printing.  The results are shown 
in Figure 6.8 and Figure 6.9. 
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Figure 6.8 – Detailed views of selected aggregates 24 and 48 hours after printing: a-b) 1st column; c-d) 
2
nd
 column; e-f) 3
rd
 column; g-h) 4
th
 column; i-j) 5
th
 column; k-l) 6
th
 column; m-n) 7
th
 column; o-p) 8
th
 
column; q-r) 9
th
 column (scale bars 250 μm) 
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g) 
i) 
k) 
m) 
o) 
q) 
h) 
j) 
l) 
n) 
p) 
r) 
b) 
d) 
f) 
24 hours post 
printing: 
48 hours post 
printing: 
Chapter 6 – Generation of Human Embryonic Stem Cell Spheroids 
 
167 
 
Figure 6.9 – A graph to show average sizes of cellular aggregates in each column measured 24 and 48 
hours after printing. 
In order to quantitatively evaluate the aggregate sizes, a best fit ellipse was used to 
calculate diameters.  It was observed that a gradient in the initial concentration of cells 
yields aggregates with a similar gradient of sizes.  In addition, higher concentrations of 
cells tended to yield larger aggregates, and these larger aggregates exhibited more 
growth over the 48 hours than smaller aggregates.  This confirms that the cells are still 
viable, even those inside the aggregates, as the larger aggregates would not have 
exhibited the increased growth indicated in these results if any cells had died.  This 
confirms results in previously reported research [21,22].  An alternative explanation for 
the increased growth is the re-aggregation of the smaller spheroids into larger ones [23]. 
An unexpected result was that multiple aggregates had formed in some of the wells.  
Although this did not occur very often, the data seems to suggest that it will occur more 
often in the wells with lower initial concentrations of cells.  Another interesting result 
was that the multi-aggregates that formed were similar in size to those in the same 
column where only single aggregates had formed.  Two possible explanations exist for 
this phenomenon: either there is a relationship between cell density and cell mobility, 
and there comes a point where the cells are too widely spread to form a single 
aggregate; or this may be a quirk of human ESCs.  An example of multi-aggregate 
formation is shown in Figure 6.10. 
0
0.1
0.2
0.3
0.4
0.5
0.6
0.7
0.8
0 1 2 3 4 5 6 7 8 9 10
A
v
er
a
g
e 
a
g
g
re
g
a
te
 d
ia
m
et
er
 (
m
m
) 
Column of the multi-well plate 
24 hours
48 hours
Chapter 6 – Generation of Human Embryonic Stem Cell Spheroids 
 
168 
 
Figure 6.10 – An example of multiple aggregates forming in the same well (scale bar 250 μm) 
The results presented here clearly show that aggregates can be created with a reasonable 
degree of control of their size by varying the initial cell concentration and culture time.  
The standardisation of aggregate sizes is much greater than those achievable by manual 
pipetting due to the inherently heterogeneous nature of manual pipetting, especially 
with regards to droplet sizes and therefore initial cell concentrations.  Further work is 
required to fully characterise the spheroids formed using this technique. 
6.5 Conclusions  
This work demonstrates that the valve-based printing process is accurate enough to 
produce spheroids of uniform size.  Due to the dual nozzle setup, the system is also able 
to create gradients of cells and other bio-inks which, when used in conjunction with the 
hanging droplet technique, yields gradients of cellular aggregates.  The resulting 
aggregates are uniform and have repeatable sizes or size ranges, meaning that they can 
be made for specific applications such as the production of macrophages or other blood 
cells that require going through an EB phase en route to the eventual terminally 
differentiated cell type.  Unlike previous studies, this project printed directly onto the 
micro-well plate, allowing the creation and culture of spheroid aggregates without the 
need to transfer them after formation, lowering the amount of stress applied to the cells 
during the aggregation procedure, increasing viability and successful aggregation 
formation rate. 
The ability to print human embryonic stem cells for the generation of 3D structures will 
allow for the creation of more accurate functional human organ tissue models by 
incorporating programmed differentiation to increase the efficiency.  These tissue 
models would increase the accuracy and reliability of existing in vitro drug 
development and toxicity-testing.   
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Additionally, this may also pave the way for human stem cells to be incorporated into 
clinical protocols either for patient implantation of in vitro regenerated organs or direct 
in vivo cell printing for tissue regeneration. 
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Chapter 7 – 3D Bioprinting towards the Creation of Liver Tissue 
7.1 Introduction 
In order to create engineered tissue structures, the ability to create precise in vitro 
microenvironments with 3D, chemical and spatial control over cells is required.  A 
number of studies have shown that certain cells such as hepatocytes require a three-
dimensional structure in order to function properly [1–3].  In vitro studies by Dunn et al. 
have shown that hepatocytes cultured as a monolayer lost many of their liver-specific 
functions after a few days, but those cultured with a layer of collagen gel in a “sandwich 
configuration” were able to retain their liver-specific functions for several weeks [4].  In 
vivo, the extracellular matrix (ECM) is the natural scaffold material that serves to 
maintain the 3D tissue structure, control cell proliferation, motility and migration [5].  
Various techniques have been developed to position cells in three-dimensions in order 
to create three-dimensional tissue constructs, some of which make use of aggregates 
similar to those created in Chapter 6.  The methods include: scaffolds, bottom-up self-
assembly, cell sheets and de-/recellularisation.  Bottom-up self-assembly of cells or 
cellular aggregates in hydrogel addresses the main limitations of the older techniques 
and it is the best suited technique for the creation of micro-tissues [6]. 
Hydrogels are important building materials for tissue engineering due to their 
similarities to extracellular matrix (ECM); they are also inherently biocompatible due to 
their hydrophilicity, and they very closely resemble the 3D biological environment 
required for cell culture [7–11].  They are extremely customizable, with a very large 
selection of available synthetic and natural components, fabrication techniques, and 
synthesis methodologies, which result in tuneable properties such as pore size and 
mechanical strength [9,10].  For these reasons, hydrogels have been used extensively in 
many biological and clinical applications, including 3D tissue and organ engineering. 
As noted in section 1.1.2, new drug development can take from 10 to 20 years with an 
estimated average of about 9 to 12 years [12,13].  In addition, only around 16% of the 
drugs that begin preclinical testing are approved for human use [14].  Some of this low 
success rate can be attributed to the different responses that animals and humans have to 
the drugs being tested; some drugs may be dropped that would have worked on humans 
because they didn’t have the desired effect on animals, while drugs such as thalidomide 
were accepted with disastrous results [15].  One possible solution to this is the creation 
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of human pluripotent stem cell-derived micro-tissues which could be used with organ-
on-a-chip devices [16].  These micro-tissues should produce the same physiological 
reaction that the entire organ would, but on a much smaller scale.  This would result in 
faster results, better drugs and an end to animal testing and vivisection.  Human 
pluripotent stem cells (hPSCs) are the ideal cells to use for this application due to their 
ability to self-renew, which enables large populations of cells to be created easily, and 
their pluripotency, which means that they can differentiate into any required adult cell 
type [17–21].   However, if these cells are to be used for these kinds of applications, 
their differentiation must be reproducibly directed to the required lineages for each 
tissue.  Unfortunately, homogeneous cellular differentiation of hPSCs into specific germ 
layers has proven to be difficult to accomplish [22,23]. 
If more complex structures such as those found in organs were to be printed, the 
bioprinter would need the ability to transfer mesoscopic patterns of viable cells into 
clearly-defined three-dimensional patterns.  This chapter describes the application of the 
valve-based bioprinting platform to the creation of 3D cell-laden hydrogel structures 
and the directed differentiation and printing of hPSC-derived hepatocyte-like cells 
(HLCs) as a precursor to the creation of multi-cellular liver micro-tissues.  This includes 
an in-depth study into the printability of alginate hydrogels of various concentrations 
and volume ratios, the viability and compatibility of 3D hydrogel structures with cells, 
and the investigation of the HLCs to verify their hepatic functions. 
7.2 Project Acknowledgements 
The project was performed in collaboration with Juan Jin, Chuang Li and Yijie Wang 
from Tsinghua University, Beijing, China, and Jason King, John Gardner, Catherine 
Fyfe, Sebastian Greenhough and Helen Bradburn from Roslin Cellab.  Human 
Embryonic Stem cells (lines RC-6, RC-7, RC-8, RC-9, and RC-10) and Human Induced 
Pluripotent Stem cells (line RCi-22) were provided by Roslin Cellab at various 
concentrations.  All stem cell culturing was provided by Roslin Cellab, in addition to 
the various different cell media types used in the following experiments.  Experiments 
involving HLCs were carried out by Roslin Cellab. 
7.3 Alginate Printing 
Alginate is a natural linear polysaccharide copolymer which is extracted from brown 
seaweed algae.  Due to their biocompatibility, non-immunogenicity, low toxicity and 
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hydrophilic nature, alginate hydrogels have many attractive features for biomedical 
applications [24].  The mechanical properties of a gelled alginate solution, including 
viscosity and overall stiffness, depend on the concentration of the polymer and its 
molecular weight distribution [9,25].  Crosslinking between the polymer chains depends 
on the amount of polymer chains and multivalent cations (e.g. Ca
2+
, Ba
2+
) present in the 
solution and the temperature [7,9,24,25].  In vitro, alginates typically degrade by 
approximately 40% within 9 days; this is most likely due to the diffusion of ions into 
the surrounding medium [26].   
Sodium alginate (W201502, Sigma-Aldrich Co. LLC) and calcium chloride dehydrate 
(223506, Sigma-Aldrich Co. LLC) were used to form alginate hydrogels.  Alginate 
hydrogel structures are bioprinted by dispensing an array of droplets of alginate solution 
from the left nozzle and then overprinting droplets of calcium solution from the right.  
After a few seconds, the alginate chains start to bond with the calcium ions, forming a 
complete hydrogel matrix in around a minute.  If adjacent droplets overlap they gel 
together and form a single continuous layer. 
 
Figure 7.1 – Schematic of the combinatorial printing process for alginate hydrogel creation. 
7.3.1 Hydrogel Spot Size Investigation 
The first task was to explore the properties of the hydrogel components and determine 
the optimum pressure, concentration and volume ratios required to generate hydrogel.  
Nozzle
Alginate 
Solution
Calcium 
Solution
Alginate 
Chain
Calcium 
ion
Egg-box
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To this end, a series of solutions with different concentrations of sodium alginate and 
calcium solutions were prepared and mixed. 
Sodium alginate solutions with concentrations from 0.1% to 5% were successfully 
dispensed using the custom bioprinter described in Chapter 4 at inlet pressures of 2-15 
PSI.  The calcium solution has a much lower viscosity and should therefore be 
dispensed at much lower pressures in order to avoid flooding the printed hydrogel 
structure with excess calcium solution. 
In order to determine the range of sizes of hydrogel droplets that can be created, an 
experiment was devised with a varying volume ratio of alginate and calcium solutions.  
Solutions of each component were created with 1% volume concentration and loaded 
into the bioprinter.  A variety of different ratios were tested and the resulting droplets 
were viewed under the microscope to measure their dimensions; the properties of the 
resulting hydrogels were then examined.  In each case a number of layers of alginate 
were dispensed before a single layer of calcium was added to cross-link the hydrogel. 
 
Chapter 7 – 3D Bioprinting towards the Creation of Liver Tissue 
 
176 
 
Figure 7.2 – Results of the alginate droplet spot size investigation: a) 8 layers of alginate; b) 7 layers of 
alginate; c) 6 layers of alginate; d) 5 layers of alginate; e) 4 layers of alginate; f) 3 layers of alginate; g) 
2 layers of alginate; h) 1 layer of alginate (scale bars 250 µm) 
The resulting droplets ranged in size from 960 to 620 µm in diameter and followed an 
expected linear increase in size.  It was noted that all the droplets contained cross-linked 
hydrogels, but the volume ratio of approximately 4:1 alginate to calcium was found to 
    
    
    
    
a) b) 
c) d) 
e) f) 
h) g) 
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create the best hydrogel.  These results were used to configure all subsequent alginate-
based hydrogel experiments. 
7.3.2 3D Hydrogel Bioprinted Structures 
In most of the experiments undertaken thus far, droplets were dispensed separately and 
discretely.  In contrast, these experiments required the droplets to merge together to 
form contiguous structures.  The spacing between droplets was set to approximately half 
the dispensed droplet diameter to ensure that they merged.  Again, 1% concentration 
solutions of sodium alginate and calcium chloride were used for these experiments. 
 
Figure 7.3 – Simple linear printed alginate structures: a-c) 10 mm ten layer structure on a microscope 
slide viewed from above and the side, and being held with tweezers; d) two single layer linear hydrogel 
structures with different droplet sizes resulting in different line widths  
The bioprinter was able to deposit multiple alternating layers of alginate and calcium 
solutions in a contiguous linear structure.  The resulting gel structures exhibited strong 
mechanical properties, were manipulatable and could even be removed from the 
substrate without fragmenting.  Several different substrate surfaces were tested, 
including standard plastic Petri dishes and glass microscope slides, and it was noted that 
the droplets drift away from the intended target locations if the surface is too 
a) b)
c) d)
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hydrophobic, greatly reducing the spatial accuracy and repeatability of the bioprinter.  
However, if the surface is too hydrophilic, the droplets spread too much, reducing the 
resolution of the printed structures; it is therefore important to find the right surface on 
which to print accurate structures. 
These structures are composed of a single layer of alginate and calcium solutions which 
form thin hydrogel structures.  By depositing more alginate and calcium on top of these 
structures in the same pattern, three-dimensional structures can be built up layer-by-
layer.  Some simple circular patterns were designed with various diameters and number 
of layers.  The results are shown in Figure 7.4. 
 
Figure 7.4 – Simple circular printed alginate structures with red dye for improved visibility: a) 5 layer 5 
mm diameter structure before the excess calcium solution was removed; b) 10 layer 5 mm diameter 
structure drained of excess calcium; c) 2 layer 3 mm diameter structure; d) resulting structure of 
reversed protocol: alginate printed onto calcium (scale bars 2 mm) 
The resulting structures were slightly more octagonal than circular and there were 
problems with the hydrogel spreading further as more layers were added (to the point 
that in some cases the hole in the centre was filled in).  Another issue was that the 
structures were sometimes disjointed; this mainly occurred when the surface was too 
a) b)
c) d)
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hydrophobic, but it also happened at the beginning/end of the circle as shown in Figure 
7.4b. 
During one experiment the alginate and calcium solutions were reversed in order to 
determine if printing alginate onto the calcium solution would yield better structures.  
Figure 7.4d shows that this is not the case; the structure is more disjointed than the 
others and there are undesired superfluous tendrils of hydrogel leading away from the 
structure.  
In order for this technique to be useful for tissue engineering applications, structures 
need to be taller to be considered truly three-dimensional.  In order to increase the 
height of the printed structures, the concentration of alginate solution was increased 
from 1% to 2% to improve the mechanical strength of the hydrogel and allow it to 
support further layers.  Square and circular structures with a large number of layers 
were designed and printed out.  These resulting structures were photographed for 
analysis. 
 
Figure 7.5 – Tall 3D printed alginate structures with 20 layers: a-b) a 10 mm square shown being held 
with tweezers a) and from the side; and c-d) a 6 mm diameter circle shown from above and from the side 
(scale bars 2 mm) 
a) b) 
c) d) 
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These taller structures were printed out in under twenty minutes.  The square structure 
was strong enough to be physically manipulated with tweezers without deforming (as 
seen in Figure 7.5a); this demonstrates the high strength of the hydrogel.  The structures 
spread slightly, but by slightly altering the volume ratio, concentrations and surface 
properties this spreading can be reduced. 
7.3.3 Spot Size Shrinking 
In order to examine the impact on the size of printed droplets, the concentration of 
alginate was reduced from 1% to 0.2% and the substrate surface was modified to be 
more hydrophilic using a plasma treatment machine (Zepto, Diener electronic).  0.2% 
alginate has many of the same characteristics as the DNA-based hydrogels used in 
chapter 8, most important of which is a similar viscosity range ensuring printed droplets 
would be a similar size. 
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Figure 7.6 – Results of the spot size shrinking experiment: a-b) 1% alginate on a Petri dish; c-d) 0.2% 
alginate on a Petri dish; e-f) 0.2% alginate on modified glass slide (scale bars 100 µm) 
As expected, on a Petri dish the 1% alginate droplets produced droplets approximately 
715 µm in diameter whereas the 0.2% alginate droplets measured ~408 µm; smaller 
concentrations of alginate produce smaller hydrogel droplets.  When this lower 
concentration of alginate was dispensed onto a glass substrate that had previously been 
plasma treated to be hydrophilic, the diameter of the droplets was much larger (~625 
µm) due to spreading on the surface. 
  
  
  
  
 
 
c) 
a) b) 
d) 
e) f) 
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7.3.4 Hydrophilic Surface Modification 
An attempt was made to improve the quality of the print, primarily the straightness and 
thickness of the hydrogel lines, by modifying the substrate surface.  Slotted masks were 
laser cut with a variety of slot widths (2 mm, 1 mm, 0.8 mm, 0.6 mm, 0.4 mm, 0.2 mm 
and 0.1 mm); these masks were fixed to the surface of glass microscope slides before 
being treated with a plasma treatment machine (Zepto, Diener electronic).  The resulting 
substrate had a hydrophobic surface with hydrophilic patches.  Hydrogel lines were 
printed onto these patches and measured under a bright-field microscope. 
 
Figure 7.7 – Printed hydrogel lines on hydrophilic treated patches: a) 0.8 mm; b) 0.7 mm; and c) 0.6 mm 
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After printing, it was observed that each printed hydrogel line has almost the same 
width, regardless of the width of the hydrophilic patch.  The hydrogel lines are also off-
centre, even though the droplets are visibly in the center of the hydrophilic patches: this 
could be due to the nozzles used for this experiment, which were extremely thin and 
more flexible than desired; it is possible they were not precisely aligned in the x-axis. 
The lines themselves were straighter than those printed previously on uniform 
substrates. 
It was apparent that printing out structures with different numbers of layers would result 
in different widths as well as different heights, but it was not clear how this would affect 
the final structure.  Three different programs were created which described hydrogel 
lines with 3, 5 and 10 layers, which were printed out and analyzed using an electron 
microscope. 
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Figure 7.8 – Images of multi-layer alginate hydrogel lines taken with an electron microscope: a) 3 layers 
= 0.81±0.06 mm; b) 5 layers =1.10±0.12 mm; c) 10 layers = 1.41±0.25 mm 
It is obvious that the lines are indeed spreading with increased number of layer but this 
increase is small; therefore, taller structures should not deform too much as the number 
of layers increases.  The relationship can be expressed in the form of an equation: 
𝑤 = 0.085(𝑛) + 0.5633                                                (7.1) 
where w is the line width (in mm) and n is the number of layers. 
a) 
b) 
c) 
Chapter 7 – 3D Bioprinting towards the Creation of Liver Tissue 
 
185 
7.3.5 Cell-laden Alginate Printing 
As a simple first test of the bioprinters ability to pattern cells-laden hydrogels, HeLa 
cells were suspended in 0.2% sodium alginate solution and loaded into one of the 
deposition systems, with calcium solution in a second deposition system.  Individual 
droplets were dispensed and viewed under the microscope immediately post-printing. 
 
Figure 7.9 – 0.2% alginate with HeLa cells (scale bars 250 µm) 
When observed under a microscope the cells were observed to be morphologically 
normal and healthy.  No cellular debris was observed and the addition of cells to the 
hydrogel did not negatively affect the printer. 
In order to verify that cells can indeed be patterned in 3D using hydrogel, a torus ring 
structure was designed with two different cell types (HeLa and 3T3) occupying different 
layers of the structure.  Three deposition systems were used for this experiment: the first 
was loaded with HeLa cells suspended in 0.2% sodium alginate solution; the second 
was loaded with 3T3 cells suspended in 0.2% sodium alginate solution; and the third 
was loaded with calcium solution.  The printed structure was observed through a bright-
field microscope to check the position of the different cells. 
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Figure 7.10 – Multi-layer torus with HeLa and 3T3 cells suspended on different layers of the structure 
(scale bar 500 µm) 
By scanning through the height of the structure at different focal depths, the two 
different cells were found to be occupying different layers of the structure, proving that 
cells can be positioned at different heights as well as horizontal positions within a 3D 
bioprinted structure.  
7.3.6 Complex Hydrogel Well Array 
Hydrogel can also be used to create walled chambers for the separate culturing of 
multiple cell types on the same substrate.  The hydrogel would allow for nutrient and 
chemical signal transfer whilst keeping the cells physically separate.  Several programs 
were created with different numbers of chambers based on an overall square outline of 
12  12 mm.  These structures were printed out onto unmodified glass microscope 
slides. 
Chapter 7 – 3D Bioprinting towards the Creation of Liver Tissue 
 
187 
 
Figure 7.11 – Hydrogel well array structures: a-b) 10 layer 2x2 viewed from a) the top and b) the side; 
c-d) 20 layer 3x3 viewed from c) the top and d) the side; e-f) 20 layer 4x4 viewed from e) the top and f) 
the side (scale bars 5 mm) 
The resulting complex well array structures were of reasonable quality, excess calcium 
solution having been manually drained with a pipette before imaging.  The excess 
calcium served to support the structure as the hydrogel cross-linked which increased the 
resolution of the structure by preventing the hydrogel from spreading too far.  This 
higher resolution is evident in Figure 7.11a, c and e as the line widths are almost 
unchanged, even though the height increases with double the number of layers. 
Some minor deformation is visible in the structures, but this occurred post-printing 
during the excess calcium solution removal. 
a) b) 
c) d) 
e) f) 
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7.4 Hepatocyte-like Cell Creation 
7.4.1 Cell Culture 
Human embryonic stem cell lines RC-6, RC-7, RC-8, RC-9 and RC-10 and human 
induced pluripotent stem cell line RCi-22 were supplied by Roslin Cells Ltd for this 
research.  The hES cells were cultured in complete StemPro® hESC SFM (supplement, 
DMEM/F-12, BSA, FGF basic, and 2-mercaptoethanol) (Life Technologies) 
supplemented with 8 ng/mL of human basic fibroblast growth factor (hbFGF) and the 
hiPS cells were cultured on Geltrex matrix with Essential 8 medium (Life 
Technologies).  Cells were cultured in a laboratory incubator set at 36.0-37.5°C, 
5.0±0.5% CO2.  Under these conditions the cells are maintained in an undifferentiated 
state. 
7.4.2 Initial EB differentiation testing of hESC lines 
Before hESCs can differentiate into mature hepatocytes, they must first become 
definitive endoderm.  The first stage-specific hepatic marker the cells must produce is 
-fetoprotein (AFP) which is expressed by foetal hepatoblasts (liver buds).  In order to 
determine which (if any) of the available hESC lines had a predilection towards hepatic 
lineages, embryoid bodies were formed using the hanging drop technique and tested for 
AFP production.   
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Figure 7.12 – Fluorescence images of HLCs showing -fetoprotein (AFP) production in green and DAPI 
in blue: a) hESC line RC-6; b) hESC line RC-7; c) hESC line RC-8; d) hESC line RC-9; e) hESC line RC-
10 (scale bars 100 µm) 
Human ESC lines RC-6 and RC-9 showed good AFP production, line RC-7 had low 
production, line RC-8 was extremely poor, but line RC-10 showed the highest AFP 
expression and the cells had better morphology with increased size and bi-nucleation.  
However, the differentiation was undirected and better results could be achieved if a 
more controlled approach was adopted. 
7.4.3 Directed differentiation of hPSCs into HLCs 
A modified version of the three-step protocol devised by Hay et al. [23] was used to 
direct the differentiation of hESCs into hepatocyte-like cells (HLCs).  After the hESCs 
a) b) 
c) d) 
e) 
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had reached a confluence level of 50-70%, StemPro® hESC SFM was replaced with 
RPMI-B27 medium (Invitrogen) and the hESCs were treated with activin A and Wnt 3a 
for three days.  Following this, the cells were cultured in serum replacement medium 
(SR/DMSO: knockout-Dulbecco's modified Eagle's medium [KO-DMEM] containing 
20% SR, 1 mM glutamine, 1% nonessential amino acids, 0.1 mM ß-mercaptoethanol, 
and 1% dimethyl sulfoxide [DMSO]) for 5 days.  For the final maturation step, cells 
were cultured in L15 medium supplemented with 8.3% foetal bovine serum (FBS), 
8.3% tryptose phosphate broth, 10 μM hydrocortisone 21-hemisuccinate, 1 μM insulin, 
and treated with 10 ng/mL hepatocyte growth factor (HGF) and 20 ng/mL oncostatin M 
(OSM) for nine days. 
 
Figure 7.13 – The three-step protocol used to differentiate hESCs into HLCs: a) Schematic 
representation of the three-steps; b) Images showing morphological changes from hESCs to HLCs 
Three different hESC lines (RC-6, RC-9 and RC-10) were subjected to the directed 
differentiation protocol in order to determine which, if any, had a tendency to produce 
better hepatocyte-like cells than the others.  The cells should be positive for hepatocyte 
nuclear factor 4 alpha (HNF4α) if they have started differentiating into hepatocytes.  As 
the cells mature they should begin to express albumin, which can only be synthesised in 
large quantities by mature hepatocytes (immature hepatocytes also express albumin but 
at much lower levels) [23,27]. 
 
Day 0 Day 10 Day 3 
Hepatic Differentiation 
DMSO 
(1%) 
KO-DMEM + 20% SR 
Hepatic Maturation 
HGF + OSM 
(10ng/mL) (20ng/mL) 
mL15 + 8.3% FBS 
Endoderm Priming 
Activin A + Wnt 3a 
(100ng/mL) (50ng/mL) 
RPMI 1640 + B27 
3 days 5 days 9 days 
a) 
b) 
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Figure 7.14 – Fluorescence images of HLCs: (a-c) showing HNF4α expression in green and DAPI in 
blue: (a) hESC line RC-6; (b) hESC line RC-9; (c) hESC line RC-10; (d-f) showing albumin expression in 
green and DAPI in blue: (d) hESC line RC-6; (e) hESC line RC-9; (f) hESC line RC-10 (scale bars 100 
µm) 
Of the three cell lines tested after being subjected to the directed differentiation 
protocol, all three were positive for hepatocyte nuclear factor 4 alpha but only line RC-
10 also showed high albumin expression, indicating the presence of mature HLCs.  
As hESC line RC-10 consistently outperformed all of the other tested lines, it was 
selected for further testing.  A number of modifications were made to the differentiation 
protocol to improve the expression of the hepatocyte markers and a fresh batch of RC-
10s was subjected to the modified protocol.  In addition to HNF4α and albumin 
expression, the cells were also given an antibody for tight junction protein zona 
occludens 1 (ZO-1), which stains the cell-cell boundaries to check the cell morphology.  
Undifferentiated RC-10 cells provided the negative control. 
a) b) c) 
d) e) f) 
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Figure 7.15 – Fluorescence images of day 17 HLCs showing hepatocyte marker expression in green and 
DAPI in blue: a) HNF4α; b) Albumin; c) ZO-1; d) Negative Control (scale bars 100 µm) 
The resulting cells remained positive for HNF4α, were highly positive for albumin, and 
albumin ELISAs have shown that there is good albumin secretion.  The ZO-1 antibody 
shows that the cells have hepatocyte-like morphology. 
7.4.4 Bioprinting HLCs 
During the course of the experimental work it was discovered that cells were the most 
stable at day 6 through the differentiation process, so a large quantity of day 6 HLCs 
were prepared to ascertain whether the bioprinting process affected the differentiation 
when in progress.  Cells were differentiated up to day 6 and frozen until a sufficient 
population was available for printing.  Subsequently, the day 6 HLCs were thawed, 
dissociated into single cells and printed into the wells of a 12-well plate.  Printing was 
carried out using a pulse time of 8 ms at an inlet pressure of 8 PSI.  Non-printed cells 
were included as a control.  Once the cells had adhered to the surface after printing, the 
differentiation protocol was resumed.  On day 17 the cells were fixed and stained for 
hepatic markers (albumin and HNF4α); ZO-1 was used to check the morphology of the 
cells.   
Both hESC- and hiPSC-derived HLCs were bioprinted, with the latter having some 
minor modifications to the differentiation protocol regarding culture media. 
a) b) 
c) d) 
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Figure 7.16 – Fluorescence images of printed hESC-derived hepatocytes showing hepatocyte marker 
expression in green: a-c) control: a) HNF4α; b) Albumin; c) ZO-1. d-f) printed: d) HNF4α; e) Albumin; 
f) ZO-1 (scale bars 50 µm) 
 
Figure 7.17 – Fluorescence images of printed hiPSC-derived hepatocytes showing hepatocyte marker 
expression in green: a-c) control: a) HNF4α; b) Albumin; c) ZO-1. d-f) printed: d) HNF4α; e) Albumin; 
f) ZO-1 (scale bars 50 µm) 
 a) b) c) 
d) e) f) 
 a) b) c) 
d) e) f) 
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When the cells were compared to the unprinted control, there was virtually no 
difference between them.  The tight junctions form clearly and are well defined in both 
cases, demonstrating that the cells have good morphology.  The average cell size 
appears to be slightly smaller in the printed sample but this is to be expected as cells 
were more confluent.  This result indicates that the HLCs can be printed using the 
valve-based bioprinter during directed differentiation without interrupting the 
differentiation or changing the lineage of the cells.  
7.5 Printing HLC Co-culture with Supporting Cells 
The process of in vivo liver organogenesis occurs in the developing foregut, when 
newly specified hepatic cells separate from the endodermal sheet and form a dense 
hepatoblast (liver bud) which is quickly vascularised [28,29].  The hepatic progenitor 
cells interact strongly with stromal cells (comprising hepatic sinusoidal endothelial 
cells, hepatic stellate cells, and Kupffer cells), which help to control various aspects of 
hepatic development such as the promotion of outgrowth from the initial liver bud [29].  
Therefore, in order to create micro-liver tissue in vitro, a co-culture of stromal cells, 
vasculature endothelial cells, and hepatocytes would be required.  The ideal ratio of 
cells required to form a liver-like micro-tissue was then investigated. 
7.5.1 Cell Culture 
Human embryonic stem cell line RC-10 was supplied by Roslin Cells Ltd for this 
research.  The hES cells were cultured in complete StemPro® hESC SFM (supplement, 
DMEM/F-12, BSA, FGF basic, and 2-mercaptoethanol) (Life Technologies) 
supplemented with 8 ng/mL of human basic fibroblast growth factor (hbFGF).  Human 
hepatic stellate cells in hepatic/pancreatic stellate growth medium and human umbilical 
vein endothelial cells in endothelial growth medium were purchased from ZenBio, Inc.  
Cells were cultured in a laboratory incubator set at 36.0-37.5°C, 5.0±0.5% CO2.  Under 
these conditions the cells are maintained in an undifferentiated state. 
7.5.2 Manual Co-Culture 
As each cell type is pre-cultured in different media, it was important to establish that 
they could be cultured in a single common medium for this co-culture experiment.  
Human umbilical vein endothelial cells (HUVECs), hepatic stellate cells and HLCs had 
their old media aspirated and were re-suspended in the same culture medium (L15) 
before being manually plated on a 24-well plate.  The cells were stained with different 
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fluorescent markers so that they could be differentiated using a fluorescent microscope; 
HUVECs were stained with Vybrant and the hepatic stellate cells with DAPI.  The cells 
were monitored under the microscope at 24 hours after printing. 
 
Figure 7.18 – Co-culture of HUVECs, hepatic stellate cells and HLCs: a-b) HLCs and HUVECs co-
culture a) phase contrast, b) vybrant stain showing HUVECs; c-d) HLCs and stellates co-culture c) phase 
contrast, d) DAPI stain showing stellates; e-g) HLCs, HUVECs and stellates co-culture e) phase contrast, 
f) vybrant stain showing HUVECs, g) DAPI stain showing stellates 
a) b) 
c) d) 
e) 
f) 
g) 
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All three cell types were found to be viable in the co-culture, demonstrating that the 
cells can be cultured together in a single medium without any detrimental effects. 
7.5.3 2D Gradient of Supporting Cells 
An experiment was devised to attempt to determine the correct ratio of supporting cells 
required to form a micro-liver.  96-well plates would be used as the substrate for this 
experiment.  20 µL of Hepatocytes suspended in media would be added to 36 wells of 
the 96-well plate.  Two programs were written to describe two perpendicular volume 
gradients from 20 µL to 0 µL, similar to those used in section 6.4.2.  One of the bio-ink 
reservoirs would be loaded with vasculature endothelial cells suspended in medium, 
while the other would be loaded with stellate cells suspended in medium.  The resulting 
array of 36 wells would have a constant concentration of HLCs, but two perpendicular 
gradients of supporting cells with every combination of ratios decreasing in 20% 
intervals. 
 
Figure 7.19 - Schematic of the combinatorial printing process for creating a 2D gradient of supporting 
cells over an array of hepatocyte-like cells 
Left nozzle: HUVECs Right nozzle: Stellate CellshPSC-derived HLCs
Gradient of HUVECs
Gradient of Stellates
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RC-10 hESCs at a concentration of 1×10
6
 cells/mL were manually seeded into 36 wells 
of a 96-well plate (20 µL in each well) and differentiated according to the protocol 
described earlier.  In order to dispense the required 20 µL maximum volume, the 
pressure was set at 3.6 PSI and the pulse time to 720 ms.  HUVECs at a concentration 
of approximately 7.5×10
5
 cells/mL loaded into the left reservoir.  The other reservoir 
was loaded with hepatic stellate cells at a concentration of approximately 7.5×10
5
 
cells/mL.  At day 14 of the differentiation process, the perpendicular gradients of 
HUVECs and stellates were printed over the differentiating cells, resulting in droplets 
representing multiple variations of ratios between the supporting cells.  The cells were 
cultured for 48 hours in a CO2 incubator at 36.0-37.5°C, 5.0±0.5% CO2 to allow the 
supporting cells to integrate with the existing HLC cell matrix prior to a media change 
and the resumption of the differentiating protocol.  The cells were sacrificed and 
analysed for cytochrome P450 (CYP) activity using the Promega Glo assay at day 20 
and day 22 of HLC differentiation.   
Stellate cells and HUVECs were also printed without HLCs on day 14 to act as a 
negative control for the Promega Glo assay by providing a background CYP level.  A 
manual version of the experiment was also carried out to act as a positive control to 
identify any possible variation caused by the printing process.  
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Figure 7.20 – Average CYP level per sample for each combination of HUVECs, stellates and HLCs: a-b) 
Day 20 – a) printed; b) manual control; c-d) Day 22 – c) printed; d) manual control 
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The results, although visually appealing, did not result in a clear indication of optimal 
co-culture conditions.  There was also very little correlation between the samples or 
clear patterns on the plates and wells without stellate or endothelial cells sometimes had 
higher CYP activity than those with both supporting cells.  However, a positive result 
was that there was no contamination present and the cells appeared to be still viable. 
7.6 Conclusions 
These experiments demonstrate that the valve-based printing process is capable of 
patterning hydrogels with reasonably high resolution, even for complex and tall 
structures.  Because the volume and component ratios of each droplet in a programmed 
structure can be specified, the system is able to create specific conditions for specific 
hydrogel properties and structure resolution, and even create different mechanical 
properties at different points in the printed structures.   
The ability to print cells encapsulated in 3D hydrogel structures will allow the creation 
of more accurate human tissue models, which would be extremely useful for in vitro 
cell studies including drug development or even drug production. 
A number of different hESC lines were directed to differentiate into HLCs and the 
resulting cells were examined for the expression of a number of hepatic factors.  Line 
RC-10 was found to result in the best HLCs, being positive for nuclear factor 4 alpha 
while also secreting albumin; the morphology was also found to be similar to that of 
hepatocytes.  It was shown that cells can be printed during directed differentiation 
without interrupting the differentiation or changing the lineage of the cells.  This is 
important as it means that these cells can be patterned in 3-dimensions using the 
bioprinter while differentiating, which will greatly speed up the creation of mini-liver 
tissue structures.  The ability to print human pluripotent stem cells (both hESCs and 
hiPSCs) whilst maintaining their pluripotency or directing their differentiation into 
specific lineages will allow us to create more accurate human tissue models, which is 
essential to the in vitro drug development and toxicity-testing. Additionally, this may 
also pave the way for human stem cells to be incorporated into clinical protocols, either 
for patient implantation of in vitro regenerated organ or direct in vivo cell printing for 
tissue regeneration. 
Chapter 7 – 3D Bioprinting towards the Creation of Liver Tissue 
 
200 
Supporting cells were dispensed with HLCs in various ratios in an attempt to improve 
the function of the HLCs.  Unfortunately, there were no clear improvements in CYP 
levels, and there was little correlation between the printed and control groups.  Further 
optimisation of this experiment is clearly required. 
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Chapter 8 – 3D Bioprinting of Smart DNA-based Hydrogels 
8.1 Introduction 
Polymeric hydrogels, such as those discussed in the previous chapter, can suffer from a 
number of limitations including poorly defined structure and irreversible bonds [1–3].  
Recently, new types of hydrogel have been developed: supramolecular hydrogels, which 
are composed of low molecular weight organic compounds and water molecules, have 
self-healing properties and reversible formation due to their transient crosslinks [2–9]; 
and DNA-based hydrogels, which do not require organic solvents or harsh formation 
conditions but can be cross-linked by enzymes and self-assemble nano-structures [10–
18]. 
Hybrid hydrogels can be created by combining DNA-based hydrogels with traditional 
polymeric hydrogels.  However, most so-called DNA-hybrid hydrogels use acrylic to 
form carbon-carbon backbones which seriously limits their applications due to the non-
biodegradability of acrylic [17,19,20].  Polypeptide-based hydrogels show great 
promise due to their biocompatibility, biodegradability, easy incorporation of functional 
groups and well-defined sub-structures [21–25].  Prior to this research, no hydrogels 
have been developed that successfully combined the unique properties of DNA and 
polypeptide materials. 
Researchers at Tsinghua University have recently created a novel hybrid hydrogel with 
a broad range of programmable properties that could be used interactively with living 
cells.  This chapter contains the report of the first investigation into the polypeptide-
DNA hybrid supramolecular hydrogel that exhibits the positive attributes of both 
polypeptide and DNA components.  The rapid and gentle in situ formation of the 
hydrogel from two low viscosity components makes it suitable and attractive for use 
with 3D bioprinting platforms to produce small structures with tissue-like architectures 
containing embedded viable and functional cells.  The biocompatibility of the hydrogel, 
and its components was verified using 3D cell viability assays, verifies its suitability for 
use in tissue engineering applications [26–28]. 
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Heriot-Watt University.  The Life Science Interface Laboratory provided the cells and 
associated medium used in the following experiments, in addition to access to and the 
use of an incubator and super-resolution microscopes for the analysis of experimental 
results. 
8.3 Polypeptide-DNA Hydrogels 
The hydrogel used in this section of the research is a novel two-component polypeptide-
DNA hybrid supramolecular hydrogel.  This hydrogel can be formed in situ in seconds 
under physiological conditions by the simple mixing of two building materials 
(polypeptide-DNA conjugate and complimentary DNA linker). The mechanical 
properties of the hydrogel can be adjusted by altering the relative molar ratio of the two 
components, the length of the “sticky ends” and the environmental pH.  Experiments 
investigating responses to multiple physical and biological stimuli – such as 
temperature, salts, pH, enzymes and proteases – can be designed due to the polypeptide-
DNA hybrid structures.  The hydrogel networks can be broken down in several ways: 
the dehybridization of DNA upon heating (cooling will rehybridize the hydrogel 
networks); the digestion of DNA linker by the addition of specific DNA restriction 
enzymes; or the breakdown of the polypeptide backbone by the addition of protease.  
Due to the two-component nature of the hydrogel, it is highly applicable for tissue 
engineering applications using bioprinting techniques. 
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Figure 8.1 – Molecular structures of the polypeptide-DNA hybrid hydrogel components: a) polypeptide-
DNA conjugate and b) DNA linker   
The hybrid hydrogel can be made by mixing two components: the polypeptide-DNA 
conjugate, which is a polypeptide backbone grafted with multiple single strand DNA 
nucleotides (ssDNA) that act as “sticky ends”; and the DNA linker which is a double 
stranded DNA nucleotide (dsDNA) with two “sticky ends”, complimentary to those in 
the polypeptide-DNA conjugate.   
DNA sequences were synthesised using a DNA synthesiser (ABI 394) following the 
standard phosphoramidite DNA synthesis protocol [29,30] and purified by high-
performance liquid chromatography (HPLC).  The following items were purchased: 
restriction enzymes BamH I and EcoR I (TaKaRa Biotech Company, Dalian, China); 
endoproteinase Glu-C (Sigma-Aldrich Co. LLC).  Hydrogel structures were bioprinted 
by dispensing an array of droplets of polypeptide-DNA conjugate solution from the left 
nozzle and then overprinting droplets of DNA linker solution from the right.  After a 
few seconds, the DNA self-assembles to form a hydrogel matrix.  If adjacent droplets 
overlap they gel together and form a single contiguous layer. 
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Figure 8.2 – Schematic of the combinatorial printing process for polypeptide-DNA hydrogel creation. 
The largest challenge encountered during the research described in this chapter was the 
extremely small quantity of polypeptide-DNA conjugate and DNA linker that was 
provided by Tsinghua University.  This was due to the extremely complex and time-
consuming process of preparing the polypeptide-DNA conjugate and DNA linker 
components.  Therefore, more of the preliminary characterisation experiments were 
carried out with alginate which, at a low concentration, had similar properties to 
polypeptide-DNA hydrogel.  This led to a number of experimental variables that had to 
be reactively fine-tuned during the experimental process.   
When the polypeptide-DNA hydrogel was used, only 100 µL was available of each 
component for testing purposes; therefore, minimal volumes had to be loaded into the 
deposition systems for printing.  However, there had to be sufficient volume loaded to 
prime the system while maintaining a meniscus seal around the feeder tube between the 
valve and the cartridge throughout the entire experiment.  If the seal broke, air would 
enter the feeder tube and disrupt the size of the droplets being generated.  The solution 
to this issue was to use mineral oil as a buffer solution.  Mineral oil was loaded on top 
of the hydrogel components and, as the oil does not mix with the water-based hydrogel 
components, it remains in a layer on top [31].  This is shown in Figure 8.3 below. 
Volumes as low as 10 µL were successfully dispensed using this technique. 
 
Nozzle
Polypeptide-
DNA conjugate 
solution
DNA linker 
solution
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Figure 8.3 – a) Detailed schematic of the oil buffer setup for small volume dispensing; b) Photograph of 
the setup 
Chitosan hydrogels were also investigated in parallel with the alginate testing as a 
precursor to using DNA-based hydrogels.  Unfortunately, chitosan hydrogels take much 
longer to crosslink than alginate and DNA-based hydrogels so they did not serve as 
analogues for the DNA-based hydrogels. 
8.4 Array Printing 
In order to characterise the size of printed polypeptide-DNA hydrogel droplets, the inlet 
pressures were set to nominal values (derived experimentally) to dispense the smallest 
possible droplets.  Droplets of hydrogel are formed in situ by alternately printing 
polypeptide-DNA conjugate and DNA linker at the same point.  A simple array of 25 
droplets, with 3 mm spacing between each droplet, was designed.  The volume gradient 
was provided by increasing the number of layers in each successive column by one.  
100 µL each of polypeptide-DNA conjugate (6 wt.%) and DNA linker (2 mM) were 
loaded into separate cartridges of the bioprinter and the array was printed. 
Pressurised 
air
Bio-ink 
i.e. hydrogel 
component
Mineral 
Oil
To solenoid 
valve
a) b)
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Figure 8.4 – An array of printed Polypeptide-DNA hydrogel droplets with an increasing volume gradient 
by overprinting droplets (blue dye added for improved visibility) 
 
Figure 8.5 – A single 20 layer droplet structure printed with polypeptide-DNA hydrogel (blue dye added 
for improved visibility) 
The smallest printed hydrogel droplet measured approximately 500 µm in diameter and 
80 µm in height, equalling a volume of approximately 60 nL.  Gel formation occurred 
very rapidly (in only a few seconds), though it should be noted that this could be due to 
the small volume and lower diffusion distance of the created droplets.  Hydrogel 
droplets were created from up to 20 layered droplets.  Each was found to be 
mechanically strong, sufficient to be physically manipulated with tweezers without 
fragmenting.  It should be noted that crosslinking occurred in all three dimensions and 
the final printed structures were solid and contiguous.  This is most likely due to the 
way the hydrogel is formed in situ in a layer-by-layer approach. 
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8.4.1 Complex Structure Printing 
More complex multi-layer structures were designed, including simple geometric shapes 
and alphabetic letters; since the polypeptide-DNA hydrogel came from Tsinghua 
University, the letters “THU” were designed; “HWU”, for Heriot-Watt University, were 
also designed. 
 
Figure 8.6 – Complex polypeptide-DNA hydrogel 3D bioprinted structures with blue dye added for 
improved visibility: a-b) 5 mm equilateral triangle with 10 layers; c-d) letters  printed with 5 layers c) 
“THU” and d) “HWU” (scale bar 5 mm) 
These complex structures were printed out in a matter of minutes.  The triangular 
structure was strong enough to be physically manipulated with tweezers, but the 
structure deformed slightly under its own weight (as seen in Figure 8.6b), which 
demonstrates the strength of the hydrogel.  This result is in contrast with the alginate 
results, which did not deform when the structures were manipulated.  Additionally, the 
printed structures are optically transparent and uniform, layer boundaries are not visible 
and no other defects are in evidence.  This is most likely due to the way the hydrogel is 
formed in situ in a layer-by-layer approach.  These results demonstrate that the novel 
polypeptide-DNA hybrid hydrogel is 3D-printable and the resulting structures are 
contiguous and optically transparent. 
a) b) 
c) d) 
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8.5 Biocompatibility Testing 
Due to the novel nature of this polypeptide-DNA hydrogel, it is important to investigate 
how, if at all, cells react to it.  In order to test the biocompatibility of this 
supramolecular hydrogel, NIH-3T3 cells (murine fibroblast cell line) were co-cultured 
with each component separately.  Each component was added into the cell culture media 
in different concentrations and the 3T3 cells were cultured for 24h in an incubator at 
36.0-37.5°C, 5.0±0.5% CO2. The viability of the cells was assessed with a fluorescent 
live/dead staining assay. 
 
 
Figure 8.7 – Cell viability test of the components in the hydrogel: (a) polypeptide; (b) DNA linker 
After 24h, cell viability was measured as 99.0±0.5% over a polypeptide concentration 
range of 0-10 mg/mL and a DNA linker concentration of 0-2 mM.  This proves that the 
two components of the polypeptide-DNA hydrogel are highly biocompatible. 
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To investigate the biocompatibility of the novel polypeptide-DNA hydrogel as a whole, 
three different cell types were chosen to be cultured over a period of a day or more in a 
manually created 3D hydrogel structure.  NIH-3T3, AtT-20 and HEK-293 cell lines 
were used to analyse the biocompatibility.   
The structures were to be cultured in a 12-well tissue culture plate and a special 
substrate was prepared for this experiment to ensure that the samples could be imaged 
as easily as possible.  Glass coverslips, which fit perfectly within the wells of the culture 
plate and are optically transparent, were chosen as the base for the substrate.  In order to 
prevent the hydrogel structures from coming off the surface of the coverslip during 
removal from the culture plate for imaging, Polydimethylsiloxane (PDMS) rings were 
created measuring 12 mm in external diameter, 4mm in internal diameter and 3 mm in 
height.  These were mounted centrally on 25 mm glass coverslips.  These substrates 
ensured optical transparency in the viewing axis whilst maintaining the structures 
position in the centre of the coverslip, and were an appropriate size for culturing the 
structures in the wells of 12-well tissue culture plates.  
 
Figure 8.8 – 3D rendering of the modified coverslip substrates with PDMS boundary rings 
In a typical experiment, cells were mixed with polypeptide-DNA conjugate into which 
an appropriate amount of DNA linker solution was added.  Hydrogel formation was 
induced by gently stirring the mixture and culture medium was added, covering the 
hydrogel structure, to provide nutrients for the cells.  The hydrogel structures were 
cultured in an incubator at 36.0-37.5°C, 5.0±0.5% CO2 for 24 hours, after which the 
culture media was removed and the encapsulated cells were stained with fluorescein 
diacetate/propidium iodide (FDA/PI) and cultured for 30 minutes.  They were then 
imaged with a confocal laser-scanning microscope (CLSM) (SP5 SMD gated-STED, 
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Leica) and the cell viability was measured using a fluorescent live/dead assay.  Multiple 
samples were created for testing over the period of several days. 
 
Figure 8.9 – Fluorescence microscopy images of 3D polypeptide-DNA hydrogel structures with different 
cell types and time points and FDA staining in green: a) A 3-D stack of NIH-3T3 cells imaged after 24 h; 
b) AtT-20 cells imaged after 48 h; c) HEK-293 cells imaged after 48h (gridlines are 50 µm) 
As shown in Figure 8.9a, the viability assays detected no dead NIH-3T3 cells after 24 
hours.  The viabilities of AtT-20 and HEK-293 cells after 48 hours was measured as 
99.1 ± 1.7% and 99.3 ± 1.4%, respectively.  After 96 hours of 3D culture the viability 
was still high at 95.8 ± 5.9%; this demonstrates that the polypeptide-DNA hydrogels 
have good biocompatibility and are permeable to nutrients for long-term culture, 
a)
b)
c)
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meaning that they would be suitable for use in 3D cell culture and tissue engineering 
applications. 
8.6 3D Printed Cell-laden Hydrogel 
Next, the viability of bioprinted cells encapsulated within 3D structures printed from 
polypeptide-DNA hydrogel was investigated.  20 μL of AtT-20 (a murine pituitary 
epithelial-like tumour cell line) cells at a concentration of 1 × 10
7 
cells/mL was added to 
100 µL of the polypeptide-DNA conjugate component (6 wt.%) which was loaded into 
one cartridge of the bioprinter.  120 µL of DNA linker (2mM) was loaded into another 
cartridge.   
A simple cylindrical pattern was programmed and hydrogel components with cells were 
printed into the modified coverslip substrates described previously.  Half of the printed 
samples were stained with 40 µg/mL Fluorescein diacetate (FDA) and 10 µg/mL of 
propidium iodide (PI) in serum-free DMEM and cultured in an incubator at 36.0-
37.5°C, 5.0±0.5% CO2 for 30 minutes.  Images were recorded using a confocal laser-
scanning microscope (CLSM) (SP5 SMD gated-STED, Leica) and the cell viability was 
measured using a fluorescent live/dead assay.  10 nM of Lysotracker-Red was added to 
the remaining samples which were cultured in the same manner as the previous samples 
before 3D image stacks were recorded using an inverted total internal reflection 
fluorescence microscope (TIRF) (IX81, Olympus).   
 
Figure 8.10 – Fluorescence microscopy images of AtT-20 cells bioprinted in polypeptide-DNA hydrogel: 
a) A 3D stack of AtT-20 cells printed in hydrogel, with FDA staining in green (gridlines are 50 µm); b) A 
higher magnification 3D stack of AtT-20 cells printed in hydrogel and stained with Lysotracker-Red 
(gridlines are 5 µm) 
a) b)
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The live/dead assay reported a 3D bioprinted viability of 98.8±1.4%, which is extremely 
high.  It should be noted that AtT-20 is a tumour cell line, so is far more resilient than 
more fragile cell lines such as hESCs.  By increasing the magnification, single cells 
could be observed (Figure 8.10b). 
 
Figure 8.11 – Vesicles tracked in AtT-20 cells bioprinted in polypeptide-DNA hydrogel: a) Wide-field 
microscopy images of AtT-20 cells printed in hydrogel and stained with Lysotracker-Red, a cross section 
of the cells shows intracellular organelles (scale bar 1 µm); b) Organelle trajectory traces from inside 
the cell in a) – the organelles are shown as red spheres and paths as coloured lines (colour represents 
time in seconds, gridlines are 1 µm) 
By further increasing the magnification of the microscope, it was possible to observe 
the intracellular organelles (including lysosomes and large, dense-cored vesicles) within 
the cytosol of a single AtT-20 cell suspended in 3D within the printed polypeptide-DNA 
structure (Figure 8.11a).  A four-dimensional image stack of this single cell was 
recorded and the intracellular organelles were tracked over time (Figure 8.11b); by 
analysing the motion paths, it was determined that the analysed AtT-20 cells suspended 
in 3D within the printed polypeptide-DNA structure were viable, had normal 
morphology in 3D, and were capable of performing cellular functions such as proton 
pump activity, metabolic turnover and membrane trafficking [32]. 
8.7 Conclusions 
This research contains the first study of a novel polypeptide-DNA hybrid 
supramolecular hydrogel which possesses a wide range of controllable and tuneable 
mechanical properties, including an analysis of its suitability for use in a 3D cell 
bioprinting process.  Several 3D structures were successfully bioprinted, all of which 
demonstrated the ability of the hydrogel to maintain its shape after printing.  The 
biocompatibility of the novel supramolecular hydrogel was verified for both 
b)a)
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components, separately and in gel form, and the viability of 3D encapsulated cells is 
very high.  3D cell-encapsulating hydrogel structures were created using the bioprinter 
and the cells were found to be highly viable, functional and morphologically normal.  
This novel hydrogel addresses several limitations in current 3D hydrogel cell culturing 
technology and will undoubtedly have important applications in tissue engineering.  
However, the synthesis methodologies require some improvement in order to enable 
larger scale manufacturing of the hydrogel components prior to more in-depth 
experiments. 
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Chapter 9 – Summary of the Conclusions and Recommendations for 
Future Work 
9.1 Research Assessment 
The initial aim of this research was to develop a novel mechanical device that could 
quickly and reliably position viable biological cells into pre-determined patterns and 
locations onto a heterogeneous substrate; regardless of cell type printed, all cells must 
be viable.  As research advanced, it became increasingly apparent that the technology 
could be applied to a much broader range of applications beyond initial simple 2D 
patterning.  Although the valve-based bioprinting platform was successfully developed, 
its development could have been greatly sped up if the base machine for the Mark I had 
been a 3D printer rather than a CNC machine which required the introduction of several 
complex workarounds to make operational.  One of the main goals was to investigate 
the response of cells to the bioprinting process, with particular emphasis on viability.  
Primary cell compatibility testing was performed with HEK 293 cells, but because this 
line is experimentally transformed, they are not a particularly good model for normal 
cells.  The world’s first investigation into the responses of both hESCs and hiPSCs to 
the bioprinting process was successfully undertaken, with validation of pluripotency 
maintenance post-printing.  Other goals involved the continued improvement and 
development of the bioprinting platform, incorporation of multiple bio-ink printing, and 
validation and characterisation of the printer’s capabilities.  To this end, experiments 
were carried out to explore the possibilities enabled by this technology. 
9.2 Conclusions Summary 
The overall aim of this thesis was to develop a novel mechanical device that can quickly 
and reliably position viable biological cells and other liquid materials into pre-
determined three-dimensional patterns – a cell printer.  This objective has been 
successfully achieved and the key findings are summarised below with images to 
illustrate each one: 
 A novel multi-nozzle valve-based bioprinting platform was developed and 
software was written to control it, including a graphical user interface.  The 
bioprinter was able to position droplets of bio-ink (down to single nanolitres in 
volume) with high spatial accuracy in three-dimensions; furthermore, the system 
was sterilisable and had high throughput. 
Chapter 9 – Summary of the Conclusions and Recommendations for Future Work 
 
220 
 
Figure 9.1 – Pictorial summary of the bioprinter development carried out 
 Human pluripotent stem cells (hESCs and hiPSCs) were shown to retain high 
viability and pluripotency post-printing, confirming that the novel bioprinting 
platform is compatible with cell transfer and gentle enough to not affect the cells 
or trigger differentiation.  This was the first investigation of this kind and will 
enable the use of hPSCs in more complex tissue (re)generation applications. 
 
Figure 9.2 – Pictorial summary of the hPSC research carried out  
 Spheroid aggregates of uniform, controllable and reproducible sizes were 
created from human embryonic stem cells using a bioprinted-hanging droplet 
hybrid technique.   Due to the programmable sizes of the spheroids, this 
technique could be used to direct the differentiation of hPSCs along specific 
lineages or to speed up tissue (re)generation, using the spheroids as primary 
building blocks. 
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Figure 9.3 – Pictorial summary of the spheroid aggregate research carried out 
 Complex three-dimensional structures were bioprinted using two-component 
hydrogels with reasonably high resolution, even for complex and tall structures.  
The properties of the hydrogel can be modified by altering the ratio and 
concentration of the two components; therefore, structures with programmable 
heterogeneous properties throughout the structure can be created. 
 
Figure 9.4 – Pictorial summary of the hydrogel research carried out 
 Cells were suspended within hydrogel components and successfully printed into 
three-dimensional structures encapsulating cells; the cells were found to be 
highly viable, functional and morphologically normal. 
 
Figure 9.5 – Pictorial summary of the cell-laden hydrogel research carried out 
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 Human pluripotent stem cells (hESCs and hiPSCs) were successfully directed to 
differentiate into hepatocyte-like cells which were positive for a number of 
hepatic markers, including HNF4α and Albumin, and had similar morphology to 
hepatocytes.  It was shown that cells can be printed during directed 
differentiation without interrupting the differentiation or changing the lineage of 
the cells.  This is an important result as it means that these cells can be patterned 
in 3-dimensions using the bioprinter while differentiating which will greatly 
speed up the creation of mini-liver tissue structures. 
 
Figure 9.6 – Pictorial summary of the HLC research carried out 
9.3 Future Work Recommendations 
With regard to the possibility of continuing this line of research, the following 
recommendations are provided: 
 Based on the feedback received from the biologists that have used the 
bioprinters, the main problem with the machine is that it is not very user-
friendly; there are a number of possible upgrades to the bioprinting platform 
itself that could help improve the machine, including a more streamlined 
interface and self-cleaning abilities.  The interface could be improved by re-
ordering the menu items to bring more frequent routines to the top and lesser-
used functions to sub-menus.  Self-cleaning could be achieved by adding 
machine-interchangeable bio-ink cartridges.  Another issue was that although the 
machine fits within a standard tissue culture hood, it takes up most of the space, 
leaving little space for bio-ink preparation.  This could be solved by decreasing 
the size of the machine by removing dead space within the machine and scaling 
down some components. 
 The development of the software for creating programs for the bioprinter to run 
has not kept up with the development of the bioprinting platform.  The most 
Hepatocyte-Like Cells 
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recent software is adequate for generating programs defining simple two-
dimensional patterns and populating multi-well plates, but further software 
development is required for the generation of programs defining complex three-
dimensional structures. 
 Each time a new material is used in the bioprinter it must be characterised to 
determine the optimum and boundary settings for its use, which is time 
consuming and requires a lot of material.  By carrying out more in-depth 
analysis and simulation of the bioprinting system, it might be possible to 
automatically determine the correct settings for new materials, as opposed to the 
current trial and error approach. 
 By combining together the work on 3D bioprinting of cell-laden hydrogels with 
the research printing HLCs and supporting cells, it should be possible to bioprint 
3D liver micro-tissues that replicate the response and functions of a human liver 
but on a much smaller scale.  Such micro-tissues could be used to improve the 
efficiency of novel drug testing, or they could alternatively be implanted into a 
patient with a damaged liver. 
 Besides the liver, there are many other types of cells and tissues that could be 
created and studied using this bioprinting platform.  Controllable and repeatable 
creation of pancreatic islets has obvious applications in the treatment of diabetes.  
Cardiac patches could be printed for implantation to repair damage or defects in 
heart tissue.  There is no limit to potential applications for this technology. 
 The next logical step for the portable bioprinting system would be the 
development of an in vivo bioprinter to create structures or repair damage in situ.  
Such a system should be as small and simple as possible to facilitate mounting to 
an existing laparoscopic probe. 
 
